
<html lang="en"     class="pb-page"  data-request-id="071786da-ea73-4b89-8819-02e94f45e3f5"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2012.55.issue-22;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm3008536"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Novel Tetrahydropyrido[1,2-a]isoindolone Derivatives (Valmerins): Potent Cyclin-Dependent Kinase/Glycogen Synthase Kinase 3 Inhibitors with Antiproliferative Activities and Antitumor Effects in Human Tumor Xenografts" /></meta><meta name="dc.Creator" content="Rajâa  Boulahjar" /></meta><meta name="dc.Creator" content="Aziz  Ouach" /></meta><meta name="dc.Creator" content="Chiurato  Matteo" /></meta><meta name="dc.Creator" content="Stephane  Bourg" /></meta><meta name="dc.Creator" content="Myriam  Ravache" /></meta><meta name="dc.Creator" content="Rémy le  Guével" /></meta><meta name="dc.Creator" content="Séverine  Marionneau" /></meta><meta name="dc.Creator" content="Thibauld  Oullier" /></meta><meta name="dc.Creator" content="Olivier  Lozach" /></meta><meta name="dc.Creator" content="Laurent  Meijer" /></meta><meta name="dc.Creator" content="Christiane  Guguen-Guillouzo" /></meta><meta name="dc.Creator" content="Saïd  Lazar" /></meta><meta name="dc.Creator" content="Mohamed  Akssira" /></meta><meta name="dc.Creator" content="Yves  Troin" /></meta><meta name="dc.Creator" content="Gérald  Guillaumet" /></meta><meta name="dc.Creator" content="Sylvain  Routier" /></meta><meta name="dc.Description" content="The development of CDK and GSK3 inhibitors has been regarded as a potential therapeutic approach, and a substantial number of diverse structures have been reported to inhibit CDKs and GSK-3β in rec..." /></meta><meta name="Description" content="The development of CDK and GSK3 inhibitors has been regarded as a potential therapeutic approach, and a substantial number of diverse structures have been reported to inhibit CDKs and GSK-3β in rec..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 1, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm3008536" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm3008536" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm3008536" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm3008536" /></link>
        
    
    

<title>Novel Tetrahydropyrido[1,2-a]isoindolone Derivatives (Valmerins): Potent Cyclin-Dependent Kinase/Glycogen Synthase Kinase 3 Inhibitors with Antiproliferative Activities and Antitumor Effects in Human Tumor Xenografts | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm3008536" /></meta><meta property="og:title" content="Novel Tetrahydropyrido[1,2-a]isoindolone Derivatives (Valmerins): Potent Cyclin-Dependent Kinase/Glycogen Synthase Kinase 3 Inhibitors with Antiproliferative Activities and Antitumor Effects in Human Tumor Xenografts" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0020.jpeg" /></meta><meta property="og:description" content="The development of CDK and GSK3 inhibitors has been regarded as a potential therapeutic approach, and a substantial number of diverse structures have been reported to inhibit CDKs and GSK-3β in recent years. Only a few molecules have gone through or are currently undergoing clinical trials as CDK and GSK inhibitors. In this paper, we prepared valmerins, a new family containing the tetrahydropyrido[1,2-a]isoindone core. The fused heterocycle was prepared with a straightforward synthesis that was functionalized by a (het)arylurea. Twelve valmerins inhibited the CDK5 and GSK3 with an IC50 &lt; 100 nM. A semiquantitative kinase scoring was realized, and a cellular screening was done. At the end of our study, we investigated the in vivo potency of one valmerin. Mice exhibited good tolerance to our lead, which proved its efficacy and clearly blocked tumor growth. Valmerins appear also as good candidates for further development as anticancer agents." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm3008536"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm3008536">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm3008536&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm3008536&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm3008536&amp;href=/doi/10.1021/jm3008536" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 9589-9606</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm300845v" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm300860j" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Tetrahydropyrido[1,2-<i>a</i>]isoindolone Derivatives (Valmerins): Potent Cyclin-Dependent Kinase/Glycogen Synthase Kinase 3 Inhibitors with Antiproliferative Activities and Antitumor Effects in Human Tumor Xenografts</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Raj%C3%A2a++Boulahjar">Rajâa Boulahjar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aziz++Ouach">Aziz Ouach</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chiurato++Matteo">Chiurato Matteo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephane++Bourg">Stephane Bourg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Myriam++Ravache">Myriam Ravache</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=R%C3%A9my+le++Gu%C3%A9vel">Rémy le Guével</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=S%C3%A9verine++Marionneau">Séverine Marionneau</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thibauld++Oullier">Thibauld Oullier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Olivier++Lozach">Olivier Lozach</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laurent++Meijer">Laurent Meijer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christiane++Guguen-Guillouzo">Christiane Guguen-Guillouzo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sa%C3%AFd++Lazar">Saïd Lazar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mohamed++Akssira">Mohamed Akssira</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yves++Troin">Yves Troin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>±</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=G%C3%A9rald++Guillaumet">Gérald Guillaumet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sylvain++Routier">Sylvain Routier</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Institut de Chimie Organique et Analytique, Université d’Orléans, UMR CNRS 7311, rue de Chartres, BP 6759, 45067 Orléans Cedex 2, France</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Laboratoire de Chimie, Bioorganique et Analytique, URAC 22 pôle Répam, Université Hassan II Mohammedia-Casablanca, BP 146, 28800 Mohammedia, Morocco</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">CNRS, “Protein Phosphorylation & Human Disease” group, USR3151, Station Biologique, B.P. 74, 29682 Roscoff Cedex, France</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">ManRos Therapeutics, Centre de Perharidy, 29680 Roscoff, France</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Plateforme ImPACcell-SFR BIOSIT UMS-CNRS3480 UMS-INSERM018, Université de Rennes 1, 35043 Rennes Cedex, France.</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">In vivo Platform, Cancéropôle Grand Ouest, 63 quai Magellan, 44000 Nantes, France</span></div><div class="aff-info" id="aff7"><span class="aff-symbol">±</span> <span class="aff-text">Clermont Université, ENSCCF, Laboratoire de Chimie des Hétérocycles et des Glucides, BP 10448, 63000 Clermont-Ferrand, France</span></div><div class="corresp-info"><strong>*</strong>Tel: 33 238 494 853. Fax: 33 238 417 281. E-mail: <a href="/cdn-cgi/l/email-protection#6c1f15001a0d0502421e03191805091e2c1902051a41031e00090d021f420a1e"><span class="__cf_email__" data-cfemail="c0b3b9acb6a1a9aeeeb2afb5b4a9a5b280b5aea9b6edafb2aca5a1aeb3eea6b2">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm3008536&amp;href=/doi/10.1021%2Fjm3008536" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 9589–9606</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 19, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 June 2012</li><li><span class="item_label"><b>Published</b> online</span>1 November 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 November 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm3008536" title="DOI URL">https://doi.org/10.1021/jm3008536</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9589%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRaj%25C3%25A2a%2BBoulahjar%252C%2BAziz%2BOuach%252C%2BChiurato%2BMatteo%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D22%26contentID%3Djm3008536%26title%3DNovel%2BTetrahydropyrido%255B1%252C2-a%255Disoindolone%2BDerivatives%2B%2528Valmerins%2529%253A%2BPotent%2BCyclin-Dependent%2BKinase%252FGlycogen%2BSynthase%2BKinase%2B3%2BInhibitors%2Bwith%2BAntiproliferative%2BActivities%2Band%2BAntitumor%2BEffects%2Bin%2BHuman%2BTumor%2BXenografts%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9606%26publicationDate%3DNovember%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm3008536"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2889</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">36</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm3008536" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Tetrahydropyrido[1,2-a]isoindolone Derivatives (Valmerins): Potent Cyclin-Dependent Kinase/Glycogen Synthase Kinase 3 Inhibitors with Antiproliferative Activities and Antitumor Effects in Human Tumor Xenografts&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Rajâa&quot;,&quot;last_name&quot;:&quot;Boulahjar&quot;},{&quot;first_name&quot;:&quot;Aziz&quot;,&quot;last_name&quot;:&quot;Ouach&quot;},{&quot;first_name&quot;:&quot;Chiurato&quot;,&quot;last_name&quot;:&quot;Matteo&quot;},{&quot;first_name&quot;:&quot;Stephane&quot;,&quot;last_name&quot;:&quot;Bourg&quot;},{&quot;first_name&quot;:&quot;Myriam&quot;,&quot;last_name&quot;:&quot;Ravache&quot;},{&quot;first_name&quot;:&quot;Rémy&quot;,&quot;last_name&quot;:&quot;le Guével&quot;},{&quot;first_name&quot;:&quot;Séverine&quot;,&quot;last_name&quot;:&quot;Marionneau&quot;},{&quot;first_name&quot;:&quot;Thibauld&quot;,&quot;last_name&quot;:&quot;Oullier&quot;},{&quot;first_name&quot;:&quot;Olivier&quot;,&quot;last_name&quot;:&quot;Lozach&quot;},{&quot;first_name&quot;:&quot;Laurent&quot;,&quot;last_name&quot;:&quot;Meijer&quot;},{&quot;first_name&quot;:&quot;Christiane&quot;,&quot;last_name&quot;:&quot;Guguen-Guillouzo&quot;},{&quot;first_name&quot;:&quot;Saïd&quot;,&quot;last_name&quot;:&quot;Lazar&quot;},{&quot;first_name&quot;:&quot;Mohamed&quot;,&quot;last_name&quot;:&quot;Akssira&quot;},{&quot;first_name&quot;:&quot;Yves&quot;,&quot;last_name&quot;:&quot;Troin&quot;},{&quot;first_name&quot;:&quot;Gérald&quot;,&quot;last_name&quot;:&quot;Guillaumet&quot;},{&quot;first_name&quot;:&quot;Sylvain&quot;,&quot;last_name&quot;:&quot;Routier&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;01&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;9589-9606&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm3008536&quot;},&quot;abstract&quot;:&quot;The development of CDK and GSK3 inhibitors has been regarded as a potential therapeutic approach, and a substantial number of diverse structures have been reported to inhibit CDKs and GSK-3β in recent years. Only a few molecules have gone through or are currently undergoing clinical trials as CDK and GSK inhibitors. In this paper, we prepared valmerins, a new family containing the tetrahydropyrido[1,2-a]isoindone core. The fused heterocycle was prepared with a straightforward synthesis that was functionalized by a (het)arylurea. Twelve valmerins inhibited the CDK5 and GSK3 with an IC50 &lt; 100 nM. A semiquantitative kinase scoring was realized, and a cellular screening was done. At the end of our study, we investigated the in vivo potency of one valmerin. Mice exhibited good tolerance to our lead, which proved its efficacy and clearly blocked tumor growth. Valmerins appear also as good candidates for further development as anticancer agents.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3008536&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3008536" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3008536&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3008536" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3008536&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3008536" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm3008536&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3008536&amp;href=/doi/10.1021/jm3008536" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm3008536" /></input><a href="/doi/pdf/10.1021/jm3008536" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm3008536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm3008536%26sid%3Dliteratum%253Aachs%26pmid%3D23083119%26genre%3Darticle%26aulast%3DBoulahjar%26date%3D2012%26atitle%3DNovel%2BTetrahydropyrido%255B1%252C2-a%255Disoindolone%2BDerivatives%2B%2528Valmerins%2529%253A%2BPotent%2BCyclin-Dependent%2BKinase%252FGlycogen%2BSynthase%2BKinase%2B3%2BInhibitors%2Bwith%2BAntiproliferative%2BActivities%2Band%2BAntitumor%2BEffects%2Bin%2BHuman%2BTumor%2BXenografts%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D22%26spage%3D9589%26epage%3D9606%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292271" title="Urea">Urea</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jmcmar.2012.55.issue-22/production/jmcmar.2012.55.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008536&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The development of CDK and GSK3 inhibitors has been regarded as a potential therapeutic approach, and a substantial number of diverse structures have been reported to inhibit CDKs and GSK-3β in recent years. Only a few molecules have gone through or are currently undergoing clinical trials as CDK and GSK inhibitors. In this paper, we prepared valmerins, a new family containing the tetrahydropyrido[1,2-<i>a</i>]isoindone core. The fused heterocycle was prepared with a straightforward synthesis that was functionalized by a (het)arylurea. Twelve valmerins inhibited the CDK5 and GSK3 with an IC<sub>50</sub> < 100 nM. A semiquantitative kinase scoring was realized, and a cellular screening was done. At the end of our study, we investigated the in vivo potency of one valmerin. Mice exhibited good tolerance to our lead, which proved its efficacy and clearly blocked tumor growth. Valmerins appear also as good candidates for further development as anticancer agents.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10825" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10825" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Abnormal protein phosphorylation is frequently involved in the development of various human pathogeneses. Among the 518 human genes encoding protein kinases, cyclin-dependent protein kinases (CDKs) and glycogen synthase kinase-3 (GSK3), two serine/threonine kinases, have attracted considerable attention because of their frequent deregulation in major pathologies. CDKs are located in the nucleus and participate mainly in processes of cell cycle control, transcription, and post-transcriptional modifications but also in cell differentiation and cancer cell death.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Consequently, many pharmacological inhibitors of CDKs have been found to display promising antitumor and/or neuroprotective activities. Although a few kinase inhibitors display a definite specificity profile, many of them are rather unselective and inhibit several kinases such as GSK3. This enzyme, which is encoded by two independent genes, -α and -β, is interestingly involved in a broad range of biological processes such as stem-cell renewal, the cell-division cycle, differentiation, apoptosis, circadian rhythm, transcription, and insulin action, and its deregulation has been associated with many diseases, such as metabolic disorders, CNS diseases, and cancer.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a></div><div class="NLM_p">The development of CDK and GSK3 inhibitors has been regarded as a potential therapeutic approach and a substantial number of diverse structures have been reported to inhibit CDKs and GSK-3β in recent years. Only a few molecules have gone through or are currently undergoing clinical trials. Flavopiridol (Alvocidib) and its analogues P276-00, (<i>R</i>)-roscovitine (Seliciclib), R547, SNS-032, PD-0332991 (CDK4 and -6 selectivity), AZD5438, AG-024322, and AT7519 are representative examples (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12">(5-12)</a> Most of them target multiple CDKs and are applied in the treatment of leukemia, melanoma and solid tumors. Only nine GSK3β inhibitors are in development, while the bis(indolylmaleimide) derivative named enzastaurin (LY317615, phase II) is appropriate for brain cancer.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Some representative CDK and GSK3 inhibitors in clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008536&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the search for heterocyclic skeletons that could be used to design new protein kinase inhibitors, we first developed novel indolocarbazole analogues and published original anticancer series possessing strong cell effects and exhibiting kinase inhibition.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Some of them have entered clinical trials. More recently, we reported an original synthesis leading to het(aryl)indolizinones <b>A</b> via an (acyl)iminium intermediate (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Thus, we envisioned the use of our optimized synthetic pathway leading to tetrahydropyrido[1,2-<i>a</i>]isoindolone <b>B</b> as the central core for new CDK inhibitors. To establish our SAR studies, we will start from the work of Honma et al. which described new bis(het)aryl ureas <b>C</b> and <b>D</b> to optimize their selective CDK4 inhibitors.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008536&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Our chemical investigations indicated that the derivatives <b>A</b> are readily available by condensation of a β-formylbenzoic acid with a primary amine (i.e., 2-(2-methyl-1,3-dioxolan-2-yl)ethanamine)<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a>or from a β-hydroxylactam under intramolecular cyclization. In our opinion, synthesis of the valmerins<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (i.e., tetrahydropyrido[1,2-<i>a</i>]isoindolone(hetaryl)ureas) <b>E</b> will also be achieved using as a key step the intramolecular cyclization of the β<i>-</i>hydroxylactam <b>4</b> which is readily accessible from the nitrophthalimide <b>1</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Retrosynthetic Scheme</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008536&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">A complete SAR study was carried out using various urea residues on <b>E</b> (alkyls, aryls, and heteroaryls) to afford a very interesting library exhibiting highly potent CDK/GSK3 inhibitors.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The best final derivatives were next evaluated against seven cancer cell lines, and, after selection we used our leader for in vivo evaluations on xenograft mice. The results, from synthesis to a full biological evaluation, are also described in this paper.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41346" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41346" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Only a few studies are related to the synthesis of the targeted tetrahydropyrido[1,2-<i>a</i>]isoindolone core.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> In our work, we envisioned that the attempted scaffold <b>E</b> could be produced from the commercially available 3-nitrophthalimide <b>1</b> after a four-step sequence.</div><div class="NLM_p">A Michael addition was first carried out with <b>1</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) and the methyl vinyl ketone in the presence of a catalytic amount of Triton B. After 12 h, the ketone <b>2</b> (85%) was isolated and then protected by treatment with ethylene glycol in refluxing toluene to afford the cyclic ketal <b>3</b> in 89% yield. A regioselective reduction of the maleimide group was carried out at low temperature with an excess of NaBH<sub>4</sub> in only a few minutes. The choice of the solvent and the strict control of temperature are important experimental criteria to obtain the desired selectivity. Formation of the other regioisomer was never observed in these conditions. The cyclization of the hydroxylactam <b>4</b> was promoted using PTSA hydrate at toluene reflux and led to the tetrahydropyrido[1,2-<i>a</i>]isoindolone core after a few hours in an acceptable 73% yield. The change in the amount of PTSA or the use of another acidic source (i.e., BF<sub>3</sub>·Et<sub>2</sub>O, HCl, or CSA) led only to lower yields.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008536&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Key: (i) methyl vinyl ketone (1.2 equiv), Triton B (cat.), EtOAc, reflux, 12 h, 85%; (ii) ethylene glycol (2.0 equiv), PTSA·H<sub>2</sub>O (cat.), toluene, Dean–Stark, reflux, 12 h, 89%; (iii) NaBH<sub>4</sub> (3.0 equiv), THF/MeOH (1/2), −20 °C, 15 min, 76% ; (iv) PTSA·H<sub>2</sub>O (0.5 equiv), toluene, Dean–Stark, reflux, 6 h, 73%; (v) HCl 10%, acetone, reflux, 3 h, 90%; (vi) Pd/C (10%), H<sub>2</sub> P<sub>atm</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h, 88%; (vii) NH<sub>2</sub>–NH<sub>2</sub>·H<sub>2</sub>O (4.0 equiv), Na (3.0 equiv), ethylene glycol, reflux, 4 h, 86%.</p></p></figure><div class="NLM_p">Once the cycloadduct <b>5</b> had been obtained, the ketone protection was removed using an aqueous hydrochloride solution in refluxing acetone in 90% yield. The selective reduction of the nitro group of <b>6</b> was successfully accomplished using hydrogenolysis at room temperature in CH<sub>2</sub>Cl<sub>2</sub>. This method led to the aniline <b>7</b> in 88% yield. Finally, we carried out a modified Wolff–Kishner reaction with hydrazine and sodium in refluxing ethylene glycol which furnished the key amine <b>8</b> in 86% yield.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Direct conversion of <b>6</b> into <b>8</b> under hydrogen pressure at high temperature failed. Ketone could be reduced prior to the nitro group, but lower yields decrease the interest of this route.</div><div class="NLM_p">Starting from <b>8</b>, classical urea formation involving triphosgene or <i>p</i>-nitrophenyl carbamate methods gave disappointing results, the low reactivity of the amine leading only to complex mixtures. We therefore focused our efforts on Curtius rearrangements. Starting from highly available acids in aliphatic, aromatic, and heteroaromatic series, the isocyanides were first generated in situ and immediately scavenged by our prebuilt amine <b>8</b>. This very attractive “one-pot” general procedure (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) was applied to several acids <b>F</b> to furnish the attempted valmerin ureas <b>E</b>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008536&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Key: (i) (a) Et<sub>3</sub>N (1.3 equiv), −10 °C, THF, 5 min, (b) ClCO<sub>2</sub>Et (1.5 equiv), −10 °C, THF, 2 h, (c) NaN<sub>3</sub> (1.7 equiv), −10 °C, H<sub>2</sub>O, 1 h, (d) toluene, reflux, 1 h; (ii) <b>8</b>, toluene, reflux, 24 h, valmerins <b>13</b>–<b>40</b>, 42–90% yields.</p></p></figure><div class="NLM_p">To provide the dissymmetrical urea library, we used 23 commercially available acids reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. Others are readily available after some chemical transformations (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).<a onclick="showRef(event, 'ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25">(23-25)</a> To prepare the MOM-protected pyridine and quinoleine derivatives <b>9</b>–<b>12</b>, we started from the corresponding hydroxy acids which were first transformed into methyl esters prior to conducting MOM protection. At the end of the sequence, a simple saponification led to the expected compounds. Overall yields of the three-step syntheses were in the 70–77% yield range.</div><div class="NLM_p">Finally, the isocyanates corresponding to 27 carboxylic acids were formed and quenched in situ by amine <b>8</b> to afford the ureas <b>13</b>–<b>39</b>. Products were isolated in 42–90% yields, which mainly depended on the nature and solubility of carboxylic acids.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008536&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Key: (i) (a) MeOH, SOCl<sub>2</sub> (1.5 equiv), 60 °C, 16 h, (b) K<sub>2</sub>CO<sub>3</sub> (2.0 equiv), MOMCl (1.5 equiv), acetone, reflux, 16 h, (c) NaOH (1.2 equiv), THF/H<sub>2</sub>O (1/1), rt, 2 h, <b>9</b> 75%, <b>10</b> 77%, <b>11</b> 70%, <b>12</b> 72%.</p></p></figure><div class="NLM_p">The sole limitation we found concerned the use of 1<i>H</i>-pyrazole-3-carboxylic acid, which led via Curtius rearrangement and in situ condensation with the amine <b>8</b> to valmerin <b>40</b> in a very poor 4% yield (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>).</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008536&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Key: (i) and (ii) see also Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, <b>40</b> 4%; (iii) BTC (1.0 equiv), Et<sub>3</sub>N (2.0 equiv), CH<sub>2</sub>Cl<sub>2</sub>, reflux, 5 h; (iv) <i>N</i>-1-Boc-3-aminopyrazole (1.0 equiv), CH<sub>2</sub>Cl<sub>2</sub>/pyridine 9/1, rt, 16 h, 56%; (v) aq NaOH (1 M)/THF 1/2, rt, 24 h, 66%; (vi) aq HCl 10%, acetone, reflux, 2 h, <b>42</b> 90%, <b>43</b> 92%, <b>44</b> 92%, <b>45</b> 95%.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Synthesis of Valmerins <b>E</b> from Acids <b>F</b> via Curtius Rearrangement</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0013.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Yields are indicated in isolated products.</p></div></div><div></div></div><div class="NLM_p last">Alternatively, we condensed in situ the <i>N-</i>1-Boc-3-aminopyrazole<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and the isocyanate of <b>8</b> which was quantitatively formed using BTC in the presence of Et<sub>3</sub>N. After 16 h, the attempted urea <b>41</b> was isolated in 56% yield. Boc deprotection was carried out in basic media to furnish <b>40</b> at room temperature in a satisfying 66% yield. The MOM protective groups of <b>36</b>–<b>39</b> were next removed under classical media to afford the final derivatives <b>42</b>–<b>45</b> in high yields.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32114" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32114" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Kinase Assays</h3><div class="NLM_p">First we tested our valmerin library against several representative kinases in order to determine the influence of urea R residues (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) on kinase inhibition (CDK5/p25, GSK3α/β, and DYRK1A). With an alkyl and phenyl group, the valmerins <b>13</b> and <b>14</b> are inactive (entries 1 and 2) on all three kinases. All other compounds exhibited a kinase inhibitory effect, and structural modifications led to a modulation in their activity.</div><div class="NLM_p">The structural key that allows interaction with the kinase active site is the presence of a nitrogen atom on the aromatic ring in position 2. Compound <b>15</b> (entry 3) inhibited CDK5 at IC<sub>50</sub> = 80 nM. This result confirms the crucial role of the pyridine nitrogen atom in position 2,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> which could be explained by the formation of an intramolecular hydrogen bond between the pyridinic nitrogen atom and a labile urea hydrogen atom. The resulting rigidity and withdrawal of the valmerins led to a maximal occupation of the ATP pocket.</div><div class="NLM_p">Adding a second electron-rich and basic nitrogen atom to the heteroaromatic residue of urea maintained this effect, and the activity of pyrazine <b>16</b> increased to 70 nM for each kinase, but this strategy is worthwhile only for the 5 position. Displacement of the second nitrogen (i) from position 4 to 5 (for number assignment see general formula table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) led to the quite inactive pyrimidine compound <b>34</b> and (ii) from position 4 to 3 a micromolar active derivative <b>35</b> (entries 22 and 23) was obtained.</div><div class="NLM_p">A contraction ring prompted us to use the thiazole, pyrazole, and oxazole heterocycles, but each synthesized valmerin showed a lack of activity (entries 7–13). Submicromolar active compounds are the less substituted <b>28</b>, <b>30</b>, and <b>33</b>. Interestingly, the more basic pyrazole containing product <b>40</b> led to the best activity, but a simple methylation increased the IC<sub>50</sub> by a factor of 5 (entry 10 vs 11), therefore decreasing the interest of this substitution.</div><div class="NLM_p">The last modification we tried was the use of fused bicyclic heterocycles. Benzothiazole <b>32</b> was poorly active, but fortunately, the isoquinoline valmerin <b>31</b> gave interesting results and activities on CDK5 that are comparable to valmerins <b>15</b> and <b>16</b> (entries 3 and 4). Nevertheless, hydroxyquinolines <b>44</b> and <b>45</b> did not have any effect on the kinases.</div><div class="NLM_p">Valmerins exhibited some selectivity in kinase inhibition. All of them were quite inactive on DYRK1A, but a good inhibition of GSK3 was observed. Except for valmerins <b>32</b> and <b>45</b>, all the other derivatives displayed an IC<sub>50</sub> in the submicromolar range.</div><div class="NLM_p">In general, the GSK3 (compared to CDK5) active site accepts bulkier groups.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> CDK5-inactive <b>26</b>, <b>27</b>,<b> 29</b>, and <b>35</b> derivatives appeared to be potent against GSK3 with IC<sub>50</sub> ranging between 130 and 330 nM. The most selective compound is without doubt valmerin <b>34</b>, which is completely inactive on CDK5 and DYRK1A (IC<sub>50</sub>> 10 μM) but exhibits a 750 nM IC<sub>50</sub> on GSK3.</div><div class="NLM_p">The three valmerins <b>15</b>, <b>16</b>, and <b>31</b> emerged as good leads to pursue our investigations. Among them, we selected the pyridine ring to explore other avenues and complete our QSAR studies (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). We added CK1 to our enzyme panel. We also showed that valmerin <b>15</b> (entry 1) and <b>16</b> (not shown) similarly affect the three structurally related kinases CDK 1, 5 and GSK3. All of the new derivatives have only moderate interactions with CK1 and DYRK1A active sites, while major effects are always observed on CDK5 and GSK3.</div><div class="NLM_p">On CDK5, a bulky and electron-rich bromo atom enhanced the activity. Positions 2 and 4 were privileged compared to position 3 (entries 2–4). Valmerins <b>18</b> and <b>19</b> exhibited remarkable IC<sub>50</sub> values of 40 and 25 nM, respectively.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Selection of R Residue on Valmerins<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0014.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0015.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>Table a</sup><p class="last">Compounds with an IC<sub>50</sub> CDK5 < 100 nM or GSK3 < 1 μM are selected. Assays were performed in triplicate.</p></div></div><div></div></div><div class="NLM_p">A slight decrease in kinase inhibition occurred when bromine was replaced by a fluorine atom (entries 5 and 2), but with this small atom, valmerin <b>20</b> was as active as the previously selected compound <b>15</b>. A poly chloration or an increase in the substitution size (i.e., piperidine or a phenyl groups, entries 7, 9, and 10) led to a full inactivation of valmerins against CDK5. In position 3, valmerins could create a supplementary hydrogen bond with the active site. Adding a hydroxyl group in this position led to derivative <b>42</b>, which inhibits CDK5 with an IC<sub>50</sub> of 37 nM. This hydrophilic group is nevertheless a handicap in position 5 since it may interact with the urea function and dramatically perturb the crucial orientation of the pyridine ring (entry 14).</div><div class="NLM_p">As mentioned previously, the GSK3 active site accepts more variations and the presence of lipophilic and hydrophilic groups is well tolerated. Five valmerins <b>17</b>–<b>20</b> and <b>42</b> showed IC<sub>50</sub> values lower than 100 nM. A bromine atom or hydroxy group could be indiscriminately placed in positions 2–4, but disubstitution led to a partial inactivation. In position 2, bulky and lipophilic piperidine or phenyl rings were partially tolerated; compounds <b>24</b> and <b>25</b> inhibited GSK3 in the submicromolar range.</div><div class="NLM_p">This pyridine variation completes our lead family. Searching for a compromise between CDK5 and GSK3 inhibition, it appeared that valmerins <b>18</b>–<b>20</b>, <b>42</b> are the most interesting molecules of the substituted pyridinic series. However, the valmerin leading to the derivative <b>15</b> deserves considerable interest because of its ability to target with high efficacy the three main kinases involved in cell cycle and/or in growth control.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Selection of Valmerin Pyridine Ring Substituents<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0016.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">entry</th><th class="colsep0 rowsep0" align="center">valmerins</th><th class="colsep0 rowsep0" align="center">Z</th><th class="colsep0 rowsep0" align="center">CDK1 IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">CDK5 IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">GSK3α/β IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">CK1 IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">DYRK1A IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.075</td><td class="colsep0 rowsep0" align="char" char=".">0.08</td><td class="colsep0 rowsep0" align="char" char=".">0.17</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">2-Br</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char=".">0.040</td><td class="colsep0 rowsep0" align="char" char=".">0.043</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">3-Br</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char=".">0.13</td><td class="colsep0 rowsep0" align="char" char=".">0.076</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">4-Br</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char=".">0.025</td><td class="colsep0 rowsep0" align="char" char=".">0.022</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">7.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char=".">0.09</td><td class="colsep0 rowsep0" align="char" char=".">0.026</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">3,5-diF</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">2,3,4,5-tetrachloro</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">5-OMe</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char=".">0.59</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">8.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">2-piperidinyl</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.36</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">3-phenyl</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">0.14</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">3-OH</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char=".">0.037</td><td class="colsep0 rowsep0" align="char" char=".">0.051</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">5-OH</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">≥10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Assays were performed in triplicate. ND: not determined. Compounds exhibiting an IC<sub>50</sub> CDK5 or GSK3 < 200 nM were selected.</p></div></div></div><div class="NLM_p">We also ran a semiquantitative kinase interaction assay (KinomeScan, Discoverx) of valmerin <b>15</b> at 10 μM on a 442 kinase panel. Results showed that CDKs (blue), CDK-like kinases (CDKLs) (orange), and GSK3 (green) are targeted in addition to quite a few other kinases (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Protein Kinase Selectivity of Valmerin <b>15</b> in a Kinase Interaction Assay (KinomeScan)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">score</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">score</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">score</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">score</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDKL2</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">CSNK2A2</td><td class="colsep0 rowsep0" align="char" char=".">0.35</td><td class="colsep0 rowsep0" align="left">CDK2</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="left">KIT</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DRAK1</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">L576P</td><td class="colsep0 rowsep0" align="char" char=".">0.35</td><td class="colsep0 rowsep0" align="left">V559D</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">KIT(D816V)</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FLT3</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">RIOK1</td><td class="colsep0 rowsep0" align="char" char=".">0.35</td><td class="colsep0 rowsep0" align="left">PIP5K2B</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">TAK1</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GSK3B</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">CDC2L5</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="left">CDK3</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="left">FLT3(K663Q)</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JNK1</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">JNK2</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="left">CDK9</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="left">PKNB</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MYLK4</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">PCTK2</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="left">PDGFRB</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="left">ABL1</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PCTK1</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">TGFBR2</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="left">RSK2</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="left">TYK2</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDKL5</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td><td class="colsep0 rowsep0" align="left">DRAK2</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="left">PFCDPK1</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="left">PRKD1</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PFTK1</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td><td class="colsep0 rowsep0" align="left">RIOK3</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="left">MEK5</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="left">PFTAIRE2</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BIKE</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="left">CIT</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="left">CDKL1</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="left">TRKB</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GSK3A</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="left">FLT3(</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="left">SRPK1</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="left">JAK1</td><td class="colsep0 rowsep0" align="char" char=".">3.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JNK3</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="left">SNARK</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="left">MLCK</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="left">RSK1</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK4-cyclinD3</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="left">MLK3</td><td class="colsep0 rowsep0" align="char" char=".">0.65</td><td class="colsep0 rowsep0" align="left">ICK</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="left">ARK5</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDKL3</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="left">PCTK3</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="left">EPHB6</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="left">FLT3</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JAK3</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="left">YSK4</td><td class="colsep0 rowsep0" align="char" char=".">0.75</td><td class="colsep0 rowsep0" align="left">PRKD3</td><td class="colsep0 rowsep0" align="char" char=".">2.4</td><td class="colsep0 rowsep0" align="left">PKN2</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ERK8</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="left">RSK4</td><td class="colsep0 rowsep0" align="char" char=".">0.85</td><td class="colsep0 rowsep0" align="left">STK36</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="left">FLT3(ITD)</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK5</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="left">AURKC</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="left">ABL1</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="left">PRKD2</td><td class="colsep0 rowsep0" align="char" char=".">4.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Valmerin <b>15</b> was tested at a 10 μM concentration on a 442 kinase interaction panel. A semiquantitative scoring of this primary screen was obtained. This score relates to the probability of a hit rather than strict affinity. Scores >10, between 1–10 and <1, indicate that the probability of a hit being a false positive is <20%, <10%, and <5%, respectively. The best scores from 0 to 5 are presented. Full results are available in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> (Table S1).</p></div></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Molecular Modeling</h3><div class="NLM_p">The binding mode of our inhibitor <b>15</b>within GSK3 was elucidated using a docking model (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) and is characteristic of those found within the kinase family.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> In this graphical representation, the valmerin <b>15</b> binds in the deep cleft between the two lobes of the catalytic core structure (the smaller <i>N</i> terminal domain at the top and the rich α helices <i>C</i> terminal domain below) and the extreme parts of the pyridine and piperidine rings are exposed to solvent.</div><div class="NLM_p">Similarly to ATP, compound <b>15</b> binds the kinase active site forming two hydrogen bonds with the hinge region: the first one is present between the NH backbone of Val 135 and the urea’s oxygen atom. The second one is realized between the oxygen of the Val 135 carbonyl group and the NH urea group again near the pyridine cycle of <b>15</b>. A supplementary hydrogen bond concerns <b>15</b> itself as it is an intra H bond connecting the second NH of urea with the nitrogen pyridine atom. This last hydrogen bond participates to the H bond pattern by orienting the urea group to the hinge residues.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Binding mode of valmerin <b>15</b> within GSK3. Left: GSK3 protein from 2OW3 and <b>15</b> docked inside. Right: zoom on the active site. Hinge region was highlighted in yellow and the DFG motif of the activation loop is highlighted in green. Protein was represented as a ribbon diagram with the cartoon style and <b>15</b> exhibits tube representation (elements colored). Nonpolar hydrogens are not represented for clarity. H bonds are represented as dashed yellow lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008536&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> In Vitro Cell Assays</h3><div class="NLM_p">To pursue our selection, all of the synthesized valmerins were evaluated against six representative human cancer cell lines (liver HuH7, colon Caco2 and HCT116, breast MDA-MB231, prostate PC3, and lung NCI-H727) as well as human normal diploid skin fibroblast cells. To simplify the presentation, we report in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> the results for derivatives that showed submicromolar IC<sub>50</sub> values against CDKs and GSK3. All of the unselected molecules exhibited micromolar effects whatever the cell line (not shown); <b>18</b> precipitated during the cell effect measurements.</div><div class="NLM_p">Effects on cells fully depended on the R substituent. Disappointingly, valmerin <b>31</b> only led to a micromolar effect on all the cancer cell lines tested. This compound was discarded because it appeared dramatically toxic on normal diploid fibroblast cells. Surprisingly, 4-bromopyridine derivative <b>19</b> affected all cell lines except the liver HuH7. This might be explained by the high expression of transporter proteins such as Pgp and MDRs, which may induce an early clearance of this target molecule in these cells.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The formation of an inactive metabolite through hepatic detoxification function cannot be ruled out.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vitro Cell Effects of Selected Valmerins<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0018.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0019.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>Table a</sup><p class="last">Assays were performed in triplicate. Fibro represents skin fibroblast cell lines. Reference compounds used (not shown) were DMSO, Taxol, roscovitine, and doxorubicin.</p></div></div><div></div></div><div class="NLM_p">The same variability in cell survival was amplified when considering compounds <b>42</b> and <b>16</b>. For compound <b>42</b>, submicromolar IC<sub>50</sub> values were obtained with HuH7, PC3, and NCI-H727 cells, while micromolar values were obtained with Caco2, MDA-MB231, HCT116 and with diploid fibroblasts; for compound <b>16</b>, no response was obtained with Caco2 and MDA-MB231 cell lines while all the others responded. Interestingly, these two cell lines carry mutations which alter growth controls, mainly those associated with Wnt-β catenin pathways which, therefore, drastically reduce the influence of GSK3 modulation, while the HCT 116 line, another colon cell line, has preserved part of these regulations.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p">Nevertheless, three compounds <b>15</b>, <b>16</b>, and <b>20</b> emerged from this in vitro cell study. The best results were obtained with the HuH7, MDA-MB231, and HCT116 cell lines and IC<sub>50</sub> values were always lower than those observed with diploid fibroblasts. The best derivative is undoubtedly valmerin <b>15</b>. In this case, the three above-mentioned 3 cell lines were affected in the nanomolar range (240, 320, 150 nM, respectively) whereas normal fibroblasts were affected to a lower extent.</div><div class="NLM_p">The strong cellular effect can be fully explained by multi kinase inhibition since the resulting effect on cells appeared as a pro-apoptotic effect. Indeed, additional studies performed on valmerin <b>15</b> and <b>16</b> provide evidence supporting the idea that the decreased number of living cells induced by these compounds was mainly associated with strong induction of an apoptotic signal, principally induction of caspase 3 activity (Figure <a data-tab="pane-pcw-Figures" href="#fig3A" id="" class=" internalNav">4</a>) as shown with the HCT116 cell line.</div><figure id="fig3A" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Immunofluorescence labeling of cleaved (active) caspase 3 in HCT116 cells untreated (DMSO) or treated with valmerin <b>15</b> (0.6 μM) and valmerin <b>16</b> (1.0 μM) for 24 h. Nuclei were stained with Hoechst (blue), and apoptotic cells were immunostained with an antiactive caspase 3 antibody (red) (magnification, ×10). (B) Quantification of apoptotic cells. Apoptotic cells were calculated as the percent of active caspase 3-positive cells/total nuclei with the Cellomics High Content Imaging System. Data shown are the mean ± sem from a typical experiment performed in triplicate. **<i>P</i> < 0.01, ***<i>P</i> < 0.001, control cells vs treated cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008536&amp;id=fig3A"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We therefore wondered whether this apoptotic effect could partly result from growth arrest induction and cell cycle inhibition. Progression into the cell cycle was estimated by using both S and M phase markers (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">5</a>). Analyses led to detect a net decrease of cells engaged in the cell cycle, supporting the hypothesis of a blockage located at the entry or during the G1 phase. Further experiments on specific signaling pathways need to be performed to further confirm these conclusions. Again, valmerin <b>15</b> appeared more efficient than valmerin <b>16</b>.</div><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of valmerins <b>15</b> and <b>16</b> on cell cycle progression. (A) Mitotic index. Different cell lines were treated with DMSO (0.4%) (control cells), roscovitine (20 μM), valmerin <b>15</b> (0.6 μM), and valmerin <b>16</b> (1 μM) for 24 h. Cells were fixed, and the mitotic index was determined using phospho-histone H3 detection. The number of dividing cells was calculated by using the Cellomics High Content Imaging System. Data shown are the mean ± SD from a typical experiment performed in triplicate. *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001, control cells vs treated cells. (B) 5′-Bromo-2′-deoxyuridine (BrdU) incorporation. Different cell lines were treated with DMSO (0.4%) (control cells), roscovitine (20 μM), valmerin <b>15</b>(0.6 μM), and valmerin <b>16</b> (1 μM) for 48 h and pulsed with BrdU for 1 h 30. Cells were fixed and immunostained for BrdU incorporation. BrdU staining was measured by the Cellomics High Content Imaging System. Data shown are the mean ± SD from a typical experiment performed in triplicate. *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001, control cells vs treated cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008536&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> In Vivo Assays</h3><div class="NLM_p">Valmerin <b>15</b> was selected for in vivo assays and was prepared in a gram scale. Tolerance was first evaluated in 6–8 week-old female NMRI mice (Janvier Laboratories). The up-and-down procedure was used with six animal per dose (0, 1, 5, and 10 mg/kg), the product was administered intraperitoneally and daily over 2 weeks, and the animals were monitored 2 weeks after the last administration. Daily observation over 14 consecutive days after product administration suggested good tolerance as shown by clinical signs, physical examination, body weight, and food consumption. Macroscopic examination of the organs at the end of the experiment showed no abnormalities and the blood formulation was normal.</div><div class="NLM_p">Valmerin <b>15</b> partially slows down tumor growth in the HCT-116 mouse xenograft model. After 4 weeks of treatment, results showed a tumor reduction of 45.3% (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">6</a>). At the end of the experiment, valmerin <b>15</b> had induced a 51% reduction in cecum BLI which correlates with the tumoral volume (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">6</a>, right).</div><figure id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Left: in vivo valmerin <b>15</b> effects on tumor growth. Mice were assessed weekly using whole-body bioluminescent imaging to quantify relative amounts of tumor burden. Data are given as cpm mean +/– SD. <i>P</i> < 0.05: *, <i>p</i> < 0.001: ***. Right: 4 weeks after the beginning of treatment, BLI of two representative mice per group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008536&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">At necropsy, mesenteric nodes, liver and lung of each mouse were assessed on Φimageur to quantify the metastasis burden (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">7</a>). There was no difference between control and Valmerin <b>15</b> treated mice in terms of mesenteric nodes or liver invasion, but only 1/9 treated mice had developed lung metastasis against 6/9 control mice. It seemed that Valmerin <b>15</b> had limited lung invasion.</div><figure id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Left: Ex vivo cecum BLI at the end of the assay (left). The cecum BLI of all mice was quantified. Data are given as cpm mean +/– SD. <i>P</i> < 0.01: **, <i>p</i> < 0.001: ***. Right: At necropsy, the number of mice in each group with mesenteric nodes, liver and lung metastasis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008536&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23888" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23888" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this paper, we prepared valmerins, a new family containing the tetrahydropyrido[1,2-<i>a</i>]isoindone core. The fused heterocycle was prepared with a straightforward synthesis which was functionalized by a (het)aryl urea. Each final compound was evaluated against representative kinases and 12 valmerin inhibited CDK5 and GSK3 with IC<sub>50</sub> < 100 nM. A semiquantitative kinase scoring confirmed that Valmerin <b>15</b> affected CDKs, CDK-like kinases (CDKLs), GSK3, and quite a few other kinases. Cellular screening on human cell lines (6 cancer cell lines and diploid fibroblasts) identified two stable lead compounds <b>15</b> and <b>16</b> with interesting submicromolar cellular effects. We have identified the cellular process which explains antiproliferative effects. Valmerins acted on proliferation and induced cell death by caspase 3 induction. At the end of our study, we investigated the in vivo potency of valmerin <b>15</b>. Mice exhibited good tolerance to our lead, which proved its efficacy and clearly blocked tumor growth. Valmerins appear as good candidates for further development as anticancer agents.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15530" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15530" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Chemistry</h3><div class="NLM_p last"><sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded on a Bruker DPX 250 or 400 MHz instrument using CDCl<sub>3</sub> or DMSO<i>-d</i><sub>6</sub>. The chemical shifts are reported in ppm (δ scale) and all coupling constants (<i>J</i>) values are in hertz (Hz). The splitting patterns are designated as follows: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), and dd (doublet doublet). Melting points are uncorrected. IR absorption spectra were obtained on a Thermo-Nicolet equipped with an ATR Ge or Diamond equipment and values were reported in cm<sup>–1</sup>. MS spectra (ion spray) were performed on a Perkin-Elmer Sciex PI 300. High-resolution mass spectra (HRMS) were performed on a Bruker maXis mass spectrometer by the “Fédération de Recherche” ICOA/CBM (FR2708) platform. Monitoring of the reactions was performed using silica gel TLC plates (silica Merck 60 F254). Spots were visualized by UV light at 254 and 356 nm. Chromatography columns were performed using silica gel 60 (0.063–0.200 mm, Merck). The purity was determined by using a VWR Hitachi HPLC equipped with a chiralpack IA column (250 × 4.6 mm). Mobile phase: A: 80% <i>n</i>-heptane. B: 20% ethanol. Flow 1 mL/min. Concentration 0.2 mg/mL in heptane/EtOH; inj 20 μL peaks were detected by UV absorption with a LaChrom Elite diode array detector L-2455 at 239, 249, and 254 nm. The HPLC profiles of all valmerins show purity up to ≥95%.</div></div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 4-Nitro-2-(3-oxobutyl)isoindoline-1,3-dione (<b>2</b>)</h3><div class="NLM_p last">3-Nitrophthalimide (5.0 g, 26.0 mmol), methyl vinyl ketone (2.8 mL, 3.3 mmol, 1.25 equiv), and Triton B (benzyltrimethylammonium hydroxide, 40% in methanol, 760 μL) in EtOAc (30 mL) were stirred at reflux overnight. Evaporation to dryness under reduced pressure and recrystallization from EtOH gives <b>2</b> as a yellow solid in 85% yield: mp 122–124 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 250 MHz) δ 2.20 (s, 3H), 2.91 (t, <i>J</i> = 7.3 Hz, 2H), 3.98 (t, <i>J</i> = 7.3 Hz, 2H), 7.93 (dd, <i>J</i> = 7.1 Hz, <i>J</i> = 8.5 Hz, 1H), 8.07–8.19 (m, 2H); MS (IS) <i>m</i>/<i>z</i> 263.0 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>12</sub>H<sub>11</sub>N<sub>2</sub>O<sub>5</sub> 263.06624, found 263.06631 [M + 1]<sup>+</sup>.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 2-(2-(2-Methyl-1,3-dioxolan-2-yl)ethyl)-4-nitroisoindoline-1,3-dione (<b>3</b>)</h3><div class="NLM_p last">A solution of the above ketone <b>2</b> (5.0 g, 19.0 mmol), ethylene glycol (2.0 mL, 38.0 mmol, 2.0 equiv), and PTSA·H<sub>2</sub>O (21.0 mg, 0.1 mmol, cat.) in toluene (60 mL) was refluxed overnight with a Dean–Stark apparatus. The cooled solution was washed with aq satd NaHCO<sub>3</sub> (20 mL), and the organic layers were extracted with EtOAc, washed with brine (20 mL), dried over MgSO<sub>4</sub>, filtered, and evaporated under reduced pressure. The crude material was recrystallized from ethanol to give <b>3</b> as a yellow crystal in 89% yield: mp 90–92 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 250 MHz) δ 1.36 (s, 3H), 2.10 (t, <i>J</i> = 7.0 Hz, 2H), 3.86 (t, <i>J</i> = 7.0 Hz, 2H), 3.90–4.00 (m, 4H), 7.90 (dd, <i>J</i> = 7.4 Hz, <i>J</i> = 8.2 Hz, 1H), 8.05–8.17 (m, 2H); MS (IS) <i>m</i>/<i>z</i> 307 [M + H]<sup>+</sup>, 324.0 [M + NH<sub>4</sub>]<sup>+</sup>; HRMS (ESI) calcd for C<sub>14</sub>H<sub>15</sub>N<sub>2</sub>O<sub>6</sub> 307.09246, found 307.09244 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 3-Hydroxy-2-(2-(2-methyl-1,3-dioxolan-2-yl)ethyl)-4-nitroisoindolin-1-one (<b>4</b>)</h3><div class="NLM_p last">To a solution of <b>3</b> (2.0 g, 6.5 mmol) in a mixture THF/MeOH (15/30 mL) at −30 °C was added NaBH<sub>4</sub> (700 mg, 19.5 mmol, 3.0 equiv) in portions. The mixture was stirred at this temperature for 15 min followed by TLC and then allowed to warm to +10 °C. Aqueous satd NaHCO<sub>3</sub> (1 M, 40 mL) was added, and the organic layers were extracted successively with CH<sub>2</sub>Cl<sub>2</sub> (10 mL) and EtOAc (10 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuum. Purification by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) led to <b>4</b> as a white solid in 76% yield: mp 130–132 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 250 MHz) δ 1.39 (s, 3H), 2.05–2.21 (m, 2H), 3.59–3.75 (m, 1H), 3.85–3.87 (m, 1H), 3.94–3.96 (m, 4H), 4.23 (d, <i>J</i> = 5.4 Hz, 1H), 6.46 (d, <i>J</i> = 5.4 Hz, 1H), 7.67–7.77 (m, 1H), 8.09 (dd, <i>J</i> = 0.7 Hz, <i>J</i> = 7.4 Hz, 1H), 8.32 (dd, <i>J</i> = 0.9 Hz, <i>J</i> = 8.2 Hz, 1H); MS (IS) <i>m</i>/<i>z</i> 309.0 [M + H]<sup>+</sup>, 326.0 [M + NH<sub>4</sub>]<sup>+</sup>; HRMS (ESI) calcd for C<sub>14</sub>H<sub>17</sub>N<sub>2</sub>O<sub>6</sub> 309.10811, found 309.10811 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 10′-Nitro-3′,4′-dihydro-1′<i>H</i>-spiro[[1,3]dioxolane-2,2′-pyrido[2,1-<i>a</i>]isoindol]-6′(10b′<i>H</i>)-one (<b>5</b>)</h3><div class="NLM_p last">A solution of β-hydroxylactam <b>4</b> (500 mg, 1.62 mmol) and PTSA·H<sub>2</sub>O (156 mg, 0.8 mmol, 0.5 equiv) in toluene (50 mL) was refluxed for 6 h with a Dean–Stark apparatus. After being cooled to room temperature, the mixture was washed three times with aq satd NaHCO<sub>3</sub> solution (45 mL), and the aqueous layers were extracted with EtOAc (3 × 20 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and evaporated under reduced pressure. Purification by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99.5/0.5) led to <b>5</b> as a yellow solid in 73% yield: mp 206–208 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 250 MHz) δ 1.17 (t, <i>J</i> = 12.2 Hz, 1H), 1.65–1.95 (m, 2H), 2.61–2.78 (m, 1H), 3.33 (td, <i>J</i> = 4.2 Hz, <i>J</i> = 13.0 Hz, 1H), 3.96–4.31 (m, 4H), 4.55 (dd, <i>J</i> = 4.3 Hz, <i>J</i> = 13.4 Hz, 1H), 5.23 (dd, <i>J</i> = 3.3 Hz, <i>J</i> = 11.7 Hz, 1H), 7.70 (t, <i>J</i> = 7.8 Hz, 1H), 8.19 (d, <i>J</i> = 7.4 Hz, 1H), 8.37 (d, <i>J</i> = 8.1 Hz, 1H); MS (IS) <i>m</i>/<i>z</i> 291.0 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>14</sub>H<sub>15</sub>N<sub>2</sub>O<sub>5</sub> 291.09754, found 291.09775 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 10-Nitro-1,3,4,10b-tetrahydropyrido[2,1-<i>a</i>]isoindole-2,6-dione (<b>6</b>)</h3><div class="NLM_p last">A mixture of keto-protected compound <b>5</b> (2.0 g, 6.91 mmol) in an aq HCl solution (10%, 20 mL) and acetone (30 mL) was refluxed for 3 h. After cooling, acetone was removed under reduced pressure, and the resulting crude material was filtered, washed with water, and dried to give compound <b>6</b> as a yellow solid in 90% yield: mp 215–217 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 2.08 (dd, <i>J</i> = 11.7 Hz, <i>J</i> = 14.5 Hz, 1H), 2.52–2.72 (m, 2H), 3.38–3.55 (m, 2H), 4.76–4.82 (m, 1H), 5.39 (dd, <i>J</i> = 4.0 Hz, <i>J</i> = 11.6 Hz, 1H), 7.78 (t, <i>J</i> = 7.8 Hz, 1H), 8.25 (d, <i>J</i> = 7.4 Hz, 1H), 8.44 (d, <i>J</i> = 8.0 Hz, 1H); MS (IS) <i>m</i>/<i>z</i> 247.0 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>12</sub>H<sub>11</sub>N<sub>2</sub>O<sub>4</sub> 247.07133, found 247.07150 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 10-Amino-1,3,4,10b-tetrahydropyrido[2,1-<i>a</i>]isoindole-2,6-dione (<b>7</b>)</h3><div class="NLM_p last">To a solution of compound <b>6</b> (2.0 g, 8.0 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (100 mL) was added Pd (C) 10% (200 mg). After being stirred at room temperature under hydrogen atmospheric pressure for 16 h, the mixture was filtered through Celite. After being washed with MeOH (20 mL), the combined organic layers were evaporated under reduced pressure. Purification by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) led to <b>7</b> as a yellow solid in 88% yield: mp 68–70 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 2.21 (dd, <i>J</i> = 12.2 Hz, <i>J</i> = 13.8 Hz, 1H), 2.47–2.65 (m, 2H), 3.16–3.21 (m, 1H), 3.32–3.40 (m, 1H), 3.90 (s, 2H), 4.66 (dd, <i>J</i> = 3.9 Hz, <i>J</i> = 11.9 Hz, 1H), 4.73–4.79 (m, 1H), 6.85 (dd, <i>J</i> = 3.9 Hz, <i>J</i> = 4.9 Hz, 1H), 7.34–7.27 (m, 2H); MS (IS) <i>m</i>/<i>z</i>: 217.0 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>12</sub>H<sub>13</sub>N<sub>2</sub>O<sub>2</sub> 21709715, found 217.09739 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 10-Amino-1,2,3,4-tetrahydropyrido[2,1-<i>a</i>]isoindol-6(10b<i>H</i>)-one (<b>8</b>)</h3><div class="NLM_p last">Keto compound <b>7</b> (500 mg, 2.31 mmol) and hydrazine monohydrate (0.45 mL, 9.24 mmol, 4.0 equiv) were added to a solution containing sodium (160 mg, 6.93 mmol, 3.0 equiv) in diethylene glycol (9 mL). After the mixture was reluxed for 4 h at 190 °C, the reaction was found to be complete (TLC) and the mixture was cooled. CH<sub>2</sub>Cl<sub>2</sub> (50 mL) was added, and the organic layer was washed with NaOH (20 mL, 1 M in water), dried over MgSO<sub>4</sub>, filtered, evaporated, and purified by silica gel chromatography column (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99.5/0.5) to give the compound <b>8</b> as a yellow solid in 86% yield: mp 50–52 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 250 MHz) δ 1.10–1.12 (m, 1H), 1.29–1.52 (m, 1H), 1.52–1.74 (m, 1H), 1.75–1.88 (m, 1H), 1.98–2.02 (m, 1H), 2.50 (dd, <i>J</i> = 3.2 Hz, <i>J</i> = 13.4 Hz, 1H), 2.96 (td, <i>J</i> = 3.5 Hz, <i>J</i> = 12.9 Hz, 1H), 3.79 (s, 2H), 4.23 (dd, <i>J</i> = 3.6 Hz, <i>J</i> = 11.7 Hz, 1H), 4.49 (dd, <i>J</i> = 4.9 Hz, <i>J</i> = 13.3 Hz, 1H), 6.80 (dd, <i>J</i> = 1.4 Hz, <i>J</i> = 7.3 Hz, 1H), 7.17 −7.35 (m, 2H); MS (IS) <i>m</i>/<i>z</i> 203.0 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>12</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub> 203.11789, found 203.11807 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Procedure a for Carboxylic Acids <b>9</b>–<b>12</b> Synthesis</h3><div class="NLM_p">The commercial hydroxycarboxylic acids (1.0 mmol) were dissolved in MeOH (50 mL), and thionyl chloride (2.0 mmol) was added dropwise at 0 °C. The reaction was warmed to room temperature and then refluxed overnight. After cooling, methanol was removed under reduced pressure and the residue was dissolved in a saturated aqueous NaHCO<sub>3</sub> (15 mL). The mixture was extracted with EtOAc (3 × 20 mL). After evaporation of the combined organic layer, the crude material was purified by flash chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 98/2) to give the desirable hydroxyesters. The previously obtained hydroxy esters (1.0 mmol) were added to a suspension of K<sub>2</sub>CO<sub>3</sub> (2.0 mmol, 2.0 equiv) in dry acetone (20 mL). Chloromethyl methyl ether (1.5 mmol, 1.5 equiv) was dropwise added, and the mixture was stirred at 0 °C for 10 min and then heated at 70 °C for 12h. After the mixture was cooled to room temperature, water (15 mL) was added, and the organic material was extracted with EtOAc (3 × 25 mL). The combined organic layers were washed with H<sub>2</sub>O (10 mL) and brine (10 mL) and dried (Na<sub>2</sub>SO<sub>4</sub>). After filtration and reduction of the volatiles under reduced pressure, the crude material was purified by flash chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 95/5) to give the desirable intermediates, which were next engaged in a last saponification step. The MOM protected esters (1.0 mmol) were dissolved in a THF/H<sub>2</sub>O 1/1 (10 mL) mixture, and NaOH (1.2 mmol, 1.2 equiv) was added. The solution was stirred for 2 h at room temperature, and THF was removed under reduced pressure. The aqueous layer was acidified with acetic acid (50%) until pH 5–6 prior to extraction with EtOAc (3 × 10 mL). The combined organic layers were dried with anhydrous MgSO<sub>4</sub>, filtered, and evaporated under reduced pressure to give the desired acids <b>9</b>–<b>12</b>.</div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 3-(Methoxymethoxy)picolinic Acid (<b>9</b>)</h4><div class="NLM_p last">The compound <b>9</b> was obtained following the general procedure <i><b>A</b></i> from the 3-hydroxypicolinic acid as a white solid in 75% yield: mp 208–210 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 3.36 (s, 3H), 5.17 (s, 2H), 7.15 (d, <i>J</i> = 4.4 Hz, <i>J</i> = 8.0 Hz, 1H), 7.40 (d, <i>J</i> = 8.0 Hz, 1H), 8.03 (d, <i>J</i> = 4.4 Hz, 1H); SM (IS) <i>m</i>/<i>z</i> 184.0 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>8</sub>H<sub>10</sub>NO<sub>4</sub> 184.06043, found 184.06066 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 5-(Methoxymethoxy)picolinic Acid (<b>10</b>)</h4><div class="NLM_p last">The compound <b>10</b> was obtained following the general procedure A from the 5-hydroxypicolinic acid as a white solid in 77% yield: mp 212–214 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 250 MHz) δ 3.42 (s, 3H), 5.36 (s, 2H), 7.58 (dd, <i>J</i> = 2.5 Hz, <i>J</i> = 8.7 Hz, 1H), 8.04 (d, <i>J</i> = 8.7 Hz, 1H), 8.42 (s, 1H), 12.88 (Sl, 1H); SM (IS) <i>m</i>/<i>z</i> 184.0 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>8</sub> H<sub>10</sub>NO<sub>4</sub> 184.06043, found 184.06073 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 8-(Methoxymethoxy)quinoline-2-carboxylic Acid (<b>11</b>)</h4><div class="NLM_p last">The compound <b>11</b> was obtained following the general procedure <i><b>A</b></i> from the 8-hydroxyquinoline-2-carboxylic acid as a white solid in 70% yield: mp 148–150 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, D<sub>2</sub>O, 400 MHz) δ 3.24 (s, 3H), 5.32 (s, 2H), 7.32 (d, <i>J</i> = 7.6 Hz, 1H), 7.48–7.61 (m, 2H), 8.18 (d, <i>J</i> = 8.5 Hz, 1H), 8.38 (d, <i>J</i> = 8.5 Hz, 1H); SM (IS) <i>m</i>/<i>z</i> 234.0 [M + H]<sup>+</sup>, 256.0 [M + Na]<sup>+</sup>; HRMS (ESI) calcd for C<sub>12</sub> H<sub>12</sub>NO<sub>4</sub> 234.07608, found 234.07615 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 4-(Methoxymethoxy)quinoline-2-carboxylic Acid (<b>12</b>)</h4><div class="NLM_p last">The compound <b>12</b> was obtained following the general procedure A from the 4-hydroxyquinoline-2-carboxylic acid as a white solid in 72% yield: mp > 260 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, D<sub>2</sub>O, 250 MHz) δ 3.50 (s, 3H), 5.62 (s, 2H), 7.69–7.75 (m, 2H), 7.88 (t, <i>J</i> = 7.5 Hz, 1H), 8.13 (d, <i>J</i> = 7.5 Hz, 1H), 8.25 (d, <i>J</i> = 7.5 Hz, 1H); SM (IS) <i>m</i>/<i>z</i> 232.0 [M – H]<sup>−</sup>; HRMS (ESI) calcd for C<sub>12</sub>H<sub>11</sub>NO<sub>4</sub>Na 256.05803, found 256.05825 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Procedure B for Isocyanate Synthesis from Acids <b>V</b></h3><div class="NLM_p last">Under argon, a stirred solution of carboxylic acid <b>V</b> (0.37 mmol) and Et<sub>3</sub>N (66 μL, 0.48 mmol, 1.3 equiv) in dry THF (7 mL) was cooled to −10 °C. Ethyl chloroformate (53 μL, 0.55 mmol, 1.5 equiv) was dropwise added, and the resultant mixture was stirred for 1 h. Afterward, a solution of sodium azide (40 mg, 0.63 mmol, 1.70 equiv) in water (2 mL) was slowly added and the reaction monitored by TLC. After completion (1 h), the reaction mixture was poured into ice–water (5 mL) and quickly extracted with EtOAc (3 × 10 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and carefully evaporated under reduced pressure. The crude acylazide was dissolved in dry toluene (20 mL) and refluxed for 1 h under argon to give the corresponding isocyanate which was used in the next step.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> General Procedure C for Synthesis of Valmerin<b>s 13–40</b></h3><div class="NLM_p">Under argon, to the freshly prepared isocyanate was added the amine <b>8</b> (0.37 mmol, 1.0 equiv) in dry dioxane (7 mL). The reacting mixture was heated at 100 °C and next cooled at room temperature. After a careful evaporation of the volatiles (<i>T</i> < 40 °C), the dark residue was purified by silica gel chromatography column to afford the desired valmerins 13–40.</div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 1-Cyclohexyl-3-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)urea (<b>13</b>)</h4><div class="NLM_p last">The compound <b>13</b> was obtained following the general procedures B and C from the cyclohexanecarboxylic acid and the amine <b>8</b> after purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) as a white solid in 86% yield: mp 240–242 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz,) δ 0.88–0.97 (m, 1H), 1.10–1.14 (m, 3H), 1.29–1.34 (m, 3H), 1.46–1.60 (m, 2H), 1.67 (d, <i>J</i> = 12.4 Hz, 2H), 1.75 (d, <i>J</i> = 10.4 Hz, 1H), 1.85–1.94 (m, 3H), 2.51 (d, <i>J</i> = 12.4 Hz, 1H), 2.90 (t, <i>J</i> = 12.4 Hz, 1H), 3.64 (d, <i>J</i> = 7.6 Hz, 1H), 4.40–4.49 (m, 2H), 5.55 (d, <i>J</i> = 7.6 Hz, 1H), 7.33 (d, <i>J</i> = 7.6 Hz, 1H), 7.46 (s, 1H), 7.51 (d, <i>J</i> = 7.6 Hz, 1H), 7.57 (d, <i>J</i> = 8.0 Hz, 1H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>26</sub>N<sub>3</sub>O<sub>2</sub> 328.20195, found 328.20249 [M + H]<sup>+</sup>; purity >99% by HPLC; <i>t</i>R =13.08 and 18.76 min; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 1-(6-Oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)-3-phenylurea (<b>14</b>)</h4><div class="NLM_p last">The compound <b>14</b> was obtained following the general procedures B and C from the benzoic acid and the amine <b>8</b> after purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 98/2) as a white solid in 80% yield: mp 134–136 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 0.89–0.95 (m, 1H), 1.26–1.34 (m, 1H), 1.43–1.49 (m, 1H), 1.74 (d, <i>J</i> = 12.4 Hz, 1H), 1.84 (d, <i>J</i> = 10.4 Hz, 1H), 2.56 (d, <i>J</i> = 11.6 Hz, 1H), 2.90 (t, <i>J</i> = 11.6 Hz, 1H), 4.40–4.49 (m, 2H), 7.01 (t, <i>J</i> = 7.2 Hz, 1H), 7.22–7.26 (m, 2H), 7.30–7.36 (m, 3H), 7.52 (d, <i>J</i> = 7.2 Hz, 1H), 7.64 (d, <i>J</i> = 8.0 Hz, 1H), 8.15 (s, 1H), 8.31 (s, 1H); SM (IS) (<i>m</i>/<i>z</i>) 322.5 [M + H]<sup>+</sup>; HRMS (ESI) calcd for C<sub>19</sub>H<sub>20</sub>N<sub>3</sub>O<sub>2</sub> 322.15500, found 322.15530 [M + H]<sup>+</sup>; purity >99% by HPLC; <i>t</i><sub>R</sub> =20.06 and 21.11 min; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 1-(6-Oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)-3-(pyridin-2-yl)urea (<b>15</b>)</h4><div class="NLM_p last">The compound <b>15</b> was obtained following the general procedures B and C from the pyridine-2-carboxylic acid and the amine <b>8</b> after purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 97/3 + 1% Et<sub>3</sub>N) as a white solid in 90% yield: mp 142–144 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.77–0.95 (m, 1H), 1.22–1.36 (m, 1H), 1.64–1.83 (m, 2H), 1.91 (d, <i>J</i> = 13.3 Hz, 1H), 2.72 (dd, <i>J</i> = 3.0 Hz, <i>J</i> = 12.6 Hz, 1H), 2.97–3.12 (m, 1H), 4.26 (dd, <i>J</i> = 4.4 Hz, <i>J</i> = 13.0 Hz, 1H), 4.59 (dd, <i>J</i> = 3.3 Hz, <i>J</i> = 11.5 Hz, 1H), 7.03–7.11 (m, 1H), 7.33 (d, <i>J</i> = 8.3 Hz, 1H), 7.38 (dd, <i>J</i> = 0.8 Hz, <i>J</i> = 7.4 Hz, 1H), 7.45 (t, <i>J</i> = 7.7 Hz, 1H), 7.74–7.85 (m, 1H), 8.23 (d, <i>J</i> = 8.0 Hz, 1H), 8.29 (d, <i>J</i> = 4.0 Hz, 1H), 10.00 (s, 1H), 11.16 (s, 1H); HRMS (ESI) calcd for C<sub>18</sub>H<sub>19</sub>N<sub>4</sub>O<sub>2</sub> 323.1508, found 323.1495 [M + H]<sup>+</sup>; purity >99% by HPLC; <i>t</i><sub>R</sub> =14.40 and 17.74 min; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 1-(6-Oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)-3-(pyrazin-2-yl)urea (<b>16</b>)</h4><div class="NLM_p last">The compound <b>16</b> was obtained following the general procedures B and C from the pyrazine-2-carboxylic acid and the amine <b>8</b> after purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 96/4) as a beige solid in 70% yield: mp 215–217 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.88 (qd, <i>J</i> = 3.0 Hz, <i>J</i> = 12.7 Hz, 1H), 1.16–1.33 (m, 1H), 1.64–1.72 (m, 1H), 1.76 (d, <i>J</i> = 15.0 Hz, 1H), 1.91 (d, <i>J</i> = 13.1 Hz, 1H), 2.63 (dd, <i>J</i> = 3.0 Hz, <i>J</i> = 12.6 Hz, 1H), 3.03 (td, <i>J</i> = 3.8 Hz, 12.8 Hz, 1H), 4.26 (dd, <i>J</i> = 3.8 Hz, <i>J</i> = 13.0 Hz, 1H), 4.56 (dd, <i>J</i> = 3.4 Hz, <i>J</i> = 11.5 Hz, 1H), 7.42 (dd, <i>J</i> = 1.0 Hz, <i>J</i> = 7.4 Hz, 1H), 7.47 (t, <i>J</i> = 7.7 Hz, 1H), 8.13 (dd, <i>J</i> = 1.0 Hz, <i>J</i> = 7.9 Hz, 1H), 8.29 (d, <i>J</i> = 2.7 Hz, 1H), 8.31–8.36 (m, 1H), 8.93 (d, <i>J</i> = 1.3 Hz, 1H), 9.81 (s, 1H), 10.05 (s, 1H); HRMS (ESI) calcd for C<sub>17</sub>H<sub>17</sub>N<sub>5</sub>O<sub>2</sub>Na 346.1280, found 346.1289 [M + Na]<sup>+</sup>; purity >99% by HPLC; <i>t</i><sub>R</sub> =14.27 and 17.99 min; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 1-(5-Bromopyridin-2-yl)-3-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)urea (<b>17</b>)</h4><div class="NLM_p last">The compound <b>17</b> was obtained the general procedures B and C from the 5-bromopicolinic acid and the amine <b>8</b> after purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) as a beige solid in 66% yield: mp 225–227 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.77–0.93 (m, 1H), 1.20–1.33 (m, 1H), 162–1.82 (m, 2H), 1.90 (d, <i>J</i> = 12.6 Hz, 1H), 2.63 (dd, <i>J</i> = 2.7 Hz, <i>J</i> = 12.6 Hz, 1H), 3.00–3.11 (m, 1H), 4.25 (dd, <i>J</i> = 4.2 Hz, <i>J</i> = 13.0 Hz, 1H), 4.59 (dd, <i>J</i> = 3.2 Hz, <i>J</i> = 11.5 Hz, 1H), 7.39 (dd, <i>J</i> = 0.8 Hz, <i>J</i> = 7.4 Hz, 1H), 7.45 (t, <i>J</i> = 7.7 Hz, 1H), 7.50 (d, <i>J</i> = 8.9 Hz, 1H), 8.00 (dd, <i>J</i> = 2.5 Hz, <i>J</i> = 8.9 Hz, 1H), 8.14 (dd, <i>J</i> = 0.7 Hz, <i>J</i> = 7.9 Hz, 1H), 8.40 (d, <i>J</i> = 2.3 Hz, 1H), 10.00 (s, 1H), 10.25 (s, 1H); HRMS (ESI) calcd for C<sub>18</sub>H<sub>17</sub>N<sub>4</sub>O<sub>2</sub>NaBr 423.0433, found 423.0427 [M + Na]<sup>+</sup>; purity >98% by HPLC; <i>t</i><sub>R</sub> = 8.77 and 18.73 min; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 1-(6-Bromopyridin-2-yl)-3-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)urea (<b>18</b>)</h4><div class="NLM_p last">The compound <b>18</b> was obtained the general procedures B and C from the 6-bromopicolinic acid and the amine <b>8</b> after purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) as a beige solid in 70% yield: mp 218–220 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.87 (qd, <i>J</i> = 3.1 Hz, <i>J</i> = 12.7 Hz, 1H), 1.20–1.34 (m, 1H), 1.61–1.81 (m, 2H), 1.89 (d, <i>J</i> = 13.0 Hz, 1H), 2.55–2.66 (m, 1H), 3.02 (td, <i>J</i> = 3.6 Hz, <i>J</i> = 12.9 Hz, 1H), 4.26 (dd, <i>J</i> = 3.6 Hz, <i>J</i> = 13.0 Hz, 1H), 4.56 (dd, <i>J</i> = 3.4 Hz, <i>J</i> = 11.5 Hz, 1H), 7.27 (dd, <i>J</i> = 1.4 Hz, <i>J</i> = 6.8 Hz, 1H), 7.38–7.43 (m, 1H), 7.46 (t, <i>J</i> = 7.7 Hz, 1H), 7.65–7.75 (m, 2H), 8.10 (dd, <i>J</i> = 0.7 Hz, <i>J</i> = 7.8 Hz, 1H), 9.28 (s, 1H), 10.04 (s, 1H); HRMS (ESI) calcd for C<sub>18</sub>H<sub>17</sub>N<sub>4</sub>O<sub>2</sub>NaBr 423.0433, found 423.0428 [M + Na]<sup>+</sup>; purity >99% by HPLC; <i>t</i><sub>R</sub> =10.31 and 13.46 min; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 1-(4-Bromopyridin-2-yl)-3-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)urea (<b>19</b>)</h4><div class="NLM_p last">The compound <b>19</b> was obtained following the general procedures B and C from the 4-bromopicolinic acid and the amine <b>8</b> after purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) as a white solid in 80% yield: mp 244–246 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.82–0.93 (m, 1H), 1.19–1.30 (m, 1H), 1.64–1.77 (m, 2H), 1.90 (d, <i>J</i> = 12.0 Hz, 1H), 2.64 (dd, <i>J</i> = 4.0 Hz, <i>J</i> = 12.0 Hz, 1H), 2.99–3.06 (m, 1H), 4.25 (dd, <i>J</i> = 4.0 Hz, <i>J</i> = 12.0 Hz, 1H), 4.59 (dd, <i>J</i> = 4.0 Hz, <i>J</i> = 12.0 Hz, 1H), 7.30 (dd, <i>J</i> = 0.8 Hz, <i>J</i> = 8.0 Hz, 1H), 7.38–7.46 (m, 2H), 7.68 (s, 1H), 8.14–8.18 (m, 2H), 9.98 (s, 1H), 10.43 (s, 1H); HRMS (ESI) calcd for C<sub>18</sub>H<sub>18</sub>N<sub>4</sub>O<sub>2</sub>Br 401.06067, found 401.06076 [M + H]<sup>+</sup>; purity >99% by HPLC; <i>t</i><sub>R</sub> = 13.77 and 16.82 min; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 1-(6-Fluoropyridin-2-yl)-3-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)urea (<b>20</b>)</h4><div class="NLM_p last">The compound <b>20</b> was obtained the general procedures B and C from the 6-fluoropicolinic acid and the amine <b>8</b> after purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) as a white solid in 70% yield: mp 244–246 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 250 MHz) δ 0.70–1.03 (m, 1H), 1.12–1.40 (m, 1H), 1.52–1.72 (m, 1H), 1.76 (d, <i>J</i> = 14.1 Hz, 1H), 1.90 (d, <i>J</i> = 13.2 Hz, 1H), 2.57–2.75 (m, 1H), 3.02 (td, <i>J</i> = 3.5 Hz, <i>J</i> = 12.7 Hz, 1H), 4.26 (dd, <i>J</i> = 3.5 Hz, 13.0 Hz, 1H), 4.51 (dd, <i>J</i> = 3.3 Hz, <i>J</i> = 11.5 Hz, 1H), 6.77 (dd, <i>J</i> = 2.0 Hz, <i>J</i> = 7.9 Hz, 1H), 7.36–7.51 (m, 2H), 7.57 (dd, <i>J</i> = 2.1 Hz, <i>J</i> = 8.0 Hz, 1H), 7.94 (q, <i>J</i> = 8.2 Hz, 1H), 8.14 (dd, <i>J</i> = 1.2 Hz, <i>J</i> = 7.6 Hz, 1H), 9.33 (s, 1H), 9.92 (s, 1H); HRMS (ESI) calcd for C<sub>18</sub>H<sub>17</sub>N<sub>4</sub>O<sub>2</sub>NaF 363.1233, found 363.1221 [M + Na]<sup>+</sup>; purity >99% by HPLC; <i>t</i><sub>R</sub> =11.39 and 13.45 min; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 1-(3,5-Difluoropyridin-2-yl)-3-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)urea (<b>21</b>)</h4><div class="NLM_p last">The compound <b>21</b> was obtained following the general procedures B and C from the 3,5-difluoropicolinic acid and the amine <b>8</b> after purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) as a white solid in 73% yield: mp 256–258 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 1.06–1.16 (m, 1H), 1.39–1.51 (m, 1H), 1.64–1.76 (m, 1H), 1.85 (d, <i>J</i> = 12.5 Hz, 1H), 2.03 (d, <i>J</i> = 12.5 Hz, 1H), 2.65 (dd, <i>J</i> = 2.8 Hz, <i>J</i> = 12.8 Hz, 1H), 3.01 (td, <i>J</i> = 3.6 Hz, <i>J</i> = 12.8 Hz, 1H), 4.47 (dd, <i>J</i> = 3.6 Hz, <i>J</i> = 11.6 Hz, 1H), 4.54 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 12.8 Hz, 1H), 7.37–7.39 (m, 2H), 7.48 (t, <i>J</i> = 8.0 Hz, 1H), 7.66 (d, <i>J</i> = 7.5 Hz, 1H), 7.98 (d, <i>J</i> = 2.4 Hz, 1H), 8.11 (d, <i>J</i> = 8.0 Hz, 1H), 11.09 (s, 1H); HRMS (ESI) calcd for C<sub>18</sub>H<sub>17</sub>F<sub>2</sub>N<sub>4</sub>O<sub>2</sub> 359.13164, found 359.13141 [M + H]<sup>+</sup>; purity >99% by HPLC; <i>t</i><sub>R</sub> = 9.70 and 14.19 min; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 1-(6-Oxo-1,2,3,4,6,10<i>b</i>-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)-3-(perchloropyridin-2-yl)urea (<b>22</b>)</h4><div class="NLM_p last">The compound <b>22</b> was obtained following the general procedures B and C from the 3,4,5,6-tetrachloropicolinic acid and the amine <b>8</b> after purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) as a beige solid in 60% yield: mp 246–248 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.84–0.92 (m, 1H), 1.15–1.29 (m, 1H), 1.64 (q, <i>J</i> = 12.8 Hz, 1H), 1.75 (d, <i>J</i> = 12.3 Hz, 1H), 1.88 (d, <i>J</i> = 13.0 Hz, 1H), 2.61 (d, <i>J</i> = 10.2 Hz, 1H), 3.02 (td, <i>J</i> = 3.8 Hz, <i>J</i> = 12.0 Hz, 1H), 4.25 (dd, <i>J</i> = 3.8 Hz, <i>J</i> = 12.6 Hz, 1H), 4.58 (dd, <i>J</i> = 3.3 Hz, <i>J</i> = 11.5 Hz, 1H), 7.44–7.49 (m, 2H), 7.97 (dd, <i>J</i> = 7.3 Hz, <i>J</i> = 1.2 Hz, 1H), 9.60 (d, <i>J</i> = 2.6 Hz, 2H); HRMS (ESI) calcd for C<sub>18</sub>H<sub>14</sub>N<sub>4</sub>O<sub>2</sub>NaCl<sub>4</sub>: 480.9769, found 480.9789 [M + Na]<sup>+</sup>. Purity >97% by HPLC ; <i>t</i><sub>R</sub> =16.02 and 18.93 min ; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 1-(3-Methoxypyridin-2-yl)-3-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-a]isoindol-10-yl)urea (<b>23</b>)</h4><div class="NLM_p last">The compound <b>23</b> was obtained following the general procedures B and C from the 3-methoxypicolinic acid and the amine <b>8</b> after purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) as a white solid in 70% yield: mp 202–204 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 1.03–1.13 (m, 1H), 1.38–1.50 (m, 1H), 1.65–1.76 (m, 1H), 1.83 (d, <i>J</i> = 12.8 Hz, 1H), 2.02 (d, <i>J</i> = 13.2 Hz, 1H), 2.81 (dd, <i>J</i> = 2.8 Hz, <i>J</i> = 12.8 Hz, 1H), 3.01 (td, <i>J</i> = 3.6 Hz, <i>J</i> = 12.8 Hz, 1H), 3.93 (s, 3H), 4.48 (dd, <i>J</i> = 3.6 Hz, <i>J</i> = 12.0 Hz, 1H), 4.54 (dd, <i>J</i> = 5.2 Hz, <i>J</i> = 13.2 Hz, 1H), 6.97 (dd, <i>J</i> = 5.2 Hz, <i>J</i> = 8.0 Hz, 1H), 7.12 (d, <i>J</i> = 8.0 Hz, 1H), 7.46 (t, <i>J</i> = 8.0 Hz, 1H), 7.59–7.62 (m, 2H), 7.79 (dd, <i>J</i> = 0.8 Hz, <i>J</i> = 5.2 Hz, 1H), 8.24 (d, <i>J</i> = 8.0 Hz, 1H), 11.86 (s, 1H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>21</sub>N<sub>4</sub>O<sub>3</sub>: 353.16100, found 353.16082 [M + H]<sup>+</sup>. Purity >99% by HPLC ; <i>t</i><sub>R</sub> =15.63 and 18.44 min ; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 1-(6-Oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-a]isoindol-10-yl)-3-(6-(piperidin-1-yl)pyridin −2-yl)urea (<b>24</b>)</h4><div class="NLM_p last">The compound <b>24</b> was obtained following the general procedures B and C from the 6-(piperidin-1-yl)picolinic acid and the amine <b>8</b> after purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) as a yellow solid in 81% yield: mp 234–236 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 0.94–1.05 (m, 1H), 1.34–1.38 (m, 1H), 1.54–1.65 (m, 7H), 1.77 (d, <i>J</i> = 12.8 Hz, 1H), 1.88 (d, <i>J</i> = 13.2 Hz, 1H), 2.43 (dd, <i>J</i> = 2.8 Hz, <i>J</i> = 12.8 Hz, 1H), 2.95 (td, <i>J</i> = 3.6 Hz, <i>J</i> = 13.2 Hz, 1H), 3.46–3.47 (m, 4H), 4.49 (dd, <i>J</i> = 3.6 Hz, <i>J</i> = 13.2 Hz, 1H), 4.69 (dd, <i>J</i> = 2.8 Hz, <i>J</i> = 12.8 Hz, 1H), 6.14 (d, <i>J</i> = 8.0 Hz, 1H), 6.31 (d, <i>J</i> = 8.0 Hz, 1H), 7.40–7.47 (m, 3H), 7.72 (d, <i>J</i> = 8.0 Hz, 1H), 8.40 (s, 1H), 11.59 (s, 1H); HRMS (ESI) calcd for C<sub>23</sub>H<sub>28</sub>N<sub>5</sub>O<sub>2</sub>: 406.22394, found 406.22375 [M + H]<sup>+</sup>. Purity >99% by HPLC ; <i>t</i><sub>R</sub> =12.93 and 19.84 min ; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 1-(6-Oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-a]isoindol-10-yl)-3-(5-phenylpyridin-2-yl)urea (<b>25</b>)</h4><div class="NLM_p last">The compound <b>25</b> was obtained following the general procedures B and C from the 5-phenylpicolinic acid and the amine <b>8</b> after purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) as a white solid in 79% yield: mp >260 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.84–0.93 (m, 1H), 1.20–1.30 (m, 1H), 1.76 (d, <i>J</i> = 12.8 Hz, 2H), 1.91 (d, <i>J</i> = 12.8 Hz, 1H), 2.72 (d, <i>J</i> = 12.8 Hz, 1H), 2.95 (t, <i>J</i> = 12.4 Hz, 1H), 4.26 (d, <i>J</i> = 13.2 Hz, 1H), 4.61 (d, <i>J</i> = 12.8 Hz, 1H), 7.38–7.50 (m, 6H), 7.68 (d, <i>J</i> = 8.0 Hz, 2H), 8.11 (d, <i>J</i> = 8.4 Hz, 1H), 8.23 (d, <i>J</i> = 8.0 Hz, 1H), 8.59 (s, 1H), 10.01 (s, 1H), 11.07 (s, 1H); HRMS (ESI) calcd for C<sub>24</sub>H<sub>23</sub>N<sub>4</sub>O<sub>2</sub>: 399.1821, found 399.1811 [M + H]<sup>+</sup>. Purity >99% by HPLC ; <i>t</i><sub>R</sub> =12.66 and 29.72 min ; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 11-(5-Methylisoxazol-3-yl)-3-(6-oxo-1,2,3,4,6,10<i>b</i>-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)urea (<b>26</b>)</h4><div class="NLM_p last">The compound <b>26</b> was obtained the general procedures B and C from the 5-methylisoxazole-3-carboxylic acid and the amine <b>8</b> after purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) as a yellow solid in 72% yield: mp 156–158 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 1.03 (qd, <i>J</i> = 3.1 Hz, <i>J</i> = 12.8 Hz, 1H), 1.29–1.46 (m, 1H), 1.53–1.70 (m, 1H), 1.80 (d, <i>J</i> = 13.1 Hz, 1H), 1.94 (d, <i>J</i> = 13.3 Hz, 1H), 2.41 (s, 3H), 2.70 (d, <i>J</i> = 11.1 Hz, 1H), 2.98 (td, <i>J</i> = 3.2 Hz, <i>J</i> = 13.0 Hz, 1H), 4.49 (td, <i>J</i> = 4.0 Hz, <i>J</i> = 11.8 Hz, 2H), 6.12 (s, 1H), 7.44 (t, <i>J</i> = 7.8 Hz, 1H), 7.64 (d, <i>J</i> = 7.3 Hz, 1H), 7.99 (d, <i>J</i> = 7.9 Hz, 1H), 9.33 (s, 1H), 9.53 (s, 1H); HRMS (ESI) calcd for C<sub>17</sub>H<sub>18</sub>N<sub>4</sub>O<sub>3</sub>Na: 349.1277, found 349.1267 [M + Na]<sup>+</sup>; purity >95% by HPLC; <i>t</i><sub>R</sub> =13.13 and 24.25 min; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 1-(6-Oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)-3-(5-phenylisoxazol-3-yl)urea (<b>27</b>)</h4><div class="NLM_p last">The compound <b>27</b> was obtained following the general procedures B and C from the 5-phenylisoxazole-3-carboxylic acid and the amine <b>8</b> after purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) as a white solid in 87% yield: mp 248–250 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.86 (qd, <i>J</i> = 2.9 Hz, <i>J</i> = 12.7 Hz, 1H), 1.17–1.34 (m, 1H), 1.54–1.71 (m, 1H), 1.76 (d, <i>J</i> = 12.5 Hz, 1H), 1.91 (d, <i>J</i> = 13.1 Hz, 1H), 2.61 (dd, <i>J</i> = 2.9 Hz, <i>J</i> = 12.5 Hz, 1H), 3.02 (td, <i>J</i> = 3.6 Hz, <i>J</i> = 12.8 Hz, 1H), 4.26 (dd, <i>J</i> = 3.6 Hz, <i>J</i> = 13.0 Hz, 1H), 4.52 (dd, <i>J</i> = 3.3 Hz, <i>J</i> = 11.5 Hz, 1H), 7.27 (s, 1H), 7.39–7.59 (m, 5H), 7.88 (dd, <i>J</i> = 1.7 Hz, <i>J</i> = 7.6 Hz, 2H), 8.04 (d, <i>J</i> = 7.7 Hz, 1H), 8.58 (s, 1H), 10.04 (s, 1H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>20</sub>N<sub>4</sub>O<sub>3</sub>Na 411.1433, found 411.1414 [M + Na]<sup>+</sup>; purity >97% by HPLC; <i>t</i><sub>R</sub> =13.16, <i>n</i>-heptane/ethanol (8:2), no separation.</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 11-(6-Oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)-3-(thiazol-4-yl)urea (<b>28</b>)</h4><div class="NLM_p last">The compound <b>28</b> was obtained following the general procedures B and C from the thiazole-4-carboxylic acid and the amine <b>8</b> after purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) as a yellow solid in 62% yield: mp 178–180 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 0.92–1.10 (m, 1H), 1.28–1.43 (m, 1H), 1.43–1.60 (m, 1H), 1.76 (d, <i>J</i> = 12.3 Hz, 1H), 1.88 (d, <i>J</i> = 12.2 Hz, 1H), 2.65 (d, <i>J</i> = 10.9 Hz, 1H), 2.91–2.97 (m, 1H), 4.38–4.57 (m, 2H), 7.11 (s, 1H), 7.41 (t, <i>J</i> = 7.8 Hz, 1H), 7.61 (d, <i>J</i> = 7.4 Hz, 1H), 7.96 (d, <i>J</i> = 7.8 Hz, 1H), 8.64 (d, <i>J</i> = 1.5 Hz, 1H), 9.68 (s, 1H); HRMS (ESI) calcd for C<sub>16</sub>H<sub>16</sub>N<sub>4</sub>O<sub>2</sub>NaS: 351.0892, found 351.0885 [M + Na]<sup>+</sup>; purity >96% by HPLC; <i>t</i><sub>R</sub> =20.45 and 29.15 min; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 1-(6-Oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)-3-(2-(pyridin-4-yl)thiazol-4-yl)urea (<b>29</b>)</h4><div class="NLM_p last">The compound <b>29</b> was obtained following the general procedures B and C from the 2-(pyridin-4-yl)thiazole-4-carboxylic acid and the amine <b>8</b> after purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) as a orange solid in 60% yield: mp 152–154 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.85 (qd, <i>J</i> = 2.9 Hz, <i>J</i> = 12.7 Hz, 1H). 1.15–1.34 (m, 1H), 1.62 (q, <i>J</i> = 13.0 Hz, 1H), 1.76 (d, <i>J</i> = 12.6 Hz, 1H), 1.90 (d, <i>J</i> = 13.1 Hz, 1H), 2.62 (dd, <i>J</i> = 2.9 Hz, <i>J</i> = 12.6 Hz, 1H), 3.03 (td, <i>J</i> = 3.7 Hz, <i>J</i> = 12.9 Hz, 1H), 4.26 (dd, <i>J</i> = 3.7 Hz, <i>J</i> = 13.0 Hz, 1H), 4.50 (dd, <i>J</i> = 3.3 Hz, <i>J</i> = 11.5 Hz, 1H), 7.38 (dd, <i>J</i> = 0.8 Hz, <i>J</i> = 7.4 Hz, 1H), 7.45 (t, <i>J</i> = 7.7 Hz, 1H), 7.55 (s, 1H), 7.84 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 4.5 Hz, 2H), 8.11 (d, <i>J</i> = 7.2 Hz, 1H), 8.48 (s, 1H), 8.72 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 4.6 Hz, 2H), 10.10 (s, 1H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>20</sub>N<sub>5</sub>O<sub>2</sub>S 406.1338, found 406.1343 [M + H]<sup>+</sup>; purity >96% by HPLC; <i>t</i><sub>R</sub> =8.20 and 28.09 min; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 1-(1-Methyl-1<i>H</i>-pyrazol-3-yl)-3-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)urea (<b>30</b>)</h4><div class="NLM_p last">The compound <b>30</b> was obtained following the general procedures B and C from the 1-methyl-1<i>H</i>-pyrazole-3-carboxylic acid and the amine <b>8</b> after purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) as a white solid in 62% yield: mp 233–235 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.87 (dd, <i>J</i> = 23.0 Hz, <i>J</i> = 11.8 Hz, 1H), 1.25 (d, <i>J</i> = 12.6 Hz, 1H), 1.55–1.74 (m, 1H), 1.76 (d, <i>J</i> = 12.5 Hz, 1H), 1.92 (d, <i>J</i> = 13.1 Hz, 1H), 2.71 (d, <i>J</i> = 11.1 Hz, 1H), 3.03 (t, <i>J</i> = 11.6 Hz, 1H), 3.78 (s, 3H), 4.26 (d, <i>J</i> = 9.5 Hz, 1H), 4.52 (d, <i>J</i> = 8.9 Hz, 1H), 6.07 (s, 1H), 7.35 (d, <i>J</i> = 7.2 Hz, 1H), 7.43 (t, <i>J</i> = 7.7 Hz, 1H), 7.59 (s, 1H), 8.18 (d, <i>J</i> = 7.3 Hz, 1H), 9.21 (s, 1H), 9.42 (s, 1H); HRMS (ESI) calcd for C<sub>17</sub>H<sub>19</sub>N<sub>5</sub>O<sub>2</sub>Na 348.1436, found 348.1431 [M + Na]<sup>+</sup>; purity >97% by HPLC; <i>t</i><sub>R</sub> =11.05 and 31.89 min; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 1-(Isoquinolin-3-yl)-3-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)urea (<b>31</b>)</h4><div class="NLM_p last">The compound <b>31</b> was obtained following the general procedures B and C from the 3-isoquinolin-3-carboxylic acid and the amine <b>8</b> after purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) as a white solid in 71% yield: mp > 260 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 1.10–1.20 (m, 1H), 1.43–1.49 (m, 1H), 1.72–1.88 (m, 2H), 2.07 (d, <i>J</i> = 13.2 Hz, 1H), 2.90 (dd, <i>J</i> = 2.8 Hz, <i>J</i> = 12.8 Hz, 1H), 3.04 (td, <i>J</i> = 3.2 Hz, <i>J</i> = 13.2 Hz, 1H), 4.54–4.60 (m, 2H), 7.38 (d, <i>J</i> = 6.0 Hz, 1H), 7.52 (t, <i>J</i> = 7.6 Hz, 1H), 7.65–7.68 (m, 2H), 7.79 (t, <i>J</i> = 7.6 Hz, 1H), 7.86 (d, <i>J</i> = 8.5 Hz, 1H), 8.08 (d, <i>J</i> = 6.0 Hz, 1H), 8.20 (d, <i>J</i> = 8.5 Hz, 1H), 8.34 (d, <i>J</i> = 8.0 Hz, 1H), 8.47 (s, 1H), 12.69 (s, 1H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>21</sub>N<sub>4</sub>O<sub>2</sub> 373.1665, found 376.1660 [M + H]<sup>+</sup>; purity >98% by HPLC; <i>t</i><sub>R</sub> =10.84 min; <i>n</i>-heptane/ethanol (8:2), no separation.</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 1-(Benzo[<i>d</i>]thiazol-2-yl)-3-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)urea (<b>32</b>)</h4><div class="NLM_p last">The compound <b>32</b> was obtained following the general procedures B and C from the acid <b>9</b> and the amine <b>8</b> after purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) as a yellow solid in 50% yield: mp 258–260 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.88 (q, <i>J</i> = 12.0 Hz, 1H), 1.15–1.32 (m, 1H), 1.64 (q, <i>J</i> = 13.0 Hz, 1H), 1.76 (d, <i>J</i> = 12.4 Hz, 1H), 1.90 (d, <i>J</i> = 12.8 Hz, 1H), 2.61 (d, <i>J</i> = 11.5 Hz, 1H), 3.01–3.07 (m, 1H), 4.26 (d, <i>J</i> = 9.2 Hz, 1H), 4.57 (d, <i>J</i> = 9.4 Hz, 1H), 7.26 (t, <i>J</i> = 7.5 Hz, 1H), 7.39–7.51 (m, 3H), 7.69 (d, <i>J</i> = 6.6 Hz, 1H), 7.93 (d, <i>J</i> = 7.7 Hz, 1H), 8.05 (d, <i>J</i> = 7.0 Hz, 1H), 9.07 (s, 1H), 11.19 (s, 1H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>18</sub>N<sub>4</sub>O<sub>2</sub>NaS 401.1048, found 401.1066 [M + Na]<sup>+</sup>; purity >97% by HPLC; <i>t</i><sub>R</sub> =17.41 and 22.78 min; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 1-(2-Methylthiazol-4-yl)-3-(6-oxo-1,2,3,4,6,10<i>b</i>-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)urea (<b>33</b>)</h4><div class="NLM_p last">The compound <b>33</b> was obtained following the general procedures B and C from the acid <b>10</b> and the amine <b>8</b> after purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) as a yellow solid in 42% yield: mp 146–148 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 1.04 (q, <i>J</i> = 12.0 Hz, 1H), 1.31–1.47 (m, 1H), 1.48–1.62 (m, 1H), 1.78 (d, <i>J</i> = 12.6 Hz, 1H), 1.92 (d, <i>J</i> = 12.6 Hz, 1H), 2.71 (m, 4H), 2.95 (t, <i>J</i> = 12.0 Hz, 1H), 4.45 (dd, <i>J</i> = 3.5 Hz, <i>J</i> = 11.6 Hz, 1H), 4.51 (dd, <i>J</i> = 4.0 Hz, <i>J</i> = 13.2 Hz, 1H), 6.70 (s, 1H), 7.41 (t, <i>J</i> = 7.8 Hz, 1H), 7.62 (d, <i>J</i> = 7.3 Hz, 1H), 8.03 (d, <i>J</i> = 6.5 Hz, 1H), 9.30 (s, 2H); HRMS (ESI) calcd for C<sub>17</sub>H<sub>18</sub>N<sub>4</sub>O<sub>2</sub>NaS 365.1048, found 365.1062 [M + Na]<sup>+</sup>; purity >99% by HPLC; <i>t</i><sub>R</sub> =14.26 and 29.06 min; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 1-(6-Oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)-3-pyrimidin-2-ylurea (<b>34</b>)</h4><div class="NLM_p last">The compound <b>34</b> was obtained following the general procedures B and C from the acid <b>12</b> and the amine <b>8</b> after purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) as a beige solid in 87% yield: mp 232–234 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.90 (dt, <i>J</i> = 12.0 Hz, <i>J</i> = 14.5 Hz, 1H), 1.25 (dd, <i>J</i> = 9.3 Hz, <i>J</i> = 13.3 Hz, 1H), 1.75 (t, <i>J</i> = 13.2 Hz, 2H), 1.92 (d, <i>J</i> = 13.1 Hz, 1H), 2.68 (d, <i>J</i> = 10.2 Hz, 1H), 2.96–3.11 (m, 1H), 4.27 (dd, <i>J</i> = 4.5 Hz, <i>J</i> = 12.8 Hz, 1H), 4.64 (dd, <i>J</i> = 3.2 Hz, <i>J</i> = 11.5 Hz, 1H), 7.20 (t, <i>J</i> = 4.9 Hz, 1H), 7.42 (d, <i>J</i> = 7.2 Hz, 1H), 7.48 (t, <i>J</i> = 7.7 Hz, 1H), 8.24 (d, <i>J</i> = 7.8 Hz, 1H), 8.70 (d, <i>J</i> = 4.9 Hz, 2H), 10.42 (s, 1H), 11.60 (s, 1H); HRMS (ESI) calcd for C<sub>17</sub>H<sub>18</sub>N<sub>5</sub>O<sub>2</sub> 324.1461, found 324.1449 [M + H]<sup>+</sup>; purity >97% by HPLC; <i>t</i><sub>R</sub> =30.41 and 49.77 min; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 1-(6-Oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)-3-(pyrimidin-4-yl)urea (<b>35</b>)</h4><div class="NLM_p last">The compound <b>35</b> was obtained following the general procedures B and C from the acid <b>12</b> and the amine <b>8</b> after purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) as a beige solid in 76% yield: mp 218–220 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.82–0.91 (m, 1H), 1.12–1.38 (m, 1H), 1.61–1.80 (m, 2H), 1.91 (d, <i>J</i> = 11.9 Hz, 1H), 2.64 (d, <i>J</i> = 10.9 Hz, 1H), 3.03 (t, <i>J</i> = 11.8 Hz, 1H), 4.26 (d, <i>J</i> = 9.6 Hz, 1H), 4.57 (d, <i>J</i> = 8.8 Hz, 1H), 7.40–7.50 (m, 2H), 7.54 (d, <i>J</i> = 5.4 Hz, 1H), 8.12 (d, <i>J</i> = 7.6 Hz, 1H), 8.58 (d, <i>J</i> = 5.6 Hz, 1H), 8.84 (s, 1H), 10.14 (s, 1H), 10.21 (s, 1H); HRMS (ESI) calcd for C<sub>17</sub>H<sub>18</sub>N<sub>5</sub>O<sub>2</sub> 324.1461, found 324.1465 [M + H]<sup>+</sup>; purity >96% by HPLC; <i>t</i><sub>R</sub> = 13.07 and 21.15 min; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 1-(3-(Methoxymethoxy)pyridin-2-yl)-3-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)urea (<b>36</b>)</h4><div class="NLM_p last">The compound <b>36</b> was obtained following the general procedures B and C from carboxylic acid <b>9</b> and the amine <b>8</b> after purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) as a white solid in 73% yield: mp 182–184 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 1.03–1.19 (m, 1H), 1.42–1.55 (m, 1H), 1.70–1.75 (m, 1H), 1.86 (d, <i>J</i> = 12.8 Hz, 1H), 2.05 (d, <i>J</i> = 13.2 Hz, 1H), 2.84 (dd, <i>J</i> = 2.8 Hz, <i>J</i> = 12.8 Hz, 1H), 3.04 (td, <i>J</i> = 2.8 Hz, <i>J</i> = 12.8 Hz, 1H), 3.54 (s, 3H), 4.48 (dd, <i>J</i> = 3.2 Hz, <i>J</i> = 12.8 Hz, 1H), 4.54 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 13.2 Hz, 1H), 5.28 (s, 2H), 6.94 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 8.0 Hz, 1H), 7.43–7.49 (m, 2H), 7.60–7.62 (m, 2H), 7.85 (dd, <i>J</i> = 1.2 Hz, <i>J</i> = 8.0 Hz, 1H), 8.23 (d, <i>J</i> = 8.0 Hz, 1H), 11.85 (s, 1H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>23</sub>N<sub>4</sub>O<sub>4</sub> 383.1719, found 383.1704 [M + H]<sup>+</sup>; purity >99% by HPLC; <i>t</i><sub>R</sub> =17.70 and 19.00 min; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 1-(5-(Methoxymethoxy)pyridin-2-yl)-3-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)urea (<b>37</b>)</h4><div class="NLM_p last">The compound <b>37</b> was obtained following the general procedures B and C from carboxylic acid <b>10</b> and the amine <b>8</b> after purification by flash chromatography(CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) as a white solid in 78% yield: mp 202–204 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 1.04–1.14 (m, 1H), 1.39–1.47 (m, 1H), 1.65–1.76 (m, 1H), 1.84 (d, <i>J</i> = 12.8 Hz, 1H), 2.03 (d, <i>J</i> = 13.2 Hz, 1H), 2.81 (dd, <i>J</i> = 3.2 Hz, <i>J</i> = 12.8 Hz, 1H), 3.02 (td, <i>J</i> = 3.2 Hz, <i>J</i> = 12.8 Hz, 1H), 3.52 (s, 3H), 4.48 (dd, <i>J</i> = 3.2 Hz, <i>J</i> = 12.0 Hz, 1H), 4.55 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 13.2 Hz, 1H), 5.17 (s, 2H), 6.96 (d, <i>J</i> = 8.8 Hz, 1H), 7.46–7.50 (m, 2H), 7.63 (d, <i>J</i> = 8.0 Hz, 1H), 8.02 (s, 1H), 8.26 (d, <i>J</i> = 8.0 Hz, 1H), 9.36 (s, 1H), 11.78 (s, 1H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>22</sub>N<sub>4</sub>O<sub>4</sub>Na 405.1539, found 405.1547 [M + Na]<sup>+</sup>; purity >97% by HPLC; <i>t</i><sub>R</sub> =17.48 and 30.68 min; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 1-(8-(Methoxymethoxy)quinolin-2-yl)-3-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)urea (<b>38</b>)</h4><div class="NLM_p last">The compound <b>38</b> was obtained following the general procedures B and C from carboxylic acid <b>11</b> and the amine <b>8</b> after purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) as a white solid in 75% yield: mp 226–228 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 0.96–1.06 (m, 1H), 1.31–1.39 (m, 1H), 1.46–1.56 (m, 1H), 1.78 (t, <i>J</i> = 16.5 Hz, 2H), 2.53 (d, <i>J</i> = 10.8 Hz, 1H), 3.00 (td, <i>J</i> = 3.2 Hz, <i>J</i> = 13.2 Hz, 1H), 3.42 (s, 3H), 4.54 (dd, <i>J</i> = 3.2 Hz, <i>J</i> = 13.2 Hz, 1H), 5.00 (dd, <i>J</i> = 3.2 Hz, <i>J</i> = 10.8 Hz, 1H), 5.34 (s, 2H), 7.14 (d, <i>J</i> = 8.8 Hz, 1H), 7.33–7.44 (m, 3H), 7.85 (t, <i>J</i> = 7.6 Hz, 1H), 7.77 (d, <i>J</i> = 7.6 Hz, 1H), 7.85 (d, <i>J</i> = 7.6 Hz, 1H), 8.09 (d, <i>J</i> = 8.8 Hz, 1H), 10.01 (s, 1H), 13.00 (s, 1H); HRMS (ESI) calcd for C<sub>24</sub>H<sub>25</sub>N<sub>4</sub>O<sub>4</sub> 433.1876, found 433.1884 [M + H]<sup>+</sup>; purity >96% by HPLC; <i>t</i><sub>R</sub> =12.85 and 21.95 min; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 1-(4-(Methoxymethoxy)quinolin-2-yl)-3-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)urea (<b>39</b>)</h4><div class="NLM_p last">The compound <b>39</b> was obtained following the general procedures B and C from carboxylic acid <b>17</b> and the amine <b>8</b> after purification by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) as a white solid in 70% yield: mp > 260 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.85–1.01 (m, 1H), 1.16–1.32 (m, 1H), 1.53–1.79 (m, 3H), 2.52 (d, <i>J</i> = 10.4 Hz, 1H), 3.11 (td, <i>J</i> = 3.2 Hz, <i>J</i> = 13.2 Hz, 1H), 3.51 (s, 3H), 4.30 (dd, <i>J</i> = 3.2 Hz, <i>J</i> = 13.2 Hz, 1H), 4.82 (d, <i>J</i> = 10.4 Hz, 1H), 5.49 (s, 3H), 6.98 (s, 1H), 7.46–7.53 (m, 3H), 7.78 (t, <i>J</i> = 7.5 Hz, 1H), 7.90 (d, <i>J</i> = 7.5 Hz, 1H), 8.08 (d, <i>J</i> = 7.5 Hz, 1H), 8.28 (d, <i>J</i> = 7.5 Hz, 1H), 10.16 (s, 1H), 11.93 (s, 1H); HRMS (ESI) calcd for C<sub>24</sub>H<sub>25</sub>N<sub>4</sub>O<sub>4</sub> 433.1876, found 433.1880 [M + H]<sup>+</sup>; purity >98% by HPLC; <i>t</i><sub>R</sub> =8.31 and 9.91 min; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 1-(6-Oxo-1,2,3,4,6,10<i>b</i>-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)-3-(1<i>H</i>-pyrazol-3-yl)urea (<b>40</b>)</h4><div class="NLM_p last">Compound <b>40</b> could be obtained as described in procedures B and C but in only a 4% yield. Alternatively, the following procedure led to <b>40</b> in a 66% yield. A mixture of <b>41</b>(60 mg, 0.146 mmol) and NaOH (1 M in water, 20 mL) in dry THF (10 mL) was stirred overnight at room temperature. The reaction mixture was extracted with hot EtOAc (3 × 20 mL). The combined organic layers were dried over MgSO<sub>4</sub> and reduced under reduced pressure to afford, after flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1), the compound <b>40</b> as a white solid: mp 185–187 <i>°C</i>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.84 (qd, <i>J</i> = 12.8 Hz, <i>J</i> = 3.2 Hz, 1H), 1.16–1.34 (m, 1H), 1.56–1.83 (m, 2H), 1.90 (d, <i>J</i> = 13.2 Hz, 1H), 2.66 (d, <i>J</i> = 10.7 Hz, 1H), 3.01 (td, <i>J</i> = 3.0 Hz, <i>J</i> = 12.7 Hz, 1H), 4.26 (dd, <i>J</i> = 4.3 Hz, <i>J</i> = 13.1 Hz, 1H), 4.48 (dd, <i>J</i> = 3.2 Hz, <i>J</i> = 11.5 Hz, 1H), 6.20 (s, 1H), 7.35 (d, <i>J</i> = 7.2 Hz, 1H), 7.42 (t, <i>J</i> = 7.7 Hz, 1H), 7.63 (s, 1H), 8.12 (d, <i>J</i> = 7.9 Hz, 1H), 9.06 (s, 1H), 9.40 (s, 1H), 12.33 (s, 1H); HRMS (ESI) calcd for C<sub>16</sub>H<sub>18</sub>N<sub>5</sub>O<sub>2</sub>: 312.1461, found 312.1475 [M + H]<sup>+</sup>; purity >97% by HPLC; <i>t</i><sub>R</sub> =12.56 and 15.98 min; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 3-[3-(6-Oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)ureido]pyrazole-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>41</b>)</h4><div class="NLM_p last">To a stirred solution of <b>8</b> (140 mg ; 0.7 mmol) and Et<sub>3</sub>N (0.2 mL, 2.0 equiv) in dry CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added at 0 °C under Ar bis(trichloromethyl) carbonate (207 mg, 1.0 equiv). After 5 h at reflux, the reaction mixture was cooled to room temperature, and a solution of 3-aminopyrazole-1-carboxylic acid <i>tert</i>-butyl ester (128 mg, 1.0 equiv) in dry pyridine (1.2 mL) was added. The reaction mixture was stirred at room temperature for 18 h and then diluted with water (30 mL) and extracted with EtOAc (2 × 30 mL). The combined organic layers were successively washed with water (30 mL), dried over MgSO<sub>4</sub>, and evaporated under reduced pressure to afford after silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99/1) the compound <b>41</b> as a yellow solid in 56% yield: mp 136–138 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 0.98 (qd, <i>J</i> = 3.2 Hz, <i>J</i> = 12.7 Hz, 1H), 1.27–1.45 (m, 1H), 1.62 (s, 9H), 1.76 (d, <i>J</i> = 11.8 Hz, 1H), 1.85 (d, <i>J</i> = 13.0 Hz, 1H), 2.18 (s, 1H), 2.65 (s, 1H), 2.99 (t, <i>J</i> = 11.8 Hz, 1H), 4.49 (dd, <i>J</i> = 3.8 Hz, <i>J</i> = 13.0 Hz, 1H), 4.64 (d, <i>J</i> = 9.8 Hz, 1H), 6.38 (s, 1H), 7.42 (t, <i>J</i> = 7.8 Hz, 1H), 7.63 (d, <i>J</i> = 7.4 Hz, 1H), 7.91 (d, <i>J</i> = 2.9 Hz, 1H), 7.99 (s, 1H), 9.59 (s, 1H), 10.32 (s, 1H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>25</sub>N<sub>5</sub>O<sub>4</sub>Na 434.1804, found 434.1791 [M + Na]<sup>+</sup>.</div></div></div><div id="sec5_1_43_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> General Procedure D</h3><div class="NLM_p">A mixture containing the protected urea (1 mmol), an aqueous solution of HCl (10%, 5 mL), and acetone (5 mL) was heated at reflux for 2 h. After cooling, acetone was removed under reduced pressure, and the resulting crude material was filtered, washed with water, and dried to give desired compound.</div><div id="sec5_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 1-(3-Hydroxypyridin-2-yl)-3-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)urea (<b>42</b>)</h4><div class="NLM_p last">The compound <b>42</b> was obtained following the general procedure D from compound <b>36</b> as a yellow solid in 90% yield: mp 190–192 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.76–0.84 (m, 1H), 1.18–1.27 (m, 1H), 1.58–1.68 (m, 1H), 1.74 (d, <i>J</i> = 12.8 Hz, 1H), 1.86 (d, <i>J</i> = 13.2 Hz, 1H), 2.69 (dd, <i>J</i> = 2.8 Hz, <i>J</i> = 12.8 Hz, 1H), 2.98 (td, <i>J</i> = 2.8 Hz, <i>J</i> = 12.8 Hz, 1H), 4.24 (dd, <i>J</i> = 4.0 Hz, <i>J</i> = 12.8 Hz, 1H), 4.66 (dd, <i>J</i> = 4.0 Hz, <i>J</i> = 12.8 Hz, 1H), 7.30 (dd, <i>J</i> = 6.4 Hz, <i>J</i> = 8.0 Hz, 1H), 7.45–7.52 (m, 2H), 7.84 (t, <i>J</i> = 9.6 Hz, 2H), 8.00 (dd, <i>J</i> = 1.2 Hz, <i>J</i> = 8.0 Hz, 1H), 10.57 (s, 1H), 10.86 (s, 1H), 12.73 (s, 1H); HRMS (ESI) calcd for C<sub>18</sub>H<sub>19</sub>N<sub>4</sub>O<sub>3</sub> 339.1457, found 339.1441 [M + H]<sup>+</sup>; purity >99% by HPLC; <i>t</i><sub>R</sub> =10.03 and 11.26 min; <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 1-(5-Hydroxypyridin-2-yl)-3-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)urea (<b>43</b>)</h4><div class="NLM_p last">The compound <b>43</b> was obtained following the general procedure D from compound <b>37</b> as a white solid in 92% yield: mp 206–208 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.79–0.89 (m, 1H), 1.20–1.27 (m, 1H), 1.63–1.75 (m, 2H), 1.88 (d, <i>J</i> = 13.2 Hz, 1H), 2.76 (dd, <i>J</i> = 2.8 Hz, <i>J</i> = 12.8 Hz, 1H), 3.01 (td, <i>J</i> = 3.2 Hz, <i>J</i> = 12.8 Hz, 1H), 4.25 (dd, <i>J</i> = 4.2 Hz, <i>J</i> = 13.2 Hz, 1H), 4.60 (dd, <i>J</i> = 3.2 Hz, <i>J</i> = 12.8 Hz, 1H), 7.33 (d, <i>J</i> = 8.8 Hz, 1H), 7.40–7.48 (m, 2H), 7.66 (d, <i>J</i> = 7.6 Hz, 1H), 7.89 (d, <i>J</i> = 2.8 Hz, 1H), 8.11 (d, <i>J</i> = 8.0 Hz, 1H), 10.34 (s, 2H), 11.01 (s, 1H); HRMS (ESI) calcd for C<sub>18</sub>H<sub>19</sub>N<sub>4</sub>O<sub>3</sub> 339.1457, found 339.1451 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 1-(8-Hydroxyquinolin-2-yl)-3-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)urea (<b>44</b>)</h4><div class="NLM_p last">The compound <b>44</b> was obtained following the general procedure D from compound <b>38</b> as a white solid in 92% yield: mp 256–258 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.77–0.86 (m, 1H), 1.17–1.26 (m, 1H), 1.56–1.75 (m, 3H), 2.71 (d, <i>J</i> = 12.4 Hz, 1H), 3.04 (t, <i>J</i> = 12.4 Hz, 1H), 4.24 (dd, <i>J</i> = 2.8 Hz, <i>J</i> = 12.8 Hz, 1H), 4.79 (d, <i>J</i> = 12.8 Hz, 1H), 7.32–7.53 (m, 7H), 8.06 (d, <i>J</i> = 7.5 Hz, 1H), 8.57 (s, 1H), 11.27 (s, 2H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>21</sub>N<sub>4</sub>O<sub>3</sub> 389.1614, found 389.1617 [M + H]<sup>+</sup>; purity >96% by HPLC; <i>t</i><sub>R</sub> =18.34 min <i>n</i>-heptane/ethanol (8:2).</div></div><div id="sec5_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 1-(4-Hydroxyquinolin-2-yl)-3-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-<i>a</i>]isoindol-10-yl)urea (<b>45</b>)</h4><div class="NLM_p last">The compound <b>45</b> was obtained following the general procedure D from compound <b>39</b> as a white solid in 95% yield: mp > 260 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.77–0.86 (m, 1H), 1.21–1.27 (m, 1H), 1.58–1.85 (m, 3H), 2.78 (d, <i>J</i> = 10.5 Hz, 1H), 2.99 (td, <i>J</i> = 3.2 Hz, 13.2 Hz, 1H), 4.24 (dd, <i>J</i> = 3.2 Hz, <i>J</i> = 13.2 Hz, 1H), 4.63 (d, <i>J</i> = 10.8 Hz, 1H), 6.95 (s, 1H), 7.45–7.51 (m, 2H), 7.59 (t, <i>J</i> = 7.6 Hz, 1H), 7.88 (t, <i>J</i> = 7.6 Hz, 1H), 8.05 (d, <i>J</i> = 7.6 Hz, 1H), 8.13 (d, <i>J</i> = 8.4 Hz, 2H), 10.26 (s, 1H), 12.14 (s, 2H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>21</sub>N<sub>4</sub>O<sub>3</sub> 389.1614, found 389.1622 [M + H]<sup>+</sup>; purity >99% by HPLC ; <i>t</i><sub>R</sub> =11.33 and 13.05 min; <i>n</i>-heptane/ethanol (8:2).</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Biochemistry</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Buffers</h4><div class="NLM_p last">A: 10 mM MgCl<sub>2</sub>, 1 mM EGTA, 1 mM DTT, 25 mM Tris-HCl pH 7.5, 50 μg heparin/mL. B: 60 mM ß-glycerophosphate, 30 mM <i>p</i>-nitrophenylphosphate, 25 mM Mops (pH 7.2), 5 mM EGTA, 15 mM MgCl<sub>2</sub>, 1 mM DTT, 0.1 mM sodium vanadate, 1 mM phenylphosphate.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Kinase Preparations and Assays</h4><div class="NLM_p">Kinase activities were assayed in buffer A or C, at 30 °C, at a final ATP concentration of 15 μM. Blank values were subtracted and activities expressed in percent of the maximal activity, i.e., in the absence of inhibitors. Controls were performed with appropriate dilutions of DMSO. The kinase peptide substrates were obtained from Proteogenix (Oberhausbergen, France).</div><div class="NLM_p">DYRK1A (human, recombinant, expressed in <i>E. coli</i> as a GST fusion protein) was purified by affinity chromatography on glutathione-agarose and assayed in buffer A (+ 0.5 mg BSA/mL) using Woodtide (KKISGRLSPIMTEQ) (1.5 μg/assay) as a substrate, in the presence of 15 μM [γ-<sup>33</sup>P] ATP (3,000 Ci/mmol; 10 mCi/mL) in a final volume of 30 μL.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> After 30 min incubation at 30 °C, the reaction was stopped by harvesting onto P81 phosphocellulose papers (Whatman) using a FilterMate harvester (Packard) and were washed in 1% phosphoric acid. Scintillation fluid was added and the radioactivity measured in a Packard counter.</div><div class="NLM_p">CDK5/p25 (human, recombinant) was prepared as previously described.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Its kinase activity was assayed in buffer B, with 1 mg of histone H1/mL.</div><div class="NLM_p">GSK-3α/β<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> (porcine brain, native) was assayed in buffer A and using a GSK3 specific substrate (GS-1: YRRAAVPPSPSLSRHSSPHQpSEDEEE) (pS = phosphorylated serine).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_p last">CK1δ/ε (porcine brain, native) was assayed in 3-fold diluted buffer B, using 25 μM CKS peptide (RRKHAAIGpSAYSITA), a CK1-specific substrate.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Cell Biology Cell Culture and Survival Assay</h4><div class="NLM_p last">Skin diploid fibroblastic cells were provided by BIOPREDIC International Co. (Rennes, France). HuH7, CaCo-2, MDA-MB-231, HCT116, PC3, and NCI-H727 cell lines were obtained from the ECACC collection. Cells were grown according to ECACC recommendations. The toxicity test of the compounds on these cells was as follows: 2 × 10<sup>3</sup> cells/well for HCT116 cell line, or 4 × 10<sup>3</sup> cells/well for the other cell lines, were seeded in 96 well plates. 24h after seeding, cells were exposed to increasing concentrations of the compounds (0.1–25 μM or 0.01–2.5 μM). After 48h of treatment, the cells were washed in PBS and fixed in cooled 90% ethanol/5% acetic acid for 20 min. Then, the nuclei were stained with Hoechst 3342 (Sigma). Image acquisition and analysis was performed using a Cellomics ArrayScan VTI/HCS Reader (Thermo Scientific).</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Cell Proliferation</h4><div class="NLM_p last">For BrdU incorporation, 2 × 10<sup>3</sup> cells/well for HCT116 cell line, or 4 × 10<sup>3</sup> cells/well for the other cell lines, were seeded in 96 well plates. Twenty-four hours after seeding, cells were exposed to the compounds. After 48 h of treatment, BrdU (Amersham) was added to the culture medium for 90 min. After fixation in 4% paraformaldehyde solution, cells were costained with Hoechst 3342 (Sigma) and anti-BrdU (Abcam). Image acquisition and analysis was performed using a Cellomics ArrayScan VTI/HCS Reader (Thermo Scientific). The percentage of proliferating cells was calculated by the amount of BrdU positive cells over the total Hoechst positive cells. For the mitotic index, 2 × 10<sup>3</sup> cells/well for HCT116 cell line, or 4 × 10<sup>3</sup> cells/well for the other cell lines, were seeded in 96 well plates. Twenty-four hours after seeding, cells were exposed to the compounds. After 24 h of treatment, cells were fixed in 4% paraformaldehyde solution and then costained with Hoechst 3342 (Sigma) and antiphospho-Histone H3 (Ser10) (Millipore). Image acquisition and analysis was performed using a Cellomics ArrayScan VTI/HCS Reader (Thermo Scientific). The mitotic index was calculated as the percentage of mitotic cells identified by the phospho-histone H3-positive staining, vs the total Hoechst positive cells.</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Apoptosis Analysis</h4><div class="NLM_p last">A total of 2 × 10<sup>3</sup> HCT116 cells/well were seeded in 96 well plates. Twenty-four hours after cell seeding, cells were exposed to the compounds. After 24 h of treatment, cells were fixed in 4% paraformaldehyde solution and then stained for cleaved caspase 3 using the Cellomics Caspase 3 activation kit (ThermoScientific). Cells were stained according to the kit protocol. Image acquisition and analysis was performed using a Cellomics ArrayScan VTI/HCS Reader (Thermo Scientific).</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Statistical Analysis</h4><div class="NLM_p last">All data are expressed as mean ± SD, except if stated otherwise. We performed analysis of significance using a one-way ANOVA test followed by Bonferroni <i>t</i> test or using a Student’s <i>t</i> test.</div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> Orthotopic Colon Tumor Model</h4><div class="NLM_p last">HCT-116-luc-cl5 is a luciferase expressing cell line that was derived from HCT-116 human adenocarcinoma cells by stable transfection of firefly luciferase gene. Cells were maintained in RPMI 1640 medium supplemented with 10% (v/v) fetal bovine serum, 2.0 mmol/L of glutamine and were grown in a humidified atmosphere at 37 °C with 5% CO<sub>2</sub>. Female nude mice NMRI, 6–8 weeks old, were purchased from Janvier laboratories. Mice were bred and housed at INSERM, U892, University of Nantes, under the animal care license no. 44278. Mice were injected orthotopically with 2 × 10<sup>6</sup> HCT-116-luc cells in 30 μL of RPMI in the cecum wall. After 7 days, mice were randomized into three groups of nine mice. Valmerin group mice received intraperitoneally (i.p.) 10 mg/kg of valmerin <b>20</b> in 0.1 mL of vehicle (DMSO in 0.9% NaCl) three times a week for four weeks. The control group received 0.1 mL of vehicle with the same schedule. The third group was treated with reference drug irinotecan 15 mg/kg twice a week.</div></div><div id="sec5_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Bioluminescence Imaging (BLI)</h4><div class="NLM_p last">All mice were assessed weekly using whole-body bioluminescent imaging to quantify relative amounts of tumor burden (Φimageur ; BIOSPACE Lab, France). Each mouse was given potassium salt of <span class="smallcaps smallerCapital">d</span>-luciferin (Interchim) at a dose of 150 mg/kg body weight by intraperitoneal injection. Bioluminescent images were collected in real time until a saturation plateau was reached. The amount of tumor burden was quantified as the relative amount of light produced from the luciferase activity in colon cancer cells and expressed in cpm using the Photovision+software (version 1.3 ; Biospace Lab). Mice were euthanized 5 weeks after inoculation of the tumor cells. At necropsy, ex vivo BLI measurement for each collected organ sample (including cecum, mesenteric nodes, liver, and lung) was performed. Drug efficacy was assessed as described below. Percent <i>T</i>/<i>C</i> in drug-treated versus control mice were expressed as follows: <i>T</i>/<i>C</i> (%) = 100 – (variation BLI treated mice/variation BLI control mice × 100). <i>T</i>/<i>C</i> (%) = 100 – (mean cecum BLI of treated mice/mean cecum BLI of control mice × 100).</div></div><div id="sec5_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Statistical analysis</h4><div class="NLM_p last">Data were computed using Prism 5.0 software (Graphpad, La Jolla, CA). Groups were compared either by the 2 way ANOVA test or by the Kruskal–Wallis test, and <i>p</i> < 0.05 values were considered as indicative of significant differences between groups.</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Molecular Modeling</h3><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Docking Protocol</h4><div class="NLM_p last">All molecular modeling studies were performed with Schrodinger Molecular Modeling Suite 2012.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Maestro is the interface piloting the diverse modules. Glide was used to dock ligands.</div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Structure Preparation</h4><div class="NLM_p last">The high-resolution crystal structure of GSK3 in complex with bis(indole)maleimide pyridinophane (BIM) was retrieved from the protein data bank,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> under <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OW3">2OW3</a> pdb code. The structure was prepared using the workflow Protein Preparation Wizard of the Schrodinger Molecular Modeling Suite 2012. A comparison of heavy atoms for the conformation of BIM cocrystallized and the conformation of BIM extracted and redocked within the receptor shows an rms derivation of 0.26 Å. Compound <b>15</b> was built within Marvin and was submitted to Corina,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> a 3D structure generator. The resulting structure became the starting point of our docking study.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i78"><a href="/doi/suppl/10.1021/jm3008536">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52241" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52241" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Additional characterization for compounds <b>2</b>–<b>45</b>, supplementary Table 1, Discoverx KinomeScan Selectivity Panel, and the <sup>1</sup>H and <sup>13</sup> C NMR spectra for compounds <b>2</b>–<b>45</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3008536/suppl_file/jm3008536_si_001.pdf">jm3008536_si_001.pdf (8.14 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm3008536" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85381" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85381" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sylvain Routier</span> - <span class="hlFld-Affiliation affiliation">Institut de Chimie Organique et Analytique, Université
d’Orléans, UMR CNRS 7311, rue de Chartres,
BP 6759, 45067 Orléans Cedex 2, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#37444e5b41565e5919455842435e52457742595e411a58455b52565944195145"><span class="__cf_email__" data-cfemail="63101a0f15020a0d4d110c16170a061123160d0a154e0c110f06020d104d0511">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rajâa Boulahjar</span> - <span class="hlFld-Affiliation affiliation">Institut de Chimie Organique et Analytique, Université
d’Orléans, UMR CNRS 7311, rue de Chartres,
BP 6759, 45067 Orléans Cedex 2, France</span>; 
    <span class="hlFld-Affiliation affiliation">Laboratoire de Chimie, Bioorganique et Analytique,
URAC 22 pôle Répam, Université Hassan
II Mohammedia-Casablanca, BP 146, 28800 Mohammedia,
Morocco</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aziz Ouach</span> - <span class="hlFld-Affiliation affiliation">Institut de Chimie Organique et Analytique, Université
d’Orléans, UMR CNRS 7311, rue de Chartres,
BP 6759, 45067 Orléans Cedex 2, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chiurato Matteo</span> - <span class="hlFld-Affiliation affiliation">Institut de Chimie Organique et Analytique, Université
d’Orléans, UMR CNRS 7311, rue de Chartres,
BP 6759, 45067 Orléans Cedex 2, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephane Bourg</span> - <span class="hlFld-Affiliation affiliation">Institut de Chimie Organique et Analytique, Université
d’Orléans, UMR CNRS 7311, rue de Chartres,
BP 6759, 45067 Orléans Cedex 2, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Myriam Ravache</span> - <span class="hlFld-Affiliation affiliation">Plateforme ImPACcell-SFR BIOSIT UMS-CNRS3480
UMS-INSERM018, Université de Rennes 1, 35043 Rennes Cedex, France.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rémy le Guével</span> - <span class="hlFld-Affiliation affiliation">Plateforme ImPACcell-SFR BIOSIT UMS-CNRS3480
UMS-INSERM018, Université de Rennes 1, 35043 Rennes Cedex, France.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Séverine Marionneau</span> - <span class="hlFld-Affiliation affiliation">In vivo Platform, Cancéropôle Grand Ouest, 63 quai Magellan, 44000 Nantes, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thibauld Oullier</span> - <span class="hlFld-Affiliation affiliation">In vivo Platform, Cancéropôle Grand Ouest, 63 quai Magellan, 44000 Nantes, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Olivier Lozach</span> - <span class="hlFld-Affiliation affiliation">CNRS, “Protein Phosphorylation & Human Disease” group,
USR3151, Station Biologique, B.P. 74, 29682 Roscoff Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurent Meijer</span> - <span class="hlFld-Affiliation affiliation">ManRos Therapeutics, Centre de Perharidy, 29680 Roscoff, France</span>; 
    <span class="hlFld-Affiliation affiliation">CNRS, “Protein Phosphorylation & Human Disease” group,
USR3151, Station Biologique, B.P. 74, 29682 Roscoff Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christiane Guguen-Guillouzo</span> - <span class="hlFld-Affiliation affiliation">Plateforme ImPACcell-SFR BIOSIT UMS-CNRS3480
UMS-INSERM018, Université de Rennes 1, 35043 Rennes Cedex, France.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Saïd Lazar</span> - <span class="hlFld-Affiliation affiliation">Laboratoire de Chimie, Bioorganique et Analytique,
URAC 22 pôle Répam, Université Hassan
II Mohammedia-Casablanca, BP 146, 28800 Mohammedia,
Morocco</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mohamed Akssira</span> - <span class="hlFld-Affiliation affiliation">Laboratoire de Chimie, Bioorganique et Analytique,
URAC 22 pôle Répam, Université Hassan
II Mohammedia-Casablanca, BP 146, 28800 Mohammedia,
Morocco</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yves Troin</span> - <span class="hlFld-Affiliation affiliation">Clermont Université, ENSCCF, Laboratoire de Chimie des Hétérocycles et
des Glucides, BP 10448, 63000 Clermont-Ferrand, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gérald Guillaumet</span> - <span class="hlFld-Affiliation affiliation">Institut de Chimie Organique et Analytique, Université
d’Orléans, UMR CNRS 7311, rue de Chartres,
BP 6759, 45067 Orléans Cedex 2, France</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15758" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15758" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the CNRS, Cancéropôle Grand Ouest axis “Valorisation des produits de la mer”, Association de Recherche contre le Cancer, and the Program Hubert Curien “Volubilis” for financial support. The ICOA synthesis team thanks Raphael Delépée and Nathalie Percina for the development of analytical methods in order to determine the purity of the Valmerins. L.M.’s group was supported by the “Cancéropole Grand-Ouest”, the “Association pour la Recherche sur le Cancer” (ARC-1092 and 5098), the “Ligue Nationale contre le Cancer (Comité Grand-Ouest)”, and the “Institut National du Cancer” project GLIOMER.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i80" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i80"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i81" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i81"> ABBREVIATIONS USED</h2><tr><td class="NLM_term">GSK</td><td class="NLM_def"><p class="first last">glycogen synthase kinase</p></td></tr><tr><td class="NLM_term">Triton B</td><td class="NLM_def"><p class="first last">benzyltrimethylammonium hydroxide</p></td></tr><tr><td class="NLM_term">CSA</td><td class="NLM_def"><p class="first last">camphorsulfonic acid</p></td></tr><tr><td class="NLM_term">PTSA</td><td class="NLM_def"><p class="first last">paratoluenesulfonic acid</p></td></tr><tr><td class="NLM_term">BTC</td><td class="NLM_def"><p class="first last">bis(trichloromethyl) carbonate</p></td></tr><tr><td class="NLM_term">DYRK</td><td class="NLM_def"><p class="first last">dual specificity tyrosine-phosphorylation-regulated kinase</p></td></tr><tr><td class="NLM_term">CK</td><td class="NLM_def"><p class="first last">cyclin kinase</p></td></tr><tr><td class="NLM_term">BrdU</td><td class="NLM_def"><p class="first last">5′-bromo-2′-deoxyuridine</p></td></tr><tr><td class="NLM_term">BLI</td><td class="NLM_def"><p class="first last">bioluminescence imaging</p></td></tr><tr><td class="NLM_term">ATR: attenuated total reflection</td><td class="NLM_def"></td></tr><tr><td class="NLM_term">IS</td><td class="NLM_def"><p class="first last">ion spray</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35226" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35226" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 36 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carnero, A.</span><span> </span><span class="NLM_article-title">Cell Cycle Deregulation: A Common Motif in Cancer</span> <span class="citation_source-journal">Prog. Cell Cycle Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm3008536&amp;key=14593696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm3008536&amp;key=1%3ACAS%3A280%3ADC%252BD3srhs1SqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=5-18&author=M.+Malumbresauthor=A.+Carnero&title=Cell+Cycle+Deregulation%3A+A+Common+Motif+in+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle deregulation: a common motif in cancer</span></div><div class="casAuthors">Malumbres Marcos; Carnero Amancio</div><div class="citationInfo"><span class="NLM_cas:title">Progress in cell cycle research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5-18</span>
        ISSN:<span class="NLM_cas:issn">1087-2957</span>.
    </div><div class="casAbstract">Uncontrolled proliferation is a hallmark of cancer cells.  Molecular analysis of human tumors and animal models have provided a clear basis for the understanding of the cellular processes that govern cell cycle progression in normal and tumor cells.  Many cell cycle regulators controlling the correct entry and progression through the cell cycle are altered in tumors.  In fact, most, if not all, human cancers show a deregulated control of G1 progression, a period when cells decide whether to start proliferation or to stay quiescent.  In addition, tumor cells have impaired cell cycle checkpoints, resulting in the accumulation of genetic aberrations.  Manipulation of these control mechanisms provides new avenues for the design of advanced therapeutic strategies against tumor development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTf8njPNJ4X7sScOqQTSkOffW6udTcc2eb9APooA7TBW7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srhs1SqsQ%253D%253D&md5=78df5bee1cb7947d6bc24c075d0d56ec</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DCarnero%26aufirst%3DA.%26atitle%3DCell%2520Cycle%2520Deregulation%253A%2520A%2520Common%2520Motif%2520in%2520Cancer%26jtitle%3DProg.%2520Cell%2520Cycle%2520Res.%26date%3D2003%26volume%3D5%26spage%3D5%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Cell Cycle, CDKs and Cancer: A Changing Paradigm</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm3008536&amp;key=10.1038%2Fnrc2602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm3008536&amp;key=19238148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm3008536&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1ans78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=153-166&author=M.+Malumbresauthor=M.+Barbacid&title=Cell+Cycle%2C+CDKs+and+Cancer%3A+A+Changing+Paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle, CDKs and cancer: a changing paradigm</span></div><div class="casAuthors">Malumbres, Marcos; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">153-166</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Tumor-assocd. cell cycle defects are often mediated by alterations in cyclin-dependent kinase (CDK) activity.  Misregulated CDKs induce unscheduled proliferation as well as genomic and chromosomal instability.  According to current models, mammalian CDKs are essential for driving each cell cycle phase, so therapeutic strategies that block CDK activity are unlikely to selectively target tumor cells.  However, recent genetic evidence has revealed that, whereas CDK1 is required for the cell cycle, interphase CDKs are only essential for proliferation of specialized cells.  Emerging evidence suggests that tumor cells may also require specific interphase CDKs for proliferation.  Thus, selective CDK inhibition may provide therapeutic benefit against certain human neoplasias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzlIKlbCPWnLVg90H21EOLACvtfcHk0ljp9XOZLkUk9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1ans78%253D&md5=2a7eb34b2381e288b3f43ec1bffc0aec</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrc2602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2602%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DCell%2520Cycle%252C%2520CDKs%2520and%2520Cancer%253A%2520A%2520Changing%2520Paradigm%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D153%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. Z.</span><span> </span><span class="NLM_article-title">Activation of Glycogen Synthase Kinase-3 Induces Alzheimer-like Tau Hyperphosphorylation in Rat Hippocampus Slices in Culture</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2006&pages=93-102&author=X.+Liauthor=F.+Luauthor=Q.+Tianauthor=Y.+Yangauthor=Q.+Wangauthor=J.+Z.+Wang&title=Activation+of+Glycogen+Synthase+Kinase-3+Induces+Alzheimer-like+Tau+Hyperphosphorylation+in+Rat+Hippocampus+Slices+in+Culture"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DF.%26aulast%3DTian%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%2BZ.%26atitle%3DActivation%2520of%2520Glycogen%2520Synthase%2520Kinase-3%2520Induces%2520Alzheimer-like%2520Tau%2520Hyperphosphorylation%2520in%2520Rat%2520Hippocampus%2520Slices%2520in%2520Culture%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2006%26volume%3D113%26spage%3D93%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Ougolkov, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billadeau, D. D.</span><span> </span><span class="NLM_article-title">Targeting GSK-3: a Promising Approach for Cancer therapy</span> <span class="citation_source-journal">Future Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm3008536&amp;key=10.2217%2F14796694.2.1.91" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm3008536&amp;key=16556076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm3008536&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhs1Wku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=91-100&author=A.+V.+Ougolkovauthor=D.+D.+Billadeau&title=Targeting+GSK-3%3A+a+Promising+Approach+for+Cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting GSK-3: a promising approach for cancer therapy?</span></div><div class="casAuthors">Ougolkov, Andrei V.; Billadeau, Daniel D.</div><div class="citationInfo"><span class="NLM_cas:title">Future Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-100</span>CODEN:
                <span class="NLM_cas:coden">FOUNBN</span>;
        ISSN:<span class="NLM_cas:issn">1479-6694</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Glycogen synthase kinase (GSK)-3 has emerged as one of the most attractive therapeutic targets for the treatment of multiple neurol. diseases, including Alzheimer's, stroke and bipolar disorders, as well as noninsulin-dependent diabetes mellitus and inflammation.  Although the prominent role of GSK-3 in the adenomatous polyposis coli (APC)-β-catenin destruction complex implies that inhibition of GSK-3 could possibly lead to tumor promotion through the activation of β-catenin, several recent studies have shed new light on the activity of GSK-3 in cancer and provide insight into the mol. mechanisms by which it regulates tumor cell proliferation and survival of multiple human malignancies.  In fact, GSK-3β is a crit. regulator of nuclear factor (NF)κB nuclear activity, suggesting that inhibition of GSK-3β could be effective in the treatment of a wide variety of tumors with constitutively active NFκB.  Herein, the authors will discuss the current understanding of the role of GSK-3 in human cancer and its potential as a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS5GCxxwsF9bVg90H21EOLACvtfcHk0liRvbXoFMsY1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhs1Wku7s%253D&md5=cd14eef69d01a22dcab963c553f6921b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2217%2F14796694.2.1.91&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252F14796694.2.1.91%26sid%3Dliteratum%253Aachs%26aulast%3DOugolkov%26aufirst%3DA.%2BV.%26aulast%3DBilladeau%26aufirst%3DD.%2BD.%26atitle%3DTargeting%2520GSK-3%253A%2520a%2520Promising%2520Approach%2520for%2520Cancer%2520therapy%26jtitle%3DFuture%2520Oncol.%26date%3D2006%26volume%3D2%26spage%3D91%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wang, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, D. M.</span><span> </span><span class="NLM_article-title">Flavopiridol, the First Cyclin-Dependent Kinase Inhibitor: Recent Advances in Combination Chemotherapy</span> <span class="citation_source-journal">Mini Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1058</span><span class="NLM_x">–</span> <span class="NLM_lpage">1070</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm3008536&amp;key=10.2174%2F1389557511009011058" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=1058-1070&author=L.+M.+Wangauthor=D.+M.+Ren&title=Flavopiridol%2C+the+First+Cyclin-Dependent+Kinase+Inhibitor%3A+Recent+Advances+in+Combination+Chemotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.2174%2F1389557511009011058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557511009011058%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%2BM.%26aulast%3DRen%26aufirst%3DD.%2BM.%26atitle%3DFlavopiridol%252C%2520the%2520First%2520Cyclin-Dependent%2520Kinase%2520Inhibitor%253A%2520Recent%2520Advances%2520in%2520Combination%2520Chemotherapy%26jtitle%3DMini%2520Rev.%2520Med.%2520Chem.%26date%3D2010%26volume%3D11%26spage%3D1058%26epage%3D1070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Raje, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raab, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chhetri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirstea, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsiades, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiziltepe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrasco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauhan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parikh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scadden, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span> </span><span class="NLM_article-title">Preclinical Activity of P276–00, a Novel Small-Molecule Cyclin-Dependent Kinase Inhibitor in the Therapy of Multiple Myeloma</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">961</span><span class="NLM_x">–</span> <span class="NLM_lpage">970</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=961-970&author=N.+Rajeauthor=T.+Hideshimaauthor=S.+Mukherjeeauthor=M.+Raabauthor=S.+Valletauthor=S.+Chhetriauthor=D.+Cirsteaauthor=S.+Pozziauthor=C.+Mitsiadesauthor=M.+Rooneyauthor=T.+Kiziltepeauthor=K.+Podarauthor=Y.+Okawaauthor=H.+Ikedaauthor=R.+Carrascoauthor=P.+G.+Richardsonauthor=D.+Chauhanauthor=N.+C.+Munshiauthor=S.+Sharmaauthor=H.+Parikhauthor=B.+Chabnerauthor=D.+Scaddenauthor=K.+C.+Anderson&title=Preclinical+Activity+of+P276%E2%80%9300%2C+a+Novel+Small-Molecule+Cyclin-Dependent+Kinase+Inhibitor+in+the+Therapy+of+Multiple+Myeloma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaje%26aufirst%3DN.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DMukherjee%26aufirst%3DS.%26aulast%3DRaab%26aufirst%3DM.%26aulast%3DVallet%26aufirst%3DS.%26aulast%3DChhetri%26aufirst%3DS.%26aulast%3DCirstea%26aufirst%3DD.%26aulast%3DPozzi%26aufirst%3DS.%26aulast%3DMitsiades%26aufirst%3DC.%26aulast%3DRooney%26aufirst%3DM.%26aulast%3DKiziltepe%26aufirst%3DT.%26aulast%3DPodar%26aufirst%3DK.%26aulast%3DOkawa%26aufirst%3DY.%26aulast%3DIkeda%26aufirst%3DH.%26aulast%3DCarrasco%26aufirst%3DR.%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DChauhan%26aufirst%3DD.%26aulast%3DMunshi%26aufirst%3DN.%2BC.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DParikh%26aufirst%3DH.%26aulast%3DChabner%26aufirst%3DB.%26aulast%3DScadden%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DPreclinical%2520Activity%2520of%2520P276%25E2%2580%259300%252C%2520a%2520Novel%2520Small-Molecule%2520Cyclin-Dependent%2520Kinase%2520Inhibitor%2520in%2520the%2520Therapy%2520of%2520Multiple%2520Myeloma%26jtitle%3DLeukemia%26date%3D2009%26volume%3D5%26spage%3D961%26epage%3D970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Meijer, L.; Bettayeb, K.; Galons, H.</span><span> </span><span class="NLM_article-title">Roscovitine (CYC202, Seliciclib)</span>. In <span class="NLM_contrib-group">Yue, E.; Smith, P. J.</span>, Eds.  <span class="citation_source-book">Monographs on Enzyme Inhibitors; Vol. 2. CDK Inhibitors and Their Potential as Anti-tumor Agents</span>; <span class="NLM_publisher-name">CRC Press</span>: <span class="NLM_publisher-loc">Boca Raton</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">9</span>, pp  <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=187-226&author=L.+Meijer&author=K.+Bettayeb&author=H.+Galonsauthor=E.+Yue&author=P.+J.+Smith&title=Monographs+on+Enzyme+Inhibitors%3B+Vol.+2.+CDK+Inhibitors+and+Their+Potential+as+Anti-tumor+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DRoscovitine%2520%2528CYC202%252C%2520Seliciclib%2529%26aulast%3DYue%26aufirst%3DE.%26btitle%3DMonographs%2520on%2520Enzyme%2520Inhibitors%253B%2520Vol.%25202.%2520CDK%2520Inhibitors%2520and%2520Their%2520Potential%2520as%2520Anti-tumor%2520Agents%26pub%3DCRC%2520Press%26date%3D2006%26volume%3D9%26spage%3D187%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Chu, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Pinto, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartkovitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">So, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goelzer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moliterni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotouhi, N.</span><span> </span><span class="NLM_article-title">Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6-methoxy phenyl)methanone (R547), a Potent and Selective Cyclin-Dependent Kinase Inhibitor with Significant <i>in Vivo</i> Antitumor Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6549</span><span class="NLM_x">–</span> <span class="NLM_lpage">6560</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0606138" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6549-6560&author=X.+J.+Chuauthor=W.+De+Pintoauthor=D.+Bartkovitzauthor=S.+S.+Soauthor=B.+T.+Vuauthor=K.+Packmanauthor=C.+Lukacsauthor=Q.+Dingauthor=N.+Jiangauthor=K.+Wangauthor=P.+Goelzerauthor=X.+Yinauthor=M.+A.+Smithauthor=B.+X.+Higginsauthor=Y.+Chenauthor=Q.+Xiangauthor=J.+Moliterniauthor=G.+Kaplanauthor=B.+Gravesauthor=A.+Loveyauthor=N.+Fotouhi&title=Discovery+of+%5B4-Amino-2-%281-methanesulfonylpiperidin-4-ylamino%29pyrimidin-5-yl%5D%282%2C3-difluoro-6-methoxy+phenyl%29methanone+%28R547%29%2C+a+Potent+and+Selective+Cyclin-Dependent+Kinase+Inhibitor+with+Significant+in+Vivo+Antitumor+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm0606138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0606138%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DX.%2BJ.%26aulast%3DDe%2BPinto%26aufirst%3DW.%26aulast%3DBartkovitz%26aufirst%3DD.%26aulast%3DSo%26aufirst%3DS.%2BS.%26aulast%3DVu%26aufirst%3DB.%2BT.%26aulast%3DPackman%26aufirst%3DK.%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DGoelzer%26aufirst%3DP.%26aulast%3DYin%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26aulast%3DHiggins%26aufirst%3DB.%2BX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DXiang%26aufirst%3DQ.%26aulast%3DMoliterni%26aufirst%3DJ.%26aulast%3DKaplan%26aufirst%3DG.%26aulast%3DGraves%26aufirst%3DB.%26aulast%3DLovey%26aufirst%3DA.%26aulast%3DFotouhi%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520%255B4-Amino-2-%25281-methanesulfonylpiperidin-4-ylamino%2529pyrimidin-5-yl%255D%25282%252C3-difluoro-6-methoxy%2520phenyl%2529methanone%2520%2528R547%2529%252C%2520a%2520Potent%2520and%2520Selective%2520Cyclin-Dependent%2520Kinase%2520Inhibitor%2520with%2520Significant%2520in%2520Vivo%2520Antitumor%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6549%26epage%3D6560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Tong, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plunkett, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badros, A. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popplewell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coutre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahadocon, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kegley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wierda, W. G.</span><span> </span><span class="NLM_article-title">Phase I and Pharmacologic Study of SNS-032, a Potent and Selective Cdk 2, 7, and 9 Inhibitor, in Patients with Advanced Chronic Lymphocytic Leukemia and Multiple Myeloma</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3015</span><span class="NLM_x">–</span> <span class="NLM_lpage">3022</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm3008536&amp;key=10.1200%2FJCO.2009.26.1347" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=3015-3022&author=W.+G.+Tongauthor=R.+Chenauthor=W.+Plunkettauthor=D.+Siegelauthor=R.+Sinhaauthor=R.+D.+Harveyauthor=A.+Z.+Badrosauthor=L.+Popplewellauthor=S.+Coutreauthor=J.+A.+Foxauthor=K.+Mahadoconauthor=T.+Chenauthor=P.+Kegleyauthor=U.+Hochauthor=W.+G.+Wierda&title=Phase+I+and+Pharmacologic+Study+of+SNS-032%2C+a+Potent+and+Selective+Cdk+2%2C+7%2C+and+9+Inhibitor%2C+in+Patients+with+Advanced+Chronic+Lymphocytic+Leukemia+and+Multiple+Myeloma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1200%2FJCO.2009.26.1347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2009.26.1347%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DW.%2BG.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DPlunkett%26aufirst%3DW.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DSinha%26aufirst%3DR.%26aulast%3DHarvey%26aufirst%3DR.%2BD.%26aulast%3DBadros%26aufirst%3DA.%2BZ.%26aulast%3DPopplewell%26aufirst%3DL.%26aulast%3DCoutre%26aufirst%3DS.%26aulast%3DFox%26aufirst%3DJ.%2BA.%26aulast%3DMahadocon%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DKegley%26aufirst%3DP.%26aulast%3DHoch%26aufirst%3DU.%26aulast%3DWierda%26aufirst%3DW.%2BG.%26atitle%3DPhase%2520I%2520and%2520Pharmacologic%2520Study%2520of%2520SNS-032%252C%2520a%2520Potent%2520and%2520Selective%2520Cdk%25202%252C%25207%252C%2520and%25209%2520Inhibitor%252C%2520in%2520Patients%2520with%2520Advanced%2520Chronic%2520Lymphocytic%2520Leukemia%2520and%2520Multiple%2520Myeloma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2010%26volume%3D18%26spage%3D3015%26epage%3D3022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Baughn, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Liberto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toogood, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottschalk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niesvizky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ely, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen-Kiang, S.</span><span> </span><span class="NLM_article-title">A Novel Orally Active Small Molecule Potently Induces G1 Arrest in Primary Myeloma Cells and Prevents Tumour Growth by Specific Inhibition of Cyclin-Dependent Kinase 4/6</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">7661</span><span class="NLM_x">–</span> <span class="NLM_lpage">7667</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=7661-7667&author=L.+B.+Baughnauthor=M.+Di+Libertoauthor=K.+Wuauthor=P.+L.+Toogoodauthor=T.+Louieauthor=R.+Gottschalkauthor=R.+Niesvizkyauthor=H.+Choauthor=S.+Elyauthor=M.+A.+Mooreauthor=S.+Chen-Kiang&title=A+Novel+Orally+Active+Small+Molecule+Potently+Induces+G1+Arrest+in+Primary+Myeloma+Cells+and+Prevents+Tumour+Growth+by+Specific+Inhibition+of+Cyclin-Dependent+Kinase+4%2F6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaughn%26aufirst%3DL.%2BB.%26aulast%3DDi%2BLiberto%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DK.%26aulast%3DToogood%26aufirst%3DP.%2BL.%26aulast%3DLouie%26aufirst%3DT.%26aulast%3DGottschalk%26aufirst%3DR.%26aulast%3DNiesvizky%26aufirst%3DR.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DEly%26aufirst%3DS.%26aulast%3DMoore%26aufirst%3DM.%2BA.%26aulast%3DChen-Kiang%26aufirst%3DS.%26atitle%3DA%2520Novel%2520Orally%2520Active%2520Small%2520Molecule%2520Potently%2520Induces%2520G1%2520Arrest%2520in%2520Primary%2520Myeloma%2520Cells%2520and%2520Prevents%2520Tumour%2520Growth%2520by%2520Specific%2520Inhibition%2520of%2520Cyclin-Dependent%2520Kinase%25204%252F6%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D7661%26epage%3D7667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Byth, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forder, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mc Gregor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oakes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcombe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Growcott, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, R. W.</span><span> </span><span class="NLM_article-title">AZD5438, a Potent Oral Inhibitor of Cyclin-Dependent Kinases 1, 2, and 9, Leads to Pharmacodynamic Changes and Potent Antitumor Effects in Human Tumor Xenografts</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1856</span><span class="NLM_x">–</span> <span class="NLM_lpage">1866</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm3008536&amp;key=10.1158%2F1535-7163.MCT-08-0836" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=1856-1866&author=K.+F.+Bythauthor=A.+Thomasauthor=G.+Hughesauthor=C.+Forderauthor=A.+Mc+Gregorauthor=C.+Gehauthor=S.+Oakesauthor=C.+Greenauthor=M.+Walkerauthor=N.+Newcombeauthor=S.+Greenauthor=J.+Growcottauthor=A.+Barkerauthor=R.+W.+Wilkinson&title=AZD5438%2C+a+Potent+Oral+Inhibitor+of+Cyclin-Dependent+Kinases+1%2C+2%2C+and+9%2C+Leads+to+Pharmacodynamic+Changes+and+Potent+Antitumor+Effects+in+Human+Tumor+Xenografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0836%26sid%3Dliteratum%253Aachs%26aulast%3DByth%26aufirst%3DK.%2BF.%26aulast%3DThomas%26aufirst%3DA.%26aulast%3DHughes%26aufirst%3DG.%26aulast%3DForder%26aufirst%3DC.%26aulast%3DMc%2BGregor%26aufirst%3DA.%26aulast%3DGeh%26aufirst%3DC.%26aulast%3DOakes%26aufirst%3DS.%26aulast%3DGreen%26aufirst%3DC.%26aulast%3DWalker%26aufirst%3DM.%26aulast%3DNewcombe%26aufirst%3DN.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DGrowcott%26aufirst%3DJ.%26aulast%3DBarker%26aufirst%3DA.%26aulast%3DWilkinson%26aufirst%3DR.%2BW.%26atitle%3DAZD5438%252C%2520a%2520Potent%2520Oral%2520Inhibitor%2520of%2520Cyclin-Dependent%2520Kinases%25201%252C%25202%252C%2520and%25209%252C%2520Leads%2520to%2520Pharmacodynamic%2520Changes%2520and%2520Potent%2520Antitumor%2520Effects%2520in%2520Human%2520Tumor%2520Xenografts%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D7%26spage%3D1856%26epage%3D1866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Brown, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Criswell, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holliman, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evering, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessen, B. A.</span><span> </span><span class="NLM_article-title">Toxicity and Toxicokinetics of the Cyclin-Dependent Kinase inhibitor AG-024322 in Cynomolgus Monkeys Following Intravenous infusion</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1091</span><span class="NLM_x">–</span> <span class="NLM_lpage">1101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm3008536&amp;key=10.1007%2Fs00280-008-0771-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm3008536&amp;key=18509643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm3008536&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFaju77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2008&pages=1091-1101&author=A.+P.+Brownauthor=C.+L.+Courtneyauthor=K.+A.+Criswellauthor=C.+L.+Hollimanauthor=W.+Everingauthor=B.+A.+Jessen&title=Toxicity+and+Toxicokinetics+of+the+Cyclin-Dependent+Kinase+inhibitor+AG-024322+in+Cynomolgus+Monkeys+Following+Intravenous+infusion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicity and toxicokinetics of the cyclin-dependent kinase inhibitor AG-024322 in cynomolgus monkeys following intravenous infusion</span></div><div class="casAuthors">Brown, Alan P.; Courtney, Cynthia L.; Criswell, Kay A.; Holliman, Christopher L.; Evering, Winston; Jessen, Bart A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1091-1101</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Cyclin-dependent kinases (CDKs) play a significant role in the control of cell-cycle progression and exhibit aberrant regulation in various neoplastic diseases.  AG-024322 is a potent inhibitor of CDK1, CDK2, and CDK4 that produces cell-cycle arrest and antitumor activity in preclin. models.  This study evaluated the toxicity of AG-024322 when given by i.v. infusion to cynomolgus monkeys, including reversibility of effects.  Male and female monkeys received AG-024322 by 30-min i.v. infusion once daily for 5 days at doses of 2, 6, and 10 mg/kg (24, 72, and 120 mg/m2, resp.).  Controls received vehicle alone which was aq. 5% dextrose, pH 3.8.  Three animals/sex/group were necropsied on day 6, and two animals/sex/group at 6 and 10 mg/kg were necropsied on day 22 (reversal cohort).  Doses were based upon the results of a dose range-finding study in monkeys; decreased white blood cells occurred at ≥3 mg/kg and 12 mg/kg produced central nervous system effects and was above the max.-tolerated dose.  No deaths occurred and clin. signs of toxicity, including swelling at the i.v. administration site, were seen at ≥6 mg/kg.  AG-024322 at ≥6 mg/kg produced pancytic bone marrow hypocellularity, lymphoid depletion, and vascular injury at the injection site.  Renal tubular degeneration occurred at 10 mg/kg.  These changes were either reversible or in a process of repair following the 17-day recovery period.  Hematol. changes included decreases in reticulocytes and/or granulocytes at ≥6 mg/kg, which were reversible and consistent with changes in the bone marrow.  Lymphoid and bone marrow depletion are consistent with pharmacol. inhibition of CDKs by AG-024322 and were expected findings.  On day 22, vacuolar degeneration of pancreatic acinar cells with increased serum amylase and lipase levels occurred in one female at 10 mg/kg.  Neither sex-related differences in toxicokinetics nor plasma accumulation over 5 days of dosing were seen.  Terminal phase overall mean half-life on day 5 ranged from 6.69 to 8.87 h (across dose levels) and was not dose dependent.  The no-adverse-effect dose of AG-024322 was 2 mg/kg and assocd. with overall mean plasma AUC(0-24.5) of 2.11 μg h/mL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR4ZxVRofSTrVg90H21EOLACvtfcHk0ljHwxm-LOyknQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFaju77L&md5=37bbd35e5b7a72dfc728162206facbeb</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs00280-008-0771-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-008-0771-1%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BP.%26aulast%3DCourtney%26aufirst%3DC.%2BL.%26aulast%3DCriswell%26aufirst%3DK.%2BA.%26aulast%3DHolliman%26aufirst%3DC.%2BL.%26aulast%3DEvering%26aufirst%3DW.%26aulast%3DJessen%26aufirst%3DB.%2BA.%26atitle%3DToxicity%2520and%2520Toxicokinetics%2520of%2520the%2520Cyclin-Dependent%2520Kinase%2520inhibitor%2520AG-024322%2520in%2520Cynomolgus%2520Monkeys%2520Following%2520Intravenous%2520infusion%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2008%26volume%3D62%26spage%3D1091%26epage%3D1101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodhead, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulstridge, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devine, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Early, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feltell, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Reilly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seavers, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squires, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trewartha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolford, A. J.</span><span> </span><span class="NLM_article-title">Identification of <i>N</i>-(4-Piperidinyl)-4-(2,6-dichlorobenzoylamino)-1<i>H</i>-pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4986</span><span class="NLM_x">–</span> <span class="NLM_lpage">4999</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800382h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4986-4999&author=P.+G.+Wyattauthor=A.+J.+Woodheadauthor=V.+Berdiniauthor=J.+A.+Boulstridgeauthor=M.+G.+Carrauthor=D.+M.+Crossauthor=D.+J.+Davisauthor=L.+A.+Devineauthor=T.+R.+Earlyauthor=R.+E.+Feltellauthor=E.+J.+Lewisauthor=R.+L.+McMenaminauthor=E.+F.+Navarroauthor=M.+A.+O%E2%80%99Brienauthor=M.+O%E2%80%99Reillyauthor=M.+Reuleauthor=G.+Saxtyauthor=L.+C.+Seaversauthor=D.+M.+Smithauthor=M.+S.+Squiresauthor=G.+Trewarthaauthor=M.+T.+Walkerauthor=A.+J.+Woolford&title=Identification+of+N-%284-Piperidinyl%29-4-%282%2C6-dichlorobenzoylamino%29-1H-pyrazole-3-carboxamide+%28AT7519%29%2C+a+Novel+Cyclin+Dependent+Kinase+Inhibitor+Using+Fragment-Based+X-Ray+Crystallography+and+Structure+Based+Drug+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm800382h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800382h%26sid%3Dliteratum%253Aachs%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26aulast%3DBerdini%26aufirst%3DV.%26aulast%3DBoulstridge%26aufirst%3DJ.%2BA.%26aulast%3DCarr%26aufirst%3DM.%2BG.%26aulast%3DCross%26aufirst%3DD.%2BM.%26aulast%3DDavis%26aufirst%3DD.%2BJ.%26aulast%3DDevine%26aufirst%3DL.%2BA.%26aulast%3DEarly%26aufirst%3DT.%2BR.%26aulast%3DFeltell%26aufirst%3DR.%2BE.%26aulast%3DLewis%26aufirst%3DE.%2BJ.%26aulast%3DMcMenamin%26aufirst%3DR.%2BL.%26aulast%3DNavarro%26aufirst%3DE.%2BF.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%2BA.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DReule%26aufirst%3DM.%26aulast%3DSaxty%26aufirst%3DG.%26aulast%3DSeavers%26aufirst%3DL.%2BC.%26aulast%3DSmith%26aufirst%3DD.%2BM.%26aulast%3DSquires%26aufirst%3DM.%2BS.%26aulast%3DTrewartha%26aufirst%3DG.%26aulast%3DWalker%26aufirst%3DM.%2BT.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.%26atitle%3DIdentification%2520of%2520N-%25284-Piperidinyl%2529-4-%25282%252C6-dichlorobenzoylamino%2529-1H-pyrazole-3-carboxamide%2520%2528AT7519%2529%252C%2520a%2520Novel%2520Cyclin%2520Dependent%2520Kinase%2520Inhibitor%2520Using%2520Fragment-Based%2520X-Ray%2520Crystallography%2520and%2520Structure%2520Based%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4986%26epage%3D4999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Jian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levitt, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonpavde, G.</span><span> </span><span class="NLM_article-title">Enzastaurin Shows Preclinical Antitumor Activity against Human Transitional Cell Carcinoma and Enhances the Activity of Gemcitabine</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1772</span><span class="NLM_x">–</span> <span class="NLM_lpage">1778</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm3008536&amp;key=10.1158%2F1535-7163.MCT-09-0141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm3008536&amp;key=19509273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm3008536&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVynu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1772-1778&author=W.+Jianauthor=H.+Yamashitaauthor=J.+M.+Levittauthor=S.+P.+Lernerauthor=G.+Sonpavde&title=Enzastaurin+Shows+Preclinical+Antitumor+Activity+against+Human+Transitional+Cell+Carcinoma+and+Enhances+the+Activity+of+Gemcitabine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Enzastaurin shows preclinical antitumor activity against human transitional cell carcinoma and enhances the activity of gemcitabine</span></div><div class="casAuthors">Jian, Weiguo; Yamashita, Hideyuki; Levitt, Jonathan M.; Lerner, Seth P.; Sonpavde, Guru</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1772-1778</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Enzastaurin, an oral serine/threonine kinase inhibitor, suppresses signaling through protein kinase C (PKC)-β and the phosphatidylinositol 3-kinase/AKT pathways.  We preclinically evaluated enzastaurin alone and in combination with gemcitabine for transitional cell cancer (TCC).  Immunohistochem. (IHC) was done on 105 human samples from a microarray to show the expression of PKC-β.  The preclin. antitumor activity of enzastaurin and gemcitabine as single agents and in combination against aggressive human -lines (-SUP and 5637) and murine s.c. xenografts bearing 5637 cells was detd.  Western Blot was done on tumor cells in vitro to detect signaling through PKC-β, GSK-3β, and AKT.  The effect on cell migration was detd. in vitro.  Modulation of proliferation (Ki-67), apoptosis (cleaved caspase-3), and angiogenesis (CD31) in vivo was detd. by IHC.  IHC done on human TCC samples from a microarray showed the expression of PKC-β in 33% of tumors.  Enzastaurin induced significant apoptosis and inhibited proliferation in vitro at low micromolar concns.  The in vitro inhibitory activity of combination enzastaurin and gemcitabine by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay seemed synergistic.  Western Blotting revealed down-regulation of Akt, PKC-β, and GSK-3 β phosphorylation.  Enzastaurin inhibited migration at an earlier time point independent of antiproliferative activity.  Combination therapy had significantly superior antitumor activity in murine xenografts compared with untreated controls, whereas single agents did not.  IHC showed reduced Ki-67 and CD31 and increased cleaved caspase-3 with combination therapy compared with controls.  Enzastaurin showed preclin. antitumor activity against human TCC and enhanced the activity of gemcitabine. [Mol Cancer Ther 2009;8(7):1772-8].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSmOhM2_Z9-7Vg90H21EOLACvtfcHk0ljHwxm-LOyknQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVynu70%253D&md5=5115f399fb81dcb9515d6d135521ebc0</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0141%26sid%3Dliteratum%253Aachs%26aulast%3DJian%26aufirst%3DW.%26aulast%3DYamashita%26aufirst%3DH.%26aulast%3DLevitt%26aufirst%3DJ.%2BM.%26aulast%3DLerner%26aufirst%3DS.%2BP.%26aulast%3DSonpavde%26aufirst%3DG.%26atitle%3DEnzastaurin%2520Shows%2520Preclinical%2520Antitumor%2520Activity%2520against%2520Human%2520Transitional%2520Cell%2520Carcinoma%2520and%2520Enhances%2520the%2520Activity%2520of%2520Gemcitabine%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D1772%26epage%3D1778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Routier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayerbe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mérour, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coudert, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailly, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierré, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caignard, D.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renard, P.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Activity of 7-Azaindolocarbazoles</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">6621</span><span class="NLM_x">–</span> <span class="NLM_lpage">6630</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=6621-6630&author=S.+Routierauthor=N.+Ayerbeauthor=J.-Y.+M%C3%A9rourauthor=G.+Coudertauthor=C.+Baillyauthor=A.+Pierr%C3%A9author=B.+Pfeifferauthor=D.-H.+Caignardauthor=P.+Renard&title=Synthesis+and+Biological+Activity+of+7-Azaindolocarbazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoutier%26aufirst%3DS.%26aulast%3DAyerbe%26aufirst%3DN.%26aulast%3DM%25C3%25A9rour%26aufirst%3DJ.-Y.%26aulast%3DCoudert%26aufirst%3DG.%26aulast%3DBailly%26aufirst%3DC.%26aulast%3DPierr%25C3%25A9%26aufirst%3DA.%26aulast%3DPfeiffer%26aufirst%3DB.%26aulast%3DCaignard%26aufirst%3DD.-H.%26aulast%3DRenard%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520Biological%2520Activity%2520of%25207-Azaindolocarbazoles%26jtitle%3DTetrahedron%26date%3D2002%26volume%3D58%26spage%3D6621%26epage%3D6630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Routier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peixoto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mérour, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coudert, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailly, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierré, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Léonce, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caignard, D.-H.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of New Naphthocarbazoles As Potential Anticancer Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1401</span><span class="NLM_x">–</span> <span class="NLM_lpage">1413</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049213f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1401-1413&author=S.+Routierauthor=P.+Peixotoauthor=J.-Y.+M%C3%A9rourauthor=G.+Coudertauthor=C.+Baillyauthor=A.+Pierr%C3%A9author=S.+L%C3%A9onceauthor=D.-H.+Caignard&title=Synthesis+and+Biological+Evaluation+of+New+Naphthocarbazoles+As+Potential+Anticancer+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1021%2Fjm049213f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049213f%26sid%3Dliteratum%253Aachs%26aulast%3DRoutier%26aufirst%3DS.%26aulast%3DPeixoto%26aufirst%3DP.%26aulast%3DM%25C3%25A9rour%26aufirst%3DJ.-Y.%26aulast%3DCoudert%26aufirst%3DG.%26aulast%3DBailly%26aufirst%3DC.%26aulast%3DPierr%25C3%25A9%26aufirst%3DA.%26aulast%3DL%25C3%25A9once%26aufirst%3DS.%26aulast%3DCaignard%26aufirst%3DD.-H.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520New%2520Naphthocarbazoles%2520As%2520Potential%2520Anticancer%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1401%26epage%3D1413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Routier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mérour, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dias, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansiaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailly, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Novel Phenylcarbazoles As Potential Anticancer Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">799</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050945x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=789-799&author=S.+Routierauthor=J.-Y.+M%C3%A9rourauthor=N.+Diasauthor=A.+Lansiauxauthor=C.+Baillyauthor=O.+Lozachauthor=L.+Meijer&title=Synthesis+and+Biological+Evaluation+of+Novel+Phenylcarbazoles+As+Potential+Anticancer+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1021%2Fjm050945x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050945x%26sid%3Dliteratum%253Aachs%26aulast%3DRoutier%26aufirst%3DS.%26aulast%3DM%25C3%25A9rour%26aufirst%3DJ.-Y.%26aulast%3DDias%26aufirst%3DN.%26aulast%3DLansiaux%26aufirst%3DA.%26aulast%3DBailly%26aufirst%3DC.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Novel%2520Phenylcarbazoles%2520As%2520Potential%2520Anticancer%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D789%26epage%3D799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ayerbe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillaizeau, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiereanu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caignard, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierré, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Léonce, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coudert, G.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Novel Benzodioxinocarbazoles (BDCZs) as Potential Anticancer Agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4670</span><span class="NLM_x">–</span> <span class="NLM_lpage">4674</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4670-4674&author=N.+Ayerbeauthor=S.+Routierauthor=I.+Gillaizeauauthor=C.+Maiereanuauthor=D.+H.+Caignardauthor=A.+Pierr%C3%A9author=S.+L%C3%A9onceauthor=G.+Coudert&title=Synthesis+and+Biological+Evaluation+of+Novel+Benzodioxinocarbazoles+%28BDCZs%29+as+Potential+Anticancer+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAyerbe%26aufirst%3DN.%26aulast%3DRoutier%26aufirst%3DS.%26aulast%3DGillaizeau%26aufirst%3DI.%26aulast%3DMaiereanu%26aufirst%3DC.%26aulast%3DCaignard%26aufirst%3DD.%2BH.%26aulast%3DPierr%25C3%25A9%26aufirst%3DA.%26aulast%3DL%25C3%25A9once%26aufirst%3DS.%26aulast%3DCoudert%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Novel%2520Benzodioxinocarbazoles%2520%2528BDCZs%2529%2520as%2520Potential%2520Anticancer%2520Agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4670%26epage%3D4674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chiurato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillaumet, G.</span><span> </span><span class="NLM_article-title">New Efficient Access to Fused Aryltetrahydroindolizinones <i>via N</i>-Acyliminium Intermediates</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3011</span><span class="NLM_x">–</span> <span class="NLM_lpage">3021</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=3011-3021&author=M.+Chiuratoauthor=S.+Routierauthor=Y.+Troinauthor=G.+Guillaumet&title=New+Efficient+Access+to+Fused+Aryltetrahydroindolizinones+via+N-Acyliminium+Intermediates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiurato%26aufirst%3DM.%26aulast%3DRoutier%26aufirst%3DS.%26aulast%3DTroin%26aufirst%3DY.%26aulast%3DGuillaumet%26aufirst%3DG.%26atitle%3DNew%2520Efficient%2520Access%2520to%2520Fused%2520Aryltetrahydroindolizinones%2520via%2520N-Acyliminium%2520Intermediates%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2009%26volume%3D18%26spage%3D3011%26epage%3D3021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chiurato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillaumet, G.</span><span> </span><span class="NLM_article-title">New Efficient Access to Fused (Het)aryltetrahydroindolizinones <i>via N</i>-Acyl Iminium Intermediates</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">4647</span><span class="NLM_x">–</span> <span class="NLM_lpage">4653</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=4647-4653&author=M.+Chiuratoauthor=S.+Routierauthor=Y.+Troinauthor=G.+Guillaumet&title=New+Efficient+Access+to+Fused+%28Het%29aryltetrahydroindolizinones+via+N-Acyl+Iminium+Intermediates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiurato%26aufirst%3DM.%26aulast%3DRoutier%26aufirst%3DS.%26aulast%3DTroin%26aufirst%3DY.%26aulast%3DGuillaumet%26aufirst%3DG.%26atitle%3DNew%2520Efficient%2520Access%2520to%2520Fused%2520%2528Het%2529aryltetrahydroindolizinones%2520via%2520N-Acyl%2520Iminium%2520Intermediates%26jtitle%3DTetrahedron%26date%3D2010%26volume%3D66%26spage%3D4647%26epage%3D4653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Honma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukasawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeura, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikuta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki-Takahashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishima, H.</span><span> </span><span class="NLM_article-title">Structure-Based Generation of a New Class of Potent Cdk4 Inhibitors: New de Novo Design Strategy and Library Design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">4615</span><span class="NLM_x">–</span> <span class="NLM_lpage">4627</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0103256" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Fjm3008536&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovFagtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=4615-4627&author=T.+Honmaauthor=Y.+Hayashiauthor=T.+Aoyamaauthor=N.+Hashimotoauthor=T.+Machidaauthor=K.+Fukasawaauthor=T.+Iwamaauthor=C.+Ikeuraauthor=M.+Ikutaauthor=I.+Suzuki-Takahashiauthor=Y.+Iwasawaauthor=T.+Hayamaauthor=S.+Nishimuraauthor=H.+Morishima&title=Structure-Based+Generation+of+a+New+Class+of+Potent+Cdk4+Inhibitors%3A+New+de+Novo+Design+Strategy+and+Library+Design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Generation of a New Class of Potent Cdk4 Inhibitors: New de Novo Design Strategy and Library Design</span></div><div class="casAuthors">Honma, Teruki; Hayashi, Kyoko; Aoyama, Tetsuya; Hashimoto, Noriaki; Machida, Takumitsu; Fukasawa, Kazuhiro; Iwama, Toshiharu; Ikeura, Chinatsu; Ikuta, Mari; Suzuki-Takahashi, Ikuko; Iwasawa, Yoshikazu; Hayama, Takashi; Nishimura, Susumu; Morishima, Hajime</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">4615-4627</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As a first step in structure-based design of highly selective and potent Cdk4 inhibitors, we performed structure-based generation of a novel series of Cdk4 inhibitors.  A Cdk4 homol. model was constructed according to x-ray anal. of an activated form of Cdk2.  Using this model, we applied a new de novo design strategy which combined the de novo design program LEGEND with our inhouse structure selection supporting system SEEDS to generate new scaffold candidates.  In this way, four classes of scaffold candidates including diarylurea were identified.  By constructing diarylurea informer libraries based on the structural requirements of Cdk inhibitors in the ATP binding pocket of the Cdk4 model, we were able to identify a potent Cdk4 inhibitor N-(9-oxo-9H-fluoren-4-yl)-N'-pyridin-2-ylurea (I) with IC50 = 0.10 μM, together with preliminary SAR.  We performed a docking study between I and the Cdk4 model and selected a reasonable binding mode which is consistent with the SAR.  Further modification based on the proposed binding mode provided a more potent compd., N-[(9bR)-5-oxo- 2,3,5,9b-tetrahydro-1H-pyrrolo[2,1-a]isoindol-9-yl]-N'-pyridin-2-ylurea (II) with IC50 = 0.042 μM, x-ray anal. of which was accomplished by the soaking method.  The predicted binding mode of I in Cdk4 was validated by x-ray anal. of the Cdk2-II complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvx3J3Bqyg9LVg90H21EOLACvtfcHk0lgNRwpwW3ru-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovFagtrs%253D&md5=0c4458fa88d41c148a672863b3a6daa0</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fjm0103256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0103256%26sid%3Dliteratum%253Aachs%26aulast%3DHonma%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DAoyama%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DN.%26aulast%3DMachida%26aufirst%3DT.%26aulast%3DFukasawa%26aufirst%3DK.%26aulast%3DIwama%26aufirst%3DT.%26aulast%3DIkeura%26aufirst%3DC.%26aulast%3DIkuta%26aufirst%3DM.%26aulast%3DSuzuki-Takahashi%26aufirst%3DI.%26aulast%3DIwasawa%26aufirst%3DY.%26aulast%3DHayama%26aufirst%3DT.%26aulast%3DNishimura%26aufirst%3DS.%26aulast%3DMorishima%26aufirst%3DH.%26atitle%3DStructure-Based%2520Generation%2520of%2520a%2520New%2520Class%2520of%2520Potent%2520Cdk4%2520Inhibitors%253A%2520New%2520de%2520Novo%2520Design%2520Strategy%2520and%2520Library%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D4615%26epage%3D4627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Honma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshizumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawanishi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukasawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeura, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikuta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki-Takahashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishima, H.</span><span> </span><span class="NLM_article-title">A Novel Approach for the Development of Selective Cdk4 Inhibitors: Library Design Based on Locations of Cdk4 Specific Amino Acid Residues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">4628</span><span class="NLM_x">–</span> <span class="NLM_lpage">4640</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010326y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=4628-4640&author=T.+Honmaauthor=T.+Yoshizumiauthor=N.+Hashimotoauthor=K.+Hayashiauthor=K.+Kawanishiauthor=K.+Fukasawaauthor=T.+Takakiauthor=C.+Ikeuraauthor=M.+Ikutaauthor=I.+Suzuki-Takahashiauthor=T.+Hayamaauthor=S.+Nishimuraauthor=H.+Morishima&title=A+Novel+Approach+for+the+Development+of+Selective+Cdk4+Inhibitors%3A+Library+Design+Based+on+Locations+of+Cdk4+Specific+Amino+Acid+Residues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Fjm010326y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010326y%26sid%3Dliteratum%253Aachs%26aulast%3DHonma%26aufirst%3DT.%26aulast%3DYoshizumi%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DN.%26aulast%3DHayashi%26aufirst%3DK.%26aulast%3DKawanishi%26aufirst%3DK.%26aulast%3DFukasawa%26aufirst%3DK.%26aulast%3DTakaki%26aufirst%3DT.%26aulast%3DIkeura%26aufirst%3DC.%26aulast%3DIkuta%26aufirst%3DM.%26aulast%3DSuzuki-Takahashi%26aufirst%3DI.%26aulast%3DHayama%26aufirst%3DT.%26aulast%3DNishimura%26aufirst%3DS.%26aulast%3DMorishima%26aufirst%3DH.%26atitle%3DA%2520Novel%2520Approach%2520for%2520the%2520Development%2520of%2520Selective%2520Cdk4%2520Inhibitors%253A%2520Library%2520Design%2520Based%2520on%2520Locations%2520of%2520Cdk4%2520Specific%2520Amino%2520Acid%2520Residues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D4628%26epage%3D4640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Alsarabi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canet, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troin, Y.</span><span> </span><span class="NLM_article-title">Short Diastereoselective Synthesis of <i>cis</i>- and <i>trans</i>-Hexahydropyrido[2,1-<i>a</i>]isoindole Derivatives</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">9003</span><span class="NLM_x">–</span> <span class="NLM_lpage">9006</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=9003-9006&author=A.+Alsarabiauthor=J.+L.+Canetauthor=Y.+Troin&title=Short+Diastereoselective+Synthesis+of+cis-+and+trans-Hexahydropyrido%5B2%2C1-a%5Disoindole+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlsarabi%26aufirst%3DA.%26aulast%3DCanet%26aufirst%3DJ.%2BL.%26aulast%3DTroin%26aufirst%3DY.%26atitle%3DShort%2520Diastereoselective%2520Synthesis%2520of%2520cis-%2520and%2520trans-Hexahydropyrido%255B2%252C1-a%255Disoindole%2520Derivatives%26jtitle%3DTetrahedron%2520Lett.%26date%3D2004%26volume%3D45%26spage%3D9003%26epage%3D9006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="note"><p class="first last">Valmerin is a nickmane which comes from the sentence “<b>Val</b>orisation des produits de la <b>Mer</b>” (see the <a class="ref internalNav" href="#ack" aria-label="Acknowledgments">Acknowledgments</a>) and from the mane of some CDK inhibitors which use the suffix “In”.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Routier, S.; Guillaumet, G.; Meijer, L.; Chiurato, M.; Boulahjar, R.</span><span> </span><span class="NLM_article-title">10-Amino-1,2,3,4-tetrahydropyrido[2,1-<i>a</i>]isoindol-6(10bH)-ones as CDK1, 5 and GSK-3 inhibitors</span>. Patent WO 201050416;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Routier%2C+S.%3B+Guillaumet%2C+G.%3B+Meijer%2C+L.%3B+Chiurato%2C+M.%3B+Boulahjar%2C+R.+10-Amino-1%2C2%2C3%2C4-tetrahydropyrido%5B2%2C1-a%5Disoindol-6%2810bH%29-ones+as+CDK1%2C+5+and+GSK-3+inhibitors.+Patent+WO+201050416%3B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRoutier%26aufirst%3DS.%26atitle%3D10-Amino-1%252C2%252C3%252C4-tetrahydropyrido%255B2%252C1-a%255Disoindol-6%252810bH%2529-ones%2520as%2520CDK1%252C%25205%2520and%2520GSK-3%2520inhibitors" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19a"><span> <span class="citation_source-journal">Chem. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">431389</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chem.+Abstr.+2009%2C+153%2C+431389."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Abstr.%26date%3D2009%26volume%3D153%26spage%3D431389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Gesson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacquesy, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rambaud, D.</span><span> </span><span class="NLM_article-title">α-<i>N</i>-Acyliminium Ion - 2-Bromoalkene Cyclizations</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2239</span><span class="NLM_x">–</span> <span class="NLM_lpage">2248</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1993&pages=2239-2248&author=J.+P.+Gessonauthor=J.+C.+Jacquesyauthor=D.+Rambaud&title=%CE%B1-N-Acyliminium+Ion+-+2-Bromoalkene+Cyclizations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGesson%26aufirst%3DJ.%2BP.%26aulast%3DJacquesy%26aufirst%3DJ.%2BC.%26aulast%3DRambaud%26aufirst%3DD.%26atitle%3D%25CE%25B1-N-Acyliminium%2520Ion%2520-%25202-Bromoalkene%2520Cyclizations%26jtitle%3DTetrahedron%26date%3D1993%26volume%3D49%26spage%3D2239%26epage%3D2248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Lochead, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proctor, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caton, M. P. L.</span><span> </span><span class="NLM_article-title">Use of Chloroalkenylamines for the Synthesis of 1-Azabicyclo[3.3.0]octane and 1-Azabicyclo[4.3.0]nonane Derivatives</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_fpage">2477</span><span class="NLM_x">–</span> <span class="NLM_lpage">2489</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1984&pages=2477-2489&author=A.+W.+Locheadauthor=G.+R.+Proctorauthor=M.+P.+L.+Caton&title=Use+of+Chloroalkenylamines+for+the+Synthesis+of+1-Azabicyclo%5B3.3.0%5Doctane+and+1-Azabicyclo%5B4.3.0%5Dnonane+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLochead%26aufirst%3DA.%2BW.%26aulast%3DProctor%26aufirst%3DG.%2BR.%26aulast%3DCaton%26aufirst%3DM.%2BP.%2BL.%26atitle%3DUse%2520of%2520Chloroalkenylamines%2520for%2520the%2520Synthesis%2520of%25201-Azabicyclo%255B3.3.0%255Doctane%2520and%25201-Azabicyclo%255B4.3.0%255Dnonane%2520Derivatives%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1984%26spage%3D2477%26epage%3D2489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Huang, M.</span> <span class="citation_source-journal">Contribution from the Chemical Laboratory of Harvard University</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1946</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2487</span><span class="NLM_x">–</span> <span class="NLM_lpage">2488</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Huang%2C+M.Contribution+from+the+Chemical+Laboratory+of+Harvard+University+1946%2C+68%2C+2487%E2%80%932488"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DM.%26jtitle%3DContribution%2520from%2520the%2520Chemical%2520Laboratory%2520of%2520Harvard%2520University%26date%3D1946%26volume%3D68%26spage%3D2487%26epage%3D2488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Löwik, D. W. P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tisi, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, C. R.</span><span> </span><span class="NLM_article-title">Synthesis of 6-Hydroxybenzothiazole-2-carboxylic Acid</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_fpage">1780</span><span class="NLM_x">–</span> <span class="NLM_lpage">1783</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm3008536&amp;key=10.1055%2Fs-2001-17533" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm3008536&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntlGisrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=1780-1783&author=D.+W.+P.+M.+L%C3%B6wikauthor=L.+C.+Tisiauthor=J.+A.+H.+Murrayauthor=C.+R.+Lowe&title=Synthesis+of+6-Hydroxybenzothiazole-2-carboxylic+Acid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 6-hydroxybenzothiazole-2-carboxylic acid</span></div><div class="casAuthors">Lowik, Dennis W. P. M.; Tisi, Lawrence C.; Murray, James A. H.; Lowe, Christopher R.</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1780-1783</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">The synthesis of 6-hydroxybenzothiazole-2-carboxylic acid (I) is presented.  The benzothiazole ring was obtained by ring contraction of a remarkably stable 2-alkoxy-7-hydroxy-2H-benzo[1,4]thiazine intermediate that could be isolated.  I slowly decarboxylated in soln. at ambient temp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiTwJ1ZmPzs7Vg90H21EOLACvtfcHk0ljEcloeV7IECQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntlGisrw%253D&md5=3e7cb79e97dba2444cfcb3c4b0ce3ea4</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1055%2Fs-2001-17533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2001-17533%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6wik%26aufirst%3DD.%2BW.%2BP.%2BM.%26aulast%3DTisi%26aufirst%3DL.%2BC.%26aulast%3DMurray%26aufirst%3DJ.%2BA.%2BH.%26aulast%3DLowe%26aufirst%3DC.%2BR.%26atitle%3DSynthesis%2520of%25206-Hydroxybenzothiazole-2-carboxylic%2520Acid%26jtitle%3DSynthesis%26date%3D2001%26spage%3D1780%26epage%3D1783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Brown, A. D.; Ellis, D.; Smith, C. R.</span>, <span> </span><span class="NLM_article-title">Substituted Triazole Derivatives As Oxytocin Antagonists Their Preparation and Use against Sexual Dysfunction</span>. Patent WO2005028452;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Brown%2C+A.+D.%3B+Ellis%2C+D.%3B+Smith%2C+C.+R.%2C+Substituted+Triazole+Derivatives+As+Oxytocin+Antagonists+Their+Preparation+and+Use+against+Sexual+Dysfunction.+Patent+WO2005028452%3B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BD.%26atitle%3DSubstituted%2520Triazole%2520Derivatives%2520As%2520Oxytocin%2520Antagonists%2520Their%2520Preparation%2520and%2520Use%2520against%2520Sexual%2520Dysfunction" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24a"><span> <span class="citation_source-journal">Chem. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">355271</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chem.+Abstr.+2005%2C+142%2C+355271."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Abstr.%26date%3D2005%26volume%3D142%26spage%3D355271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Aakeröy, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desper, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valdés-Martinez, J.</span><span> </span><span class="NLM_article-title">Robust Building Blocks for Inorganic Crystal Engineering</span> <span class="citation_source-journal">Inorg. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">359</span><span class="NLM_x">, </span> <span class="NLM_fpage">1255</span><span class="NLM_x">–</span> <span class="NLM_lpage">1262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm3008536&amp;key=10.1016%2Fj.ica.2005.09.051" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=2006&pages=1255-1262&author=C.+B.+Aaker%C3%B6yauthor=J.+Desperauthor=B.+Levinauthor=J.+Vald%C3%A9s-Martinez&title=Robust+Building+Blocks+for+Inorganic+Crystal+Engineering"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.ica.2005.09.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ica.2005.09.051%26sid%3Dliteratum%253Aachs%26aulast%3DAaker%25C3%25B6y%26aufirst%3DC.%2BB.%26aulast%3DDesper%26aufirst%3DJ.%26aulast%3DLevin%26aufirst%3DB.%26aulast%3DVald%25C3%25A9s-Martinez%26aufirst%3DJ.%26atitle%3DRobust%2520Building%2520Blocks%2520for%2520Inorganic%2520Crystal%2520Engineering%26jtitle%3DInorg.%2520Chim.%2520Acta%26date%3D2006%26volume%3D359%26spage%3D1255%26epage%3D1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boñaga, L. V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derian, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damiano, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, B. E.</span><span> </span><span class="NLM_article-title">Novel Bis(indolyl)maleimide Pyridinophosphanes That Are Potent, Selective Inhibitors of Glycogen Synthase Kinase-3</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2863</span><span class="NLM_x">–</span> <span class="NLM_lpage">2868</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2863-2868&author=H.+C.+Zhangauthor=L.+V.+R.+Bo%C3%B1agaauthor=H.+Yeauthor=C.+K.+Derianauthor=B.+P.+Damianoauthor=B.+E.+Maryanoff&title=Novel+Bis%28indolyl%29maleimide+Pyridinophosphanes+That+Are+Potent%2C+Selective+Inhibitors+of+Glycogen+Synthase+Kinase-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%2BC.%26aulast%3DBo%25C3%25B1aga%26aufirst%3DL.%2BV.%2BR.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DDerian%26aufirst%3DC.%2BK.%26aulast%3DDamiano%26aufirst%3DB.%2BP.%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26atitle%3DNovel%2520Bis%2528indolyl%2529maleimide%2520Pyridinophosphanes%2520That%2520Are%2520Potent%252C%2520Selective%2520Inhibitors%2520of%2520Glycogen%2520Synthase%2520Kinase-3%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2863%26epage%3D2868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Targeting Cancer with Small Molecule Kinase Inhibitors</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=16&amp;doi=10.1021%2Fjm3008536&amp;key=10.1038%2Fnrc2559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=8&amp;doi=10.1021%2Fjm3008536&amp;key=19104514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Fjm3008536&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1yg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=28-39&author=J.+Zhangauthor=P.+L.+Yangauthor=N.+S.+Gray&title=Targeting+Cancer+with+Small+Molecule+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer with small molecule kinase inhibitors</span></div><div class="casAuthors">Zhang, Jianming; Yang, Priscilla L.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiol. constraints on growth and survival.  To date, 11 kinase inhibitors have received US Food and Drug Administration approval as cancer treatments, and there are considerable efforts to develop selective small mol. inhibitors for a host of other kinases that are implicated in cancer and other diseases.  Herein we discuss the current challenges in the field, such as designing selective inhibitors and developing strategies to overcome resistance mutations.  This Review provides a broad overview of some of the approaches currently used to discover and characterize new kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriSM3BN_uEz7Vg90H21EOLACvtfcHk0lizts3WhYsqDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1yg&md5=35bc38f414cd21eef5e61ce181b580fb</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1038%2Fnrc2559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2559%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DP.%2BL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520Cancer%2520with%2520Small%2520Molecule%2520Kinase%2520Inhibitors%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D28%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Jacquemard, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dias, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansiaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailly, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logé, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mérour, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routier, S.</span><span> </span><span class="NLM_article-title">Synthesis of 3,5-Bis(2-indolyl)pyridine and 3-[(2-Indolyl)-5-phenyl]pyridine Derivatives as CDK Inhibitors and Cytotoxic Agents</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4932</span><span class="NLM_x">–</span> <span class="NLM_lpage">4953</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=4932-4953&author=U.+Jacquemardauthor=N.+Diasauthor=A.+Lansiauxauthor=C.+Baillyauthor=C.+Log%C3%A9author=J.-M.+Robertauthor=O.+Lozachauthor=L.+Meijerauthor=J.+Y.+M%C3%A9rourauthor=S.+Routier&title=Synthesis+of+3%2C5-Bis%282-indolyl%29pyridine+and+3-%5B%282-Indolyl%29-5-phenyl%5Dpyridine+Derivatives+as+CDK+Inhibitors+and+Cytotoxic+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacquemard%26aufirst%3DU.%26aulast%3DDias%26aufirst%3DN.%26aulast%3DLansiaux%26aufirst%3DA.%26aulast%3DBailly%26aufirst%3DC.%26aulast%3DLog%25C3%25A9%26aufirst%3DC.%26aulast%3DRobert%26aufirst%3DJ.-M.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DM%25C3%25A9rour%26aufirst%3DJ.%2BY.%26aulast%3DRoutier%26aufirst%3DS.%26atitle%3DSynthesis%2520of%25203%252C5-Bis%25282-indolyl%2529pyridine%2520and%25203-%255B%25282-Indolyl%2529-5-phenyl%255Dpyridine%2520Derivatives%2520as%2520CDK%2520Inhibitors%2520and%2520Cytotoxic%2520Agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D4932%26epage%3D4953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Hoffman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Büchler, M. W..</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schemmer, P.</span><span> </span><span class="NLM_article-title">Sorafenib Modulates the Gene Expression of Multi-drug Resistance Mediating ATP-Binding Cassette Proteins in Experimental Hepatocellular Carcinoma</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">4503</span><span class="NLM_x">–</span> <span class="NLM_lpage">4508</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm3008536&amp;key=21115899" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=4503-4508&author=K.+Hoffmanauthor=C.+Franzauthor=Z.+Xiaoauthor=E.+Mohrauthor=S.+Serbaauthor=M.+W..+B%C3%BCchlerauthor=P.+Schemmer&title=Sorafenib+Modulates+the+Gene+Expression+of+Multi-drug+Resistance+Mediating+ATP-Binding+Cassette+Proteins+in+Experimental+Hepatocellular+Carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoffman%26aufirst%3DK.%26aulast%3DFranz%26aufirst%3DC.%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DMohr%26aufirst%3DE.%26aulast%3DSerba%26aufirst%3DS.%26aulast%3DB%25C3%25BCchler%26aufirst%3DM.%2BW..%26aulast%3DSchemmer%26aufirst%3DP.%26atitle%3DSorafenib%2520Modulates%2520the%2520Gene%2520Expression%2520of%2520Multi-drug%2520Resistance%2520Mediating%2520ATP-Binding%2520Cassette%2520Proteins%2520in%2520Experimental%2520Hepatocellular%2520Carcinoma%26jtitle%3DAnticancer%2520Res.%26date%3D2010%26volume%3D30%26spage%3D4503%26epage%3D4508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Fukuyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niculaita, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obusez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalady, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aung, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sizemore, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuyama, R.</span><span> </span><span class="NLM_article-title">Mutated in colorectal Cancer, A Putative Tumor Suppressor for Serrated Colorectal Cancer, Selectively Represses Beta-Catenin-Dependent Transcription</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">6044</span><span class="NLM_x">–</span> <span class="NLM_lpage">6055</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=6044-6055&author=R.+Fukuyamaauthor=R.+Niculaitaauthor=K.+P.+Ngauthor=E.+Obusezauthor=J.+Sanchezauthor=M.+Kaladyauthor=P.+P.+Aungauthor=G.+Caseyauthor=N.+Sizemoreauthor=R.+Fukuyama&title=Mutated+in+colorectal+Cancer%2C+A+Putative+Tumor+Suppressor+for+Serrated+Colorectal+Cancer%2C+Selectively+Represses+Beta-Catenin-Dependent+Transcription"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFukuyama%26aufirst%3DR.%26aulast%3DNiculaita%26aufirst%3DR.%26aulast%3DNg%26aufirst%3DK.%2BP.%26aulast%3DObusez%26aufirst%3DE.%26aulast%3DSanchez%26aufirst%3DJ.%26aulast%3DKalady%26aufirst%3DM.%26aulast%3DAung%26aufirst%3DP.%2BP.%26aulast%3DCasey%26aufirst%3DG.%26aulast%3DSizemore%26aufirst%3DN.%26aulast%3DFukuyama%26aufirst%3DR.%26atitle%3DMutated%2520in%2520colorectal%2520Cancer%252C%2520A%2520Putative%2520Tumor%2520Suppressor%2520for%2520Serrated%2520Colorectal%2520Cancer%252C%2520Selectively%2520Represses%2520Beta-Catenin-Dependent%2520Transcription%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D6044%26epage%3D6055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Debdab, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreaux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renault, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soundararajan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babault, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahtouh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baratte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenreich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazureau, J.-P.</span><span> </span><span class="NLM_article-title">Leucettines, a Class of Potent Inhibitors of cdc2-like Kinases and Dual Specificity, Tyrosine Phosphorylation Regulated Kinases Derived from the Marine Sponge Leucettamine B. Modulation of Alternative Pre-RNA Splicing</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4172</span><span class="NLM_x">–</span> <span class="NLM_lpage">4186</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200274d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4172-4186&author=M.+Debdabauthor=F.+Carreauxauthor=S.+Renaultauthor=M.+Soundararajanauthor=O.+Fedorovauthor=P.+Filippakopoulosauthor=O.+Lozachauthor=L.+Babaultauthor=T.+Tahtouhauthor=B.+Baratteauthor=Y.+Ogawaauthor=M.+Hagiwaraauthor=A.+Eisenreichauthor=U.+Rauchauthor=S.+Knappauthor=L.+Meijerauthor=J.-P.+Bazureau&title=Leucettines%2C+a+Class+of+Potent+Inhibitors+of+cdc2-like+Kinases+and+Dual+Specificity%2C+Tyrosine+Phosphorylation+Regulated+Kinases+Derived+from+the+Marine+Sponge+Leucettamine+B.+Modulation+of+Alternative+Pre-RNA+Splicing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm200274d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200274d%26sid%3Dliteratum%253Aachs%26aulast%3DDebdab%26aufirst%3DM.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DRenault%26aufirst%3DS.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DBabault%26aufirst%3DL.%26aulast%3DTahtouh%26aufirst%3DT.%26aulast%3DBaratte%26aufirst%3DB.%26aulast%3DOgawa%26aufirst%3DY.%26aulast%3DHagiwara%26aufirst%3DM.%26aulast%3DEisenreich%26aufirst%3DA.%26aulast%3DRauch%26aufirst%3DU.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBazureau%26aufirst%3DJ.-P.%26atitle%3DLeucettines%252C%2520a%2520Class%2520of%2520Potent%2520Inhibitors%2520of%2520cdc2-like%2520Kinases%2520and%2520Dual%2520Specificity%252C%2520Tyrosine%2520Phosphorylation%2520Regulated%2520Kinases%2520Derived%2520from%2520the%2520Marine%2520Sponge%2520Leucettamine%2520B.%2520Modulation%2520of%2520Alternative%2520Pre-RNA%2520Splicing%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4172%26epage%3D4186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Leclerc, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoessel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marko, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibb, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greengard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenbrand, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Indirubins Inhibit Glycogen Synthase Kinase - 3<i>β</i> and CDK5/p25, Two Kinases Involved in Abnormal Tau Phosphorylation in Alzheimer’s Disease - A Property Common to Most CDK Inhibitors?</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=251-260&author=S.+Leclercauthor=M.+Garnierauthor=R.+Hoesselauthor=D.+Markoauthor=J.+A.+Bibbauthor=G.+L.+Snyderauthor=P.+Greengardauthor=J.+Biernatauthor=E.-M.+Mandelkowauthor=G.+Eisenbrandauthor=L.+Meijer&title=Indirubins+Inhibit+Glycogen+Synthase+Kinase+-+3%CE%B2+and+CDK5%2Fp25%2C+Two+Kinases+Involved+in+Abnormal+Tau+Phosphorylation+in+Alzheimer%E2%80%99s+Disease+-+A+Property+Common+to+Most+CDK+Inhibitors%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeclerc%26aufirst%3DS.%26aulast%3DGarnier%26aufirst%3DM.%26aulast%3DHoessel%26aufirst%3DR.%26aulast%3DMarko%26aufirst%3DD.%26aulast%3DBibb%26aufirst%3DJ.%2BA.%26aulast%3DSnyder%26aufirst%3DG.%2BL.%26aulast%3DGreengard%26aufirst%3DP.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.-M.%26aulast%3DEisenbrand%26aufirst%3DG.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DIndirubins%2520Inhibit%2520Glycogen%2520Synthase%2520Kinase%2520-%25203%25CE%25B2%2520and%2520CDK5%252Fp25%252C%2520Two%2520Kinases%2520Involved%2520in%2520Abnormal%2520Tau%2520Phosphorylation%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%2520-%2520A%2520Property%2520Common%2520to%2520Most%2520CDK%2520Inhibitors%253F%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D251%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Primot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baratte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gompel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liabeuf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romette, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costantini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Purification of GSK-3 by Affinity Chromatography on Immobilised Axin</span> <span class="citation_source-journal">Protein Expr. Purif.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">394</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm3008536&amp;key=10.1006%2Fprep.2000.1321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm3008536&amp;key=11087679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm3008536&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotFyqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=394-404&author=A.+Primotauthor=B.+Baratteauthor=M.+Gompelauthor=A.+Borgneauthor=S.+Liabeufauthor=J.+L.+Rometteauthor=F.+Costantiniauthor=L.+Meijer&title=Purification+of+GSK-3+by+Affinity+Chromatography+on+Immobilised+Axin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Purification of GSK-3 by Affinity Chromatography on Immobilized Axin</span></div><div class="casAuthors">Primot, Aline; Baratte, Blandine; Gompel, Marie; Borgne, Annie; Liabeuf, Sylvie; Romette, Jean-Louis; Jho, Eek-hoon; Costantini, Frank; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression and Purification</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">394-404</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Glycogen synthase kinase 3 (GSK-3), an element of the Wnt signalling pathway, plays a key role in numerous cellular processes including cell proliferation, embryonic development, and neuronal functions.  It is directly involved in diseases such as cancer (by controlling apoptosis and the levels of β-catenin and cyclin D1), Alzheimer's disease (tau hyperphosphorylation), and diabetes (as a downstream element of insulin action, GSK-3 regulates glycogen and lipid synthesis).  We describe here a rapid and efficient method for the purifn. of GSK-3 by affinity chromatog. on an immobilized fragment of axin.  Axin is a docking protein which interacts with GSK-3β, β-catenin, phosphatase 2A, and APC.  A polyhistidine-tagged axin peptide (residues 419-672) was produced in Escherichia coli and either immobilized on Ni-NTA agarose beads or purified and immobilized on CNBr-activated Sepharose 4B.  These Axin-His6 matrixes were found to selectively bind recombinant rat GSK-3β and native GSK-3 from yeast, sea urchin embryos, and porcine brain.  The affinity-purified enzymes displayed high kinase activity.  This single step purifn. method provides a convenient tool to follow the status of GSK-3 (protein level, phosphorylation state, kinase activity) under various physiol. settings.  It also provides a simple and efficient way to purify large amts. of active recombinant or native GSK-3 for screening purposes.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotZ_PC6B5jmrVg90H21EOLACvtfcHk0lhIf-LpeevsBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotFyqsbo%253D&md5=e15577cd02c0fcfa388aa64f9ec544f1</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1006%2Fprep.2000.1321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fprep.2000.1321%26sid%3Dliteratum%253Aachs%26aulast%3DPrimot%26aufirst%3DA.%26aulast%3DBaratte%26aufirst%3DB.%26aulast%3DGompel%26aufirst%3DM.%26aulast%3DBorgne%26aufirst%3DA.%26aulast%3DLiabeuf%26aufirst%3DS.%26aulast%3DRomette%26aufirst%3DJ.%2BL.%26aulast%3DCostantini%26aufirst%3DF.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DPurification%2520of%2520GSK-3%2520by%2520Affinity%2520Chromatography%2520on%2520Immobilised%2520Axin%26jtitle%3DProtein%2520Expr.%2520Purif.%26date%3D2000%26volume%3D20%26spage%3D394%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Reinhardt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferandin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Purification CK1 by Affinity Chromatography on Immobilised Axin</span> <span class="citation_source-journal">Protein Expr. Puri.f</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm3008536&amp;key=10.1016%2Fj.pep.2007.02.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm3008536&amp;key=17434749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm3008536&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslCnt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2007&pages=101-109&author=J.+Reinhardtauthor=Y.+Ferandinauthor=L.+Meijer&title=Purification+CK1+by+Affinity+Chromatography+on+Immobilised+Axin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Purification of CK1 by affinity chromatography on immobilised axin</span></div><div class="casAuthors">Reinhardt, Jens; Ferandin, Yoan; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression and Purification</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-109</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Members of the Casein Kinase 1 (CK1) family are implicated in the regulation of a variety of physiol. processes like development and circadian rhythm, as well as in diseases like cancer and Alzheimer's disease.  From that perspective, CK1 family members are interesting targets for potential chemotherapy.  We describe here a rapid and efficient method for the purifn. of CK1 by affinity chromatog. on an immobilized fragment of axin.  Axin is a scaffolding protein that interacts with a multitude of proteins, amongst them APC, GSK-3, β-catenin, CK1α, δ, and ε, and PP2A.  A GST-tagged axin peptide (residues 495-684) was produced in Escherichia coli and either immobilized on glutathione agarose beads or purified and immobilized on CNBr-activated Sepharose 4B.  These "GST-axin" matrixes were found to selectively bind native CK1α and CK1ε from porcine brain.  The affinity-purified enzymes displayed high kinase activity.  This single step purifn. provides a convenient tool to efficiently purify large amts. of active native CK1 for screening purposes.  This single step purifn. also provides a convenient tool to follow the status of the axin-binding CK1 isoforms α, δ, and ε (protein levels, compn. of isoforms, kinase activity) under different physiol. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojnaZtPudqbbVg90H21EOLACvtfcHk0lhIf-LpeevsBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslCnt7w%253D&md5=8edde52c867ca4879a797e498fea8797</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.pep.2007.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pep.2007.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DReinhardt%26aufirst%3DJ.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DPurification%2520CK1%2520by%2520Affinity%2520Chromatography%2520on%2520Immobilised%2520Axin%26jtitle%3DProtein%2520Expr.%2520Puri.f%26date%3D2007%26volume%3D54%26spage%3D101%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span>Maestro, version 9.3, Glide, version 5.8, <span class="NLM_publisher-name">Schrödinger, LLC</span>, <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro%2C+version+9.3%2C+Glide%2C+version+5.8%2C+Schr%C3%B6dinger%2C+LLC%2C+New+York%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><a href="http://www.rcsb.org/pdb/home/home.do" class="extLink">http://www.rcsb.org/pdb/home/home.do</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.rcsb.org%2Fpdb%2Fhome%2Fhome.do."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36a"><span><span class="NLM_label">(a) </span>Marvin 5.8.0,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">, </span>ChemAxon (<a href="http://www.chemaxon.com" class="extLink">http://www.chemaxon.com</a>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Marvin+5.8.0%2C+2012%2C+ChemAxon+%28http%3A%2F%2Fwww.chemaxon.com%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2012%26jtitle%3DChemAxon" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit36b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sadowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasteiger, J.</span><span> </span><span class="NLM_article-title">From Atoms and Bonds to Three-Dimensional Atomic Coordinates: Automatic Model Builders</span> <span class="citation_source-journal">Chem. Reviews</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">2567</span><span class="NLM_x">–</span> <span class="NLM_lpage">2581</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr00023a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=32&amp;doi=10.1021%2Fjm3008536&amp;key=1%3ACAS%3A528%3ADyaK3sXmt1GgsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1993&pages=2567-2581&author=J.+Sadowskiauthor=J.+Gasteiger&title=From+Atoms+and+Bonds+to+Three-Dimensional+Atomic+Coordinates%3A+Automatic+Model+Builders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36bR"><div class="casContent"><span class="casTitleNuber">36b</span><div class="casTitle"><span class="NLM_cas:atitle">From atoms and bonds to three-dimensional atomic coordinates: automatic model builders</span></div><div class="casAuthors">Sadowski, Jens; Gasteiger, Johann</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2567-81</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    </div><div class="casAbstract">A review with ∼75 refs. in which WIZARD, COBRA, CONCORD, and CORINA are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbdmHfCX7f77Vg90H21EOLACvtfcHk0lippuuqvNAlvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmt1GgsLs%253D&md5=fcdb50dfbd981c8f122da06e06e62e27</span></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=10.1021%2Fcr00023a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00023a012%26sid%3Dliteratum%253Aachs%26aulast%3DSadowski%26aufirst%3DJ.%26aulast%3DGasteiger%26aufirst%3DJ.%26atitle%3DFrom%2520Atoms%2520and%2520Bonds%2520to%2520Three-Dimensional%2520Atomic%2520Coordinates%253A%2520Automatic%2520Model%2520Builders%26jtitle%3DChem.%2520Reviews%26date%3D1993%26volume%3D93%26spage%3D2567%26epage%3D2581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit36c"><span><span class="NLM_label">(c) </span><a href="http://www.molecular-networks.com/products/corina" class="extLink">http://www.molecular-networks.com/products/corina</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.molecular-networks.com%2Fproducts%2Fcorina."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5a','cit5b'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b','cit14c','cit14d'],'ref15':['cit15a','cit15b'],'ref16':['cit16a','cit16b'],'ref17':['cit17'],'ref18':[],'ref19':['cit19','cit19a'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24','cit24a'],'ref25':['cit25'],'ref26':['cit26a','cit26b'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36a','cit36b','cit36c']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 36 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yarkali Krishna, <span class="NLM_string-name hlFld-ContribAuthor">Fujie Tanaka</span>. </span><span class="cited-content_cbyCitation_article-title">Intramolecular Formal [4 + 2] Cycloadditions: Synthesis of Spiro Isoindolinone Derivatives and Related Molecules. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (5)
                                     , 1874-1879. <a href="https://doi.org/10.1021/acs.orglett.1c00283" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c00283</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c00283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c00283%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DIntramolecular%252BFormal%252B%25255B4%252B%25252B%252B2%25255D%252BCycloadditions%25253A%252BSynthesis%252Bof%252BSpiro%252BIsoindolinone%252BDerivatives%252Band%252BRelated%252BMolecules%26aulast%3DKrishna%26aufirst%3DYarkali%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D25012021%26date%3D18022021%26volume%3D23%26issue%3D5%26spage%3D1874%26epage%3D1879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tengfei Yao, Fang Zhang, Junliang Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Lu Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Intermolecular Heck-Type Dearomative [4 + 2] Annulation of 2H-Isoindole Derivatives with Internal Alkynes. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (13)
                                     , 5063-5067. <a href="https://doi.org/10.1021/acs.orglett.0c01643" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c01643</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c01643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c01643%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPalladium-Catalyzed%252BIntermolecular%252BHeck-Type%252BDearomative%252B%25255B4%252B%25252B%252B2%25255D%252BAnnulation%252Bof%252B2H-Isoindole%252BDerivatives%252Bwith%252BInternal%252BAlkynes%26aulast%3DYao%26aufirst%3DTengfei%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14052020%26date%3D15062020%26volume%3D22%26issue%3D13%26spage%3D5063%26epage%3D5067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tengfei Yao, Tong Xia, Wei Yan, Haofeng Xu, Fang Zhang, Yuanjing Xiao, Junliang Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Lu Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Chemodivergent Cyclization of N-(ortho-alkynyl)aryl-Pyrrole and Indoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (11)
                                     , 4511-4516. <a href="https://doi.org/10.1021/acs.orglett.0c01519" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c01519</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c01519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c01519%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCopper-Catalyzed%252BChemodivergent%252BCyclization%252Bof%252BN-%252528ortho-alkynyl%252529aryl-Pyrrole%252Band%252BIndoles%26aulast%3DYao%26aufirst%3DTengfei%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03052020%26date%3D14052020%26volume%3D22%26issue%3D11%26spage%3D4511%26epage%3D4516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yovanny Quevedo-Acosta, Igor D. Jurberg, <span class="NLM_string-name hlFld-ContribAuthor">Diego Gamba-Sánchez</span>. </span><span class="cited-content_cbyCitation_article-title">Activating Imides with Triflic Acid: A General Intramolecular Aldol Condensation Strategy Toward Indolizidine, Quinolizidine, and Valmerin Alkaloids. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (1)
                                     , 239-243. <a href="https://doi.org/10.1021/acs.orglett.9b04199" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b04199</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b04199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b04199%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DActivating%252BImides%252Bwith%252BTriflic%252BAcid%25253A%252BA%252BGeneral%252BIntramolecular%252BAldol%252BCondensation%252BStrategy%252BToward%252BIndolizidine%25252C%252BQuinolizidine%25252C%252Band%252BValmerin%252BAlkaloids%26aulast%3DQuevedo-Acosta%26aufirst%3DYovanny%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D25112019%26date%3D17122019%26volume%3D22%26issue%3D1%26spage%3D239%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yarkali Krishna, Kola Shilpa, <span class="NLM_string-name hlFld-ContribAuthor">Fujie Tanaka</span>. </span><span class="cited-content_cbyCitation_article-title">Intramolecular Mannich and Michael Annulation Reactions of Lactam Derivatives Bearing Enals To Afford Bicyclic N-Heterocycles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (20)
                                     , 8444-8448. <a href="https://doi.org/10.1021/acs.orglett.9b03210" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b03210</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b03210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b03210%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DIntramolecular%252BMannich%252Band%252BMichael%252BAnnulation%252BReactions%252Bof%252BLactam%252BDerivatives%252BBearing%252BEnals%252BTo%252BAfford%252BBicyclic%252BN-Heterocycles%26aulast%3DKrishna%26aufirst%3DYarkali%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D10092019%26date%3D04102019%26volume%3D21%26issue%3D20%26spage%3D8444%26epage%3D8448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Malay Das, <span class="NLM_string-name hlFld-ContribAuthor">Anil K. Saikia</span>. </span><span class="cited-content_cbyCitation_article-title">Stereoselective Synthesis of Pyrroloisoindolone and Pyridoisoindolone via aza-Prins Cyclization of Endocyclic N-Acyliminium Ions. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (11)
                                     , 6178-6185. <a href="https://doi.org/10.1021/acs.joc.8b00440" title="DOI URL">https://doi.org/10.1021/acs.joc.8b00440</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b00440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b00440%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DStereoselective%252BSynthesis%252Bof%252BPyrroloisoindolone%252Band%252BPyridoisoindolone%252Bvia%252Baza-Prins%252BCyclization%252Bof%252BEndocyclic%252BN-Acyliminium%252BIons%26aulast%3DDas%26aufirst%3DMalay%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D15022018%26date%3D10052018%26date%3D01052018%26volume%3D83%26issue%3D11%26spage%3D6178%26epage%3D6185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akira  Yada</span>, <span class="hlFld-ContribAuthor ">Satoshi  Okajima</span>, and <span class="hlFld-ContribAuthor ">Masahiro  Murakami</span>  . </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Intramolecular Insertion of Alkenes into the Carbon–Nitrogen Bond of β-Lactams. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2015,</strong> <em>137 </em>
                                    (27)
                                     , 8708-8711. <a href="https://doi.org/10.1021/jacs.5b05308" title="DOI URL">https://doi.org/10.1021/jacs.5b05308</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.5b05308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.5b05308%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DPalladium-Catalyzed%252BIntramolecular%252BInsertion%252Bof%252BAlkenes%252Binto%252Bthe%252BCarbon%2525E2%252580%252593Nitrogen%252BBond%252Bof%252B%2525CE%2525B2-Lactams%26aulast%3DYada%26aufirst%3DAkira%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D22052015%26date%3D01072015%26date%3D15072015%26date%3D29062015%26volume%3D137%26issue%3D27%26spage%3D8708%26epage%3D8711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kiran  Indukuri</span>, <span class="hlFld-ContribAuthor ">R.  Unnava</span>, <span class="hlFld-ContribAuthor ">Manash J.  Deka</span>, and <span class="hlFld-ContribAuthor ">Anil K.  Saikia</span>  . </span><span class="cited-content_cbyCitation_article-title">Stereoselective Synthesis of Amido and Phenyl Azabicyclic Derivatives via a Tandem Aza Prins-Ritter/Friedel–Crafts Type Reaction of Endocyclic N-Acyliminium Ions. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>78 </em>
                                    (21)
                                     , 10629-10641. <a href="https://doi.org/10.1021/jo401450j" title="DOI URL">https://doi.org/10.1021/jo401450j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo401450j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo401450j%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DStereoselective%252BSynthesis%252Bof%252BAmido%252Band%252BPhenyl%252BAzabicyclic%252BDerivatives%252Bvia%252Ba%252BTandem%252BAza%252BPrins-Ritter%25252FFriedel%2525E2%252580%252593Crafts%252BType%252BReaction%252Bof%252BEndocyclic%252BN-Acyliminium%252BIons%26aulast%3DIndukuri%26aufirst%3DKiran%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D04072013%26date%3D14102013%26date%3D01112013%26date%3D01102013%26volume%3D78%26issue%3D21%26spage%3D10629%26epage%3D10641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hendra  Gunosewoyo</span>, <span class="hlFld-ContribAuthor ">Andrew  Midzak</span>, <span class="hlFld-ContribAuthor ">Irina N.  Gaisina</span>, <span class="hlFld-ContribAuthor ">Emily V.  Sabath</span>, <span class="hlFld-ContribAuthor ">Allison  Fedolak</span>, <span class="hlFld-ContribAuthor ">Taleen  Hanania</span>, <span class="hlFld-ContribAuthor ">Dani  Brunner</span>, <span class="hlFld-ContribAuthor ">Vassilios  Papadopoulos</span>, and <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>  . </span><span class="cited-content_cbyCitation_article-title">Characterization of Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitors as Stimulators of Steroidogenesis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (12)
                                     , 5115-5129. <a href="https://doi.org/10.1021/jm400511s" title="DOI URL">https://doi.org/10.1021/jm400511s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400511s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400511s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCharacterization%252Bof%252BMaleimide-Based%252BGlycogen%252BSynthase%252BKinase-3%252B%252528GSK-3%252529%252BInhibitors%252Bas%252BStimulators%252Bof%252BSteroidogenesis%26aulast%3DGunosewoyo%26aufirst%3DHendra%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D08042013%26date%3D17062013%26date%3D27062013%26date%3D31052013%26volume%3D56%26issue%3D12%26spage%3D5115%26epage%3D5129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wagdy M.  Eldehna</span>, <span class="hlFld-ContribAuthor ">Sara T.  Al-Rashood</span>, <span class="hlFld-ContribAuthor ">Tarfah  Al-Warhi</span>, <span class="hlFld-ContribAuthor ">Razan O.  Eskandrani</span>, <span class="hlFld-ContribAuthor ">Amal  Alharbi</span>, <span class="hlFld-ContribAuthor ">Ahmed M.  El Kerdawy</span>. </span><span class="cited-content_cbyCitation_article-title">Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and
              in silico
              studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2021,</strong> <em>36 </em>
                                    (1)
                                     , 270-285. <a href="https://doi.org/10.1080/14756366.2020.1862101" title="DOI URL">https://doi.org/10.1080/14756366.2020.1862101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2020.1862101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2020.1862101%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Boxindole%25252Fbenzofuran%252Bhybrids%252Bas%252Bpotential%252Bdual%252BCDK2%25252FGSK-3%2525CE%2525B2%252Binhibitors%252Btargeting%252Bbreast%252Bcancer%25253A%252Bdesign%25252C%252Bsynthesis%25252C%252Bbiological%252Bevaluation%25252C%252Band%252Bin%252Bsilico%252Bstudies%26aulast%3DEldehna%26aufirst%3DWagdy%2BM.%26date%3D2021%26date%3D2020%26volume%3D36%26issue%3D1%26spage%3D270%26epage%3D285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Omar  Sánchez-Antonio</span>, <span class="hlFld-ContribAuthor ">Rodrigo  González-Olvera</span>, <span class="hlFld-ContribAuthor ">Alejandro  Aguilera-Cruz</span>, <span class="hlFld-ContribAuthor ">Adelfo  Reyes-Ramírez</span>, <span class="hlFld-ContribAuthor ">Eusebio  Juaristi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of novel isoindolone derivatives via cascade reactions. Contrasting diastereoselectivity under solution-phase vis-a-vis solvent-free ball-milling reaction conditions. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2019,</strong> <em>75 </em>
                                    (45)
                                     , 130594. <a href="https://doi.org/10.1016/j.tet.2019.130594" title="DOI URL">https://doi.org/10.1016/j.tet.2019.130594</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2019.130594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2019.130594%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252Bnovel%252Bisoindolone%252Bderivatives%252Bvia%252Bcascade%252Breactions.%252BContrasting%252Bdiastereoselectivity%252Bunder%252Bsolution-phase%252Bvis-a-vis%252Bsolvent-free%252Bball-milling%252Breaction%252Bconditions%26aulast%3DS%25C3%25A1nchez-Antonio%26aufirst%3DOmar%26date%3D2019%26volume%3D75%26issue%3D45%26spage%3D130594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kirill  Geyl</span>, <span class="hlFld-ContribAuthor ">Sergey  Baykov</span>, <span class="hlFld-ContribAuthor ">Marina  Tarasenko</span>, <span class="hlFld-ContribAuthor ">Lev E.  Zelenkov</span>, <span class="hlFld-ContribAuthor ">Vladislava  Matveevskaya</span>, <span class="hlFld-ContribAuthor ">Vadim P.  Boyarskiy</span>. </span><span class="cited-content_cbyCitation_article-title">Convenient entry to N-pyridinylureas with pharmaceutically privileged oxadiazole substituents via the acid-catalyzed C H activation of N-oxides. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2019,</strong> <em>60 </em>
                                    (40)
                                     , 151108. <a href="https://doi.org/10.1016/j.tetlet.2019.151108" title="DOI URL">https://doi.org/10.1016/j.tetlet.2019.151108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2019.151108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2019.151108%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DConvenient%252Bentry%252Bto%252BN-pyridinylureas%252Bwith%252Bpharmaceutically%252Bprivileged%252Boxadiazole%252Bsubstituents%252Bvia%252Bthe%252Bacid-catalyzed%252BC%252BH%252Bactivation%252Bof%252BN-oxides%26aulast%3DGeyl%26aufirst%3DKirill%26date%3D2019%26volume%3D60%26issue%3D40%26spage%3D151108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Killian  Oukoloff</span>, <span class="hlFld-ContribAuthor ">Nicolas  Coquelle</span>, <span class="hlFld-ContribAuthor ">Manuela  Bartolini</span>, <span class="hlFld-ContribAuthor ">Marina  Naldi</span>, <span class="hlFld-ContribAuthor ">Rémy  Le Guevel</span>, <span class="hlFld-ContribAuthor ">Stéphane  Bach</span>, <span class="hlFld-ContribAuthor ">Béatrice  Josselin</span>, <span class="hlFld-ContribAuthor ">Sandrine  Ruchaud</span>, <span class="hlFld-ContribAuthor ">Marco  Catto</span>, <span class="hlFld-ContribAuthor ">Leonardo  Pisani</span>, <span class="hlFld-ContribAuthor ">Nunzio  Denora</span>, <span class="hlFld-ContribAuthor ">Rosa Maria  Iacobazzi</span>, <span class="hlFld-ContribAuthor ">Israel  Silman</span>, <span class="hlFld-ContribAuthor ">Joel L.  Sussman</span>, <span class="hlFld-ContribAuthor ">Frédéric  Buron</span>, <span class="hlFld-ContribAuthor ">Jacques-Philippe  Colletier</span>, <span class="hlFld-ContribAuthor ">Ludovic  Jean</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>, <span class="hlFld-ContribAuthor ">Pierre-Yves  Renard</span>. </span><span class="cited-content_cbyCitation_article-title">Design, biological evaluation and X-ray crystallography of nanomolar multifunctional ligands targeting simultaneously acetylcholinesterase and glycogen synthase kinase-3. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>168 </em>, 58-77. <a href="https://doi.org/10.1016/j.ejmech.2018.12.063" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.063%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bbiological%252Bevaluation%252Band%252BX-ray%252Bcrystallography%252Bof%252Bnanomolar%252Bmultifunctional%252Bligands%252Btargeting%252Bsimultaneously%252Bacetylcholinesterase%252Band%252Bglycogen%252Bsynthase%252Bkinase-3%26aulast%3DOukoloff%26aufirst%3DKillian%26date%3D2019%26volume%3D168%26spage%3D58%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Poornimaa  Mu</span>, <span class="hlFld-ContribAuthor ">Ramanathan  Karuppasamy</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of human autophagy initiation kinase ULK1 inhibitors by multi-directional
              in silico
              screening strategies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Receptors and Signal Transduction</span><span> <strong>2019,</strong> <em>39 </em>
                                    (2)
                                     , 122-133. <a href="https://doi.org/10.1080/10799893.2019.1638401" title="DOI URL">https://doi.org/10.1080/10799893.2019.1638401</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10799893.2019.1638401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10799893.2019.1638401%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Receptors%2520and%2520Signal%2520Transduction%26atitle%3DDiscovery%252Bof%252Bhuman%252Bautophagy%252Binitiation%252Bkinase%252BULK1%252Binhibitors%252Bby%252Bmulti-directional%252Bin%252Bsilico%252Bscreening%252Bstrategies%26aulast%3DMu%26aufirst%3DPoornimaa%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D2%26spage%3D122%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vladimir S.  D’yachenko</span>, <span class="hlFld-ContribAuthor ">Dmitry V.  Danilov</span>, <span class="hlFld-ContribAuthor ">Tatyana K.  Shkineva</span>, <span class="hlFld-ContribAuthor ">Irina А.  Vatsadze</span>, <span class="hlFld-ContribAuthor ">Vladimir V.  Burmistrov</span>, <span class="hlFld-ContribAuthor ">Gennady M.  Butov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and properties of 1-[(adamantan-1-yl)methyl]-3-pyrazolyl ureas. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2019,</strong> <em>55 </em>
                                    (2)
                                     , 129-134. <a href="https://doi.org/10.1007/s10593-019-02428-2" title="DOI URL">https://doi.org/10.1007/s10593-019-02428-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-019-02428-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-019-02428-2%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DSynthesis%252Band%252Bproperties%252Bof%252B1-%25255B%252528adamantan-1-yl%252529methyl%25255D-3-pyrazolyl%252Bureas%26aulast%3DD%25E2%2580%2599yachenko%26aufirst%3DVladimir%2BS.%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D2%26spage%3D129%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui-Xuan  Chen</span>, <span class="hlFld-ContribAuthor ">Yongsu  Li</span>, <span class="hlFld-ContribAuthor ">Xuefeng  He</span>, <span class="hlFld-ContribAuthor ">Yaqi  Zhang</span>, <span class="hlFld-ContribAuthor ">Wenhuan  He</span>, <span class="hlFld-ContribAuthor ">Hao  Liang</span>, <span class="hlFld-ContribAuthor ">Yuyang  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaoding  Jiang</span>, <span class="hlFld-ContribAuthor ">Xiangmeng  Chen</span>, <span class="hlFld-ContribAuthor ">Rihui  Cao</span>, <span class="hlFld-ContribAuthor ">Gao-Feng  Liu</span>, <span class="hlFld-ContribAuthor ">Liqin  Qiu</span>. </span><span class="cited-content_cbyCitation_article-title">Unexpected Brønsted Acid-Catalyzed Domino Reaction of 3-Hydroxyisoindolin-1-ones and
              N
              -
              tert
              -Butyl Hydrazones for the Synthesis of 3-(Hydrazono)isoindolin-1-ones. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>2018 </em>
                                    (47)
                                     , 6733-6737. <a href="https://doi.org/10.1002/ejoc.201801293" title="DOI URL">https://doi.org/10.1002/ejoc.201801293</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201801293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201801293%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DUnexpected%252BBr%2525C3%2525B8nsted%252BAcid-Catalyzed%252BDomino%252BReaction%252Bof%252B3-Hydroxyisoindolin-1-ones%252Band%252BN%252B-%252Btert%252B-Butyl%252BHydrazones%252Bfor%252Bthe%252BSynthesis%252Bof%252B3-%252528Hydrazono%252529isoindolin-1-ones%26aulast%3DChen%26aufirst%3DHui-Xuan%26date%3D2018%26date%3D2018%26volume%3D2018%26issue%3D47%26spage%3D6733%26epage%3D6737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arun K.  Ghosh</span>, <span class="hlFld-ContribAuthor ">Margherita  Brindisi</span>, <span class="hlFld-ContribAuthor ">Anindya  Sarkar</span>. </span><span class="cited-content_cbyCitation_article-title">The Curtius Rearrangement: Applications in Modern Drug Discovery and Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (22)
                                     , 2351-2373. <a href="https://doi.org/10.1002/cmdc.201800518" title="DOI URL">https://doi.org/10.1002/cmdc.201800518</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800518%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DThe%252BCurtius%252BRearrangement%25253A%252BApplications%252Bin%252BModern%252BDrug%252BDiscovery%252Band%252BMedicinal%252BChemistry%26aulast%3DGhosh%26aufirst%3DArun%2BK.%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D22%26spage%3D2351%26epage%3D2373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vanessa  Desplat</span>, <span class="hlFld-ContribAuthor ">Marian  Vincenzi</span>, <span class="hlFld-ContribAuthor ">Romain  Lucas</span>, <span class="hlFld-ContribAuthor ">Stéphane  Moreau</span>, <span class="hlFld-ContribAuthor ">Solène  Savrimoutou</span>, <span class="hlFld-ContribAuthor ">Sandra  Rubio</span>, <span class="hlFld-ContribAuthor ">Noël  Pinaud</span>, <span class="hlFld-ContribAuthor ">David  Bigat</span>, <span class="hlFld-ContribAuthor ">Elodie  Enriquez</span>, <span class="hlFld-ContribAuthor ">Mathieu  Marchivie</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>, <span class="hlFld-ContribAuthor ">Pascal  Sonnet</span>, <span class="hlFld-ContribAuthor ">Filomena  Rossi</span>, <span class="hlFld-ContribAuthor ">Luisa  Ronga</span>, <span class="hlFld-ContribAuthor ">Jean  Guillon</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Antiproliferative Effect of Ethyl 4-[4-(4-Substituted Piperidin-1-yl)]benzylpyrrolo[1,2-
              a
              ]quinoxalinecarboxylate Derivatives on Human Leukemia Cells. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2017,</strong> <em>12 </em>
                                    (12)
                                     , 940-953. <a href="https://doi.org/10.1002/cmdc.201700049" title="DOI URL">https://doi.org/10.1002/cmdc.201700049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201700049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201700049%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSynthesis%252Band%252BAntiproliferative%252BEffect%252Bof%252BEthyl%252B4-%25255B4-%2525284-Substituted%252BPiperidin-1-yl%252529%25255Dbenzylpyrrolo%25255B1%25252C2-%252Ba%252B%25255Dquinoxalinecarboxylate%252BDerivatives%252Bon%252BHuman%252BLeukemia%252BCells%26aulast%3DDesplat%26aufirst%3DVanessa%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D12%26spage%3D940%26epage%3D953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anisha S.  Bhounsule</span>, <span class="hlFld-ContribAuthor ">Lokesh Kumar  Bhatt</span>, <span class="hlFld-ContribAuthor ">Kedar S.  Prabhavalkar</span>, <span class="hlFld-ContribAuthor ">Manisha  Oza</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclin dependent kinase 5: A novel avenue for Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Brain Research Bulletin</span><span> <strong>2017,</strong> <em>132 </em>, 28-38. <a href="https://doi.org/10.1016/j.brainresbull.2017.05.006" title="DOI URL">https://doi.org/10.1016/j.brainresbull.2017.05.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.brainresbull.2017.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.brainresbull.2017.05.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Research%2520Bulletin%26atitle%3DCyclin%252Bdependent%252Bkinase%252B5%25253A%252BA%252Bnovel%252Bavenue%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DBhounsule%26aufirst%3DAnisha%2BS.%26date%3D2017%26volume%3D132%26spage%3D28%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Piątek</span>, <span class="hlFld-ContribAuthor ">Christian  Chapuis</span>. </span><span class="cited-content_cbyCitation_article-title">Grignard
              1,4-Additions to
              para
              -Substituted (2
              R
              )-
              N
              -Cinnamoylbornane-10,2-sultam Derivatives: Revised Configuration for the N,OAc-Keteneacetal Formation in the Presence of Cu(I). </span><span class="cited-content_cbyCitation_journal-name">Helvetica Chimica Acta</span><span> <strong>2016,</strong> <em>99 </em>
                                    (8)
                                     , 573-582. <a href="https://doi.org/10.1002/hlca.201500521" title="DOI URL">https://doi.org/10.1002/hlca.201500521</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hlca.201500521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhlca.201500521%26sid%3Dliteratum%253Aachs%26jtitle%3DHelvetica%2520Chimica%2520Acta%26atitle%3DGrignard%252B1%25252C4-Additions%252Bto%252Bpara%252B-Substituted%252B%2525282%252BR%252B%252529-%252BN%252B-Cinnamoylbornane-10%25252C2-sultam%252BDerivatives%25253A%252BRevised%252BConfiguration%252Bfor%252Bthe%252BN%25252COAc-Keteneacetal%252BFormation%252Bin%252Bthe%252BPresence%252Bof%252BCu%252528I%252529%26aulast%3DPi%25C4%2585tek%26aufirst%3DAnna%26date%3D2016%26date%3D2016%26volume%3D99%26issue%3D8%26spage%3D573%26epage%3D582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aziz  Ouach</span>, <span class="hlFld-ContribAuthor ">Rajâa  Boulahjar</span>, <span class="hlFld-ContribAuthor ">Christine  Vala</span>, <span class="hlFld-ContribAuthor ">Stéphane  Bourg</span>, <span class="hlFld-ContribAuthor ">Pascal  Bonnet</span>, <span class="hlFld-ContribAuthor ">Christiane  Guguen-Guillouzo</span>, <span class="hlFld-ContribAuthor ">Myriam  Ravache</span>, <span class="hlFld-ContribAuthor ">Rémy  Le Guevel</span>, <span class="hlFld-ContribAuthor ">Olivier  Lozach</span>, <span class="hlFld-ContribAuthor ">Saïd  Lazar</span>, <span class="hlFld-ContribAuthor ">Yves  Troin</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Sandrine  Ruchaud</span>, <span class="hlFld-ContribAuthor ">Mohamed  Akssira</span>, <span class="hlFld-ContribAuthor ">Gérald  Guillaumet</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>. </span><span class="cited-content_cbyCitation_article-title">Novel optimization of valmerins (tetrahydropyrido[1,2-a]isoindolones) as potent dual CDK5/GSK3 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>115 </em>, 311-325. <a href="https://doi.org/10.1016/j.ejmech.2016.02.072" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.02.072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.02.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.02.072%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Boptimization%252Bof%252Bvalmerins%252B%252528tetrahydropyrido%25255B1%25252C2-a%25255Disoindolones%252529%252Bas%252Bpotent%252Bdual%252BCDK5%25252FGSK3%252Binhibitors%26aulast%3DOuach%26aufirst%3DAziz%26date%3D2016%26volume%3D115%26spage%3D311%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vanessa  Desplat</span>, <span class="hlFld-ContribAuthor ">Marian  Vincenzi</span>, <span class="hlFld-ContribAuthor ">Romain  Lucas</span>, <span class="hlFld-ContribAuthor ">Stéphane  Moreau</span>, <span class="hlFld-ContribAuthor ">Solène  Savrimoutou</span>, <span class="hlFld-ContribAuthor ">Noël  Pinaud</span>, <span class="hlFld-ContribAuthor ">Jordi  Lesbordes</span>, <span class="hlFld-ContribAuthor ">Elodie  Peyrilles</span>, <span class="hlFld-ContribAuthor ">Mathieu  Marchivie</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>, <span class="hlFld-ContribAuthor ">Pascal  Sonnet</span>, <span class="hlFld-ContribAuthor ">Filomena  Rossi</span>, <span class="hlFld-ContribAuthor ">Luisa  Ronga</span>, <span class="hlFld-ContribAuthor ">Jean  Guillon</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of the cytotoxic activity of novel ethyl 4-[4-(4-substitutedpiperidin-1-yl)]benzyl-phenylpyrrolo[1,2-a]quinoxaline-carboxylate derivatives in myeloid and lymphoid leukemia cell lines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>113 </em>, 214-227. <a href="https://doi.org/10.1016/j.ejmech.2016.02.047" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.02.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.02.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.02.047%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bthe%252Bcytotoxic%252Bactivity%252Bof%252Bnovel%252Bethyl%252B4-%25255B4-%2525284-substitutedpiperidin-1-yl%252529%25255Dbenzyl-phenylpyrrolo%25255B1%25252C2-a%25255Dquinoxaline-carboxylate%252Bderivatives%252Bin%252Bmyeloid%252Band%252Blymphoid%252Bleukemia%252Bcell%252Blines%26aulast%3DDesplat%26aufirst%3DVanessa%26date%3D2016%26volume%3D113%26spage%3D214%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajâa  Boulahjar</span>, <span class="hlFld-ContribAuthor ">Aziz  Ouach</span>, <span class="hlFld-ContribAuthor ">Stéphane  Bourg</span>, <span class="hlFld-ContribAuthor ">Pascal  Bonnet</span>, <span class="hlFld-ContribAuthor ">Olivier  Lozach</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Christiane  Guguen-Guillouzo</span>, <span class="hlFld-ContribAuthor ">Rémy  Le Guevel</span>, <span class="hlFld-ContribAuthor ">Saïd  Lazar</span>, <span class="hlFld-ContribAuthor ">Mohamed  Akssira</span>, <span class="hlFld-ContribAuthor ">Yves  Troin</span>, <span class="hlFld-ContribAuthor ">Gérald  Guillaumet</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in tetrahydropyrido[1,2- a ]isoindolone (valmerins) series: Potent glycogen synthase kinase 3 and cyclin dependent kinase 5 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>101 </em>, 274-287. <a href="https://doi.org/10.1016/j.ejmech.2015.06.046" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.06.046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.06.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.06.046%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAdvances%252Bin%252Btetrahydropyrido%25255B1%25252C2-%252Ba%252B%25255Disoindolone%252B%252528valmerins%252529%252Bseries%25253A%252BPotent%252Bglycogen%252Bsynthase%252Bkinase%252B3%252Band%252Bcyclin%252Bdependent%252Bkinase%252B5%252Binhibitors%26aulast%3DBoulahjar%26aufirst%3DRaj%25C3%25A2a%26date%3D2015%26volume%3D101%26spage%3D274%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah  Sulzer-Mosse</span>, <span class="hlFld-ContribAuthor ">Fredrik  Cederbaum</span>, <span class="hlFld-ContribAuthor ">Clemens  Lamberth</span>, <span class="hlFld-ContribAuthor ">Guillaume  Berthon</span>, <span class="hlFld-ContribAuthor ">Jayant  Umarye</span>, <span class="hlFld-ContribAuthor ">Valeria  Grasso</span>, <span class="hlFld-ContribAuthor ">Alexandra  Schlereth</span>, <span class="hlFld-ContribAuthor ">Mathias  Blum</span>, <span class="hlFld-ContribAuthor ">Rita  Waldmeier</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and fungicidal activity of N-thiazol-4-yl-salicylamides, a new family of anti-oomycete compounds. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (9)
                                     , 2129-2138. <a href="https://doi.org/10.1016/j.bmc.2015.03.007" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.03.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.03.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bfungicidal%252Bactivity%252Bof%252BN-thiazol-4-yl-salicylamides%25252C%252Ba%252Bnew%252Bfamily%252Bof%252Banti-oomycete%252Bcompounds%26aulast%3DSulzer-Mosse%26aufirst%3DSarah%26date%3D2015%26volume%3D23%26issue%3D9%26spage%3D2129%26epage%3D2138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Killian  Oukoloff</span>, <span class="hlFld-ContribAuthor ">Frédéric  Buron</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>, <span class="hlFld-ContribAuthor ">Ludovic  Jean</span>, <span class="hlFld-ContribAuthor ">Pierre-Yves  Renard</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Route to Rare Isoindolones Derivatives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>2015 </em>
                                    (11)
                                     , 2450-2456. <a href="https://doi.org/10.1002/ejoc.201403649" title="DOI URL">https://doi.org/10.1002/ejoc.201403649</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201403649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201403649%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthetic%252BRoute%252Bto%252BRare%252BIsoindolones%252BDerivatives%26aulast%3DOukoloff%26aufirst%3DKillian%26date%3D2015%26date%3D2015%26volume%3D2015%26issue%3D11%26spage%3D2450%26epage%3D2456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">L.  Jayalakshmi</span>, <span class="hlFld-ContribAuthor ">C.  Ramalingan</span>, <span class="hlFld-ContribAuthor ">B.  Sridhar</span>, <span class="hlFld-ContribAuthor ">S.  Selvanayagam</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal structure of 1-(2,4-dimethylphenyl)urea. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section E Crystallographic Communications</span><span> <strong>2015,</strong> <em>71 </em>
                                    (1)
                                     , o60-o61. <a href="https://doi.org/10.1107/S2056989014027431" title="DOI URL">https://doi.org/10.1107/S2056989014027431</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S2056989014027431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS2056989014027431%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520E%2520Crystallographic%2520Communications%26atitle%3DCrystal%252Bstructure%252Bof%252B1-%2525282%25252C4-dimethylphenyl%252529urea%26aulast%3DJayalakshmi%26aufirst%3DL.%26date%3D2015%26date%3D2015%26volume%3D71%26issue%3D1%26spage%3Do60%26epage%3Do61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. K.  Bratenko</span>, <span class="hlFld-ContribAuthor ">M. M.  Barus</span>, <span class="hlFld-ContribAuthor ">D. V.  Rotar</span>, <span class="hlFld-ContribAuthor ">M. V.  Vovk</span>. </span><span class="cited-content_cbyCitation_article-title">Polyfunctional Pyrazoles. 9*. Synthesis of 1-Alkyl(Aryl)-3-[4-(Hydroxymethyl)-1Н-Pyrazol-3-Yl]UReas. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2014,</strong> <em>50 </em>
                                    (9)
                                     , 1252-1258. <a href="https://doi.org/10.1007/s10593-014-1587-z" title="DOI URL">https://doi.org/10.1007/s10593-014-1587-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-014-1587-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-014-1587-z%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DPolyfunctional%252BPyrazoles.%252B9%252A.%252BSynthesis%252Bof%252B1-Alkyl%252528Aryl%252529-3-%25255B4-%252528Hydroxymethyl%252529-1%2525D0%25259D-Pyrazol-3-Yl%25255DUReas%26aulast%3DBratenko%26aufirst%3DM.%2BK.%26date%3D2014%26date%3D2014%26volume%3D50%26issue%3D9%26spage%3D1252%26epage%3D1258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jignesh P.  Dalvadi</span>, <span class="hlFld-ContribAuthor ">Poojan K.  Patel</span>, <span class="hlFld-ContribAuthor ">Kishor H.  Chikhalia</span>. </span><span class="cited-content_cbyCitation_article-title">A tandem and tunable Pd catalyzed C–N coupling of heteroarenols with ureas via C–OH bond activation. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2014,</strong> <em>70 </em>
                                    (49)
                                     , 9394-9404. <a href="https://doi.org/10.1016/j.tet.2014.10.036" title="DOI URL">https://doi.org/10.1016/j.tet.2014.10.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.10.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.10.036%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DA%252Btandem%252Band%252Btunable%252BPd%252Bcatalyzed%252BC%2525E2%252580%252593N%252Bcoupling%252Bof%252Bheteroarenols%252Bwith%252Bureas%252Bvia%252BC%2525E2%252580%252593OH%252Bbond%252Bactivation%26aulast%3DDalvadi%26aufirst%3DJignesh%2BP.%26date%3D2014%26volume%3D70%26issue%3D49%26spage%3D9394%26epage%3D9404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-Yves  Mérour</span>, <span class="hlFld-ContribAuthor ">Frédéric  Buron</span>, <span class="hlFld-ContribAuthor ">Karen  Plé</span>, <span class="hlFld-ContribAuthor ">Pascal  Bonnet</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>. </span><span class="cited-content_cbyCitation_article-title">The Azaindole Framework in the Design of Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2014,</strong> <em>19 </em>
                                    (12)
                                     , 19935-19979. <a href="https://doi.org/10.3390/molecules191219935" title="DOI URL">https://doi.org/10.3390/molecules191219935</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules191219935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules191219935%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DThe%252BAzaindole%252BFramework%252Bin%252Bthe%252BDesign%252Bof%252BKinase%252BInhibitors%26aulast%3DM%25C3%25A9rour%26aufirst%3DJean-Yves%26date%3D2014%26date%3D2014%26volume%3D19%26issue%3D12%26spage%3D19935%26epage%3D19979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Binia  Drung</span>, <span class="hlFld-ContribAuthor ">Christoph  Scholz</span>, <span class="hlFld-ContribAuthor ">Valéria A.  Barbosa</span>, <span class="hlFld-ContribAuthor ">Azadeh  Nazari</span>, <span class="hlFld-ContribAuthor ">Maria H.  Sarragiotto</span>, <span class="hlFld-ContribAuthor ">Boris  Schmidt</span>. </span><span class="cited-content_cbyCitation_article-title">Computational & experimental evaluation of the structure/activity relationship of β-carbolines as DYRK1A inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (20)
                                     , 4854-4860. <a href="https://doi.org/10.1016/j.bmcl.2014.08.054" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.08.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.08.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.08.054%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DComputational%252B%252526%252Bexperimental%252Bevaluation%252Bof%252Bthe%252Bstructure%25252Factivity%252Brelationship%252Bof%252B%2525CE%2525B2-carbolines%252Bas%252BDYRK1A%252Binhibitors%26aulast%3DDrung%26aufirst%3DBinia%26date%3D2014%26volume%3D24%26issue%3D20%26spage%3D4854%26epage%3D4860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaolong  Li</span>, <span class="hlFld-ContribAuthor ">Xiaowei  Wang</span>, <span class="hlFld-ContribAuthor ">Zibin  Tian</span>, <span class="hlFld-ContribAuthor ">Houling  Zhao</span>, <span class="hlFld-ContribAuthor ">Da  Liang</span>, <span class="hlFld-ContribAuthor ">Weisong  Li</span>, <span class="hlFld-ContribAuthor ">Yujin  Qiu</span>, <span class="hlFld-ContribAuthor ">Shaoyong  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Structural basis of valmerins as dual inhibitors of GSK3β/CDK5. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2014,</strong> <em>20 </em>
                                    (9)
                                     <a href="https://doi.org/10.1007/s00894-014-2407-1" title="DOI URL">https://doi.org/10.1007/s00894-014-2407-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-014-2407-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-014-2407-1%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DStructural%252Bbasis%252Bof%252Bvalmerins%252Bas%252Bdual%252Binhibitors%252Bof%252BGSK3%2525CE%2525B2%25252FCDK5%26aulast%3DLi%26aufirst%3DXiaolong%26date%3D2014%26date%3D2014%26volume%3D20%26issue%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frédéric  Pin</span>, <span class="hlFld-ContribAuthor ">Johnny  Vercouillie</span>, <span class="hlFld-ContribAuthor ">Aziz  Ouach</span>, <span class="hlFld-ContribAuthor ">Sylvie  Mavel</span>, <span class="hlFld-ContribAuthor ">Zuhal  Gulhan</span>, <span class="hlFld-ContribAuthor ">Gabrielle  Chicheri</span>, <span class="hlFld-ContribAuthor ">Christian  Jarry</span>, <span class="hlFld-ContribAuthor ">Stephane  Massip</span>, <span class="hlFld-ContribAuthor ">Jean-Bernard  Deloye</span>, <span class="hlFld-ContribAuthor ">Denis  Guilloteau</span>, <span class="hlFld-ContribAuthor ">Franck  Suzenet</span>, <span class="hlFld-ContribAuthor ">Sylvie  Chalon</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>. </span><span class="cited-content_cbyCitation_article-title">Design of α7 nicotinic acetylcholine receptor ligands in quinuclidine, tropane and quinazoline series. Chemistry, molecular modeling, radiochemistry, in vitro and in rats evaluations of a [18F] quinuclidine derivative. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>82 </em>, 214-224. <a href="https://doi.org/10.1016/j.ejmech.2014.04.057" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.04.057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.04.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.04.057%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Bof%252B%2525CE%2525B17%252Bnicotinic%252Bacetylcholine%252Breceptor%252Bligands%252Bin%252Bquinuclidine%25252C%252Btropane%252Band%252Bquinazoline%252Bseries.%252BChemistry%25252C%252Bmolecular%252Bmodeling%25252C%252Bradiochemistry%25252C%252Bin%2525C2%2525A0vitro%252Band%252Bin%252Brats%252Bevaluations%252Bof%252Ba%252B%25255B18F%25255D%252Bquinuclidine%252Bderivative%26aulast%3DPin%26aufirst%3DFr%25C3%25A9d%25C3%25A9ric%26date%3D2014%26volume%3D82%26spage%3D214%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oussama  Dehbi</span>, <span class="hlFld-ContribAuthor ">Abdellatif  Tikad</span>, <span class="hlFld-ContribAuthor ">Stéphane  Bourg</span>, <span class="hlFld-ContribAuthor ">Pascal  Bonnet</span>, <span class="hlFld-ContribAuthor ">Olivier  Lozach</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Mina  Aadil</span>, <span class="hlFld-ContribAuthor ">Mohammed  Akssira</span>, <span class="hlFld-ContribAuthor ">Gérald  Guillaumet</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and optimization of an original V-shaped collection of 4-7-disubstituted Pyrido[3,2-d]pyrimidines as CDK5 and DYRK1A inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>80 </em>, 352-363. <a href="https://doi.org/10.1016/j.ejmech.2014.04.055" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.04.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.04.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.04.055%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Boptimization%252Bof%252Ban%252Boriginal%252BV-shaped%252Bcollection%252Bof%252B4-7-disubstituted%252BPyrido%25255B3%25252C2-d%25255Dpyrimidines%252Bas%252BCDK5%252Band%252BDYRK1A%252Binhibitors%26aulast%3DDehbi%26aufirst%3DOussama%26date%3D2014%26volume%3D80%26spage%3D352%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James J.  Sahn</span>, <span class="hlFld-ContribAuthor ">Brett A.  Granger</span>, <span class="hlFld-ContribAuthor ">Stephen F.  Martin</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of a strategy for preparing bioactive small molecules by sequential multicomponent assembly processes, cyclizations, and diversification. </span><span class="cited-content_cbyCitation_journal-name">Org. Biomol. Chem.</span><span> <strong>2014,</strong> <em>12 </em>
                                    (39)
                                     , 7659-7672. <a href="https://doi.org/10.1039/C4OB00835A" title="DOI URL">https://doi.org/10.1039/C4OB00835A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4OB00835A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4OB00835A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26atitle%3DEvolution%252Bof%252Ba%252Bstrategy%252Bfor%252Bpreparing%252Bbioactive%252Bsmall%252Bmolecules%252Bby%252Bsequential%252Bmulticomponent%252Bassembly%252Bprocesses%25252C%252Bcyclizations%25252C%252Band%252Bdiversification%26aulast%3DSahn%26aufirst%3DJames%2BJ.%26date%3D2014%26date%3D2014%26volume%3D12%26issue%3D39%26spage%3D7659%26epage%3D7672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adrian  L. Schwan</span>, <span class="hlFld-ContribAuthor ">Mohanad  Gh. Shkoor</span>, <span class="hlFld-ContribAuthor ">Irena  Nikoloska</span>. </span><span class="cited-content_cbyCitation_article-title">Introducing the Diels-Alder Reactivity of 2-Furanmethanethiol with Selected Maleic Acid Derivatives. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2014,</strong> <em>88 </em>
                                    (2)
                                     , 1603. <a href="https://doi.org/10.3987/COM-13-S(S)112" title="DOI URL">https://doi.org/10.3987/COM-13-S(S)112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-13-S(S)112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-13-S%28S%29112%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DIntroducing%252Bthe%252BDiels-Alder%252BReactivity%252Bof%252B2-Furanmethanethiol%252Bwith%252BSelected%252BMaleic%252BAcid%252BDerivatives%26aulast%3DL.%2BSchwan%26aufirst%3DAdrian%26date%3D2014%26volume%3D88%26issue%3D2%26spage%3D1603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana G.  Neo</span>, <span class="hlFld-ContribAuthor ">Ana  Bornadiego</span>, <span class="hlFld-ContribAuthor ">Jesús  Díaz</span>, <span class="hlFld-ContribAuthor ">Stefano  Marcaccini</span>, <span class="hlFld-ContribAuthor ">Carlos F.  Marcos</span>. </span><span class="cited-content_cbyCitation_article-title">Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2013,</strong> <em>11 </em>
                                    (38)
                                     , 6546. <a href="https://doi.org/10.1039/c3ob41411f" title="DOI URL">https://doi.org/10.1039/c3ob41411f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3ob41411f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3ob41411f%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DElusive%252B2-aminofuran%252BDiels%2525E2%252580%252593Alder%252Bsubstrates%252Bfor%252Ba%252Bstraightforward%252Bsynthesis%252Bof%252Bpolysubstituted%252Banilines%26aulast%3DNeo%26aufirst%3DAna%2BG.%26date%3D2013%26volume%3D11%26issue%3D38%26spage%3D6546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008536&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Some representative CDK and GSK3 inhibitors in clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008536&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008536&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Retrosynthetic Scheme</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008536&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008536&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Key: (i) methyl vinyl ketone (1.2 equiv), Triton B (cat.), EtOAc, reflux, 12 h, 85%; (ii) ethylene glycol (2.0 equiv), PTSA·H<sub>2</sub>O (cat.), toluene, Dean–Stark, reflux, 12 h, 89%; (iii) NaBH<sub>4</sub> (3.0 equiv), THF/MeOH (1/2), −20 °C, 15 min, 76% ; (iv) PTSA·H<sub>2</sub>O (0.5 equiv), toluene, Dean–Stark, reflux, 6 h, 73%; (v) HCl 10%, acetone, reflux, 3 h, 90%; (vi) Pd/C (10%), H<sub>2</sub> P<sub>atm</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h, 88%; (vii) NH<sub>2</sub>–NH<sub>2</sub>·H<sub>2</sub>O (4.0 equiv), Na (3.0 equiv), ethylene glycol, reflux, 4 h, 86%.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008536&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Key: (i) (a) Et<sub>3</sub>N (1.3 equiv), −10 °C, THF, 5 min, (b) ClCO<sub>2</sub>Et (1.5 equiv), −10 °C, THF, 2 h, (c) NaN<sub>3</sub> (1.7 equiv), −10 °C, H<sub>2</sub>O, 1 h, (d) toluene, reflux, 1 h; (ii) <b>8</b>, toluene, reflux, 24 h, valmerins <b>13</b>–<b>40</b>, 42–90% yields.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008536&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Key: (i) (a) MeOH, SOCl<sub>2</sub> (1.5 equiv), 60 °C, 16 h, (b) K<sub>2</sub>CO<sub>3</sub> (2.0 equiv), MOMCl (1.5 equiv), acetone, reflux, 16 h, (c) NaOH (1.2 equiv), THF/H<sub>2</sub>O (1/1), rt, 2 h, <b>9</b> 75%, <b>10</b> 77%, <b>11</b> 70%, <b>12</b> 72%.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008536&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Key: (i) and (ii) see also Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, <b>40</b> 4%; (iii) BTC (1.0 equiv), Et<sub>3</sub>N (2.0 equiv), CH<sub>2</sub>Cl<sub>2</sub>, reflux, 5 h; (iv) <i>N</i>-1-Boc-3-aminopyrazole (1.0 equiv), CH<sub>2</sub>Cl<sub>2</sub>/pyridine 9/1, rt, 16 h, 56%; (v) aq NaOH (1 M)/THF 1/2, rt, 24 h, 66%; (vi) aq HCl 10%, acetone, reflux, 2 h, <b>42</b> 90%, <b>43</b> 92%, <b>44</b> 92%, <b>45</b> 95%.</p></p></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Binding mode of valmerin <b>15</b> within GSK3. Left: GSK3 protein from 2OW3 and <b>15</b> docked inside. Right: zoom on the active site. Hinge region was highlighted in yellow and the DFG motif of the activation loop is highlighted in green. Protein was represented as a ribbon diagram with the cartoon style and <b>15</b> exhibits tube representation (elements colored). Nonpolar hydrogens are not represented for clarity. H bonds are represented as dashed yellow lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008536&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3A" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Immunofluorescence labeling of cleaved (active) caspase 3 in HCT116 cells untreated (DMSO) or treated with valmerin <b>15</b> (0.6 μM) and valmerin <b>16</b> (1.0 μM) for 24 h. Nuclei were stained with Hoechst (blue), and apoptotic cells were immunostained with an antiactive caspase 3 antibody (red) (magnification, ×10). (B) Quantification of apoptotic cells. Apoptotic cells were calculated as the percent of active caspase 3-positive cells/total nuclei with the Cellomics High Content Imaging System. Data shown are the mean ± sem from a typical experiment performed in triplicate. **<i>P</i> < 0.01, ***<i>P</i> < 0.001, control cells vs treated cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008536&amp;id=fig3A"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of valmerins <b>15</b> and <b>16</b> on cell cycle progression. (A) Mitotic index. Different cell lines were treated with DMSO (0.4%) (control cells), roscovitine (20 μM), valmerin <b>15</b> (0.6 μM), and valmerin <b>16</b> (1 μM) for 24 h. Cells were fixed, and the mitotic index was determined using phospho-histone H3 detection. The number of dividing cells was calculated by using the Cellomics High Content Imaging System. Data shown are the mean ± SD from a typical experiment performed in triplicate. *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001, control cells vs treated cells. (B) 5′-Bromo-2′-deoxyuridine (BrdU) incorporation. Different cell lines were treated with DMSO (0.4%) (control cells), roscovitine (20 μM), valmerin <b>15</b>(0.6 μM), and valmerin <b>16</b> (1 μM) for 48 h and pulsed with BrdU for 1 h 30. Cells were fixed and immunostained for BrdU incorporation. BrdU staining was measured by the Cellomics High Content Imaging System. Data shown are the mean ± SD from a typical experiment performed in triplicate. *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001, control cells vs treated cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008536&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Left: in vivo valmerin <b>15</b> effects on tumor growth. Mice were assessed weekly using whole-body bioluminescent imaging to quantify relative amounts of tumor burden. Data are given as cpm mean +/– SD. <i>P</i> < 0.05: *, <i>p</i> < 0.001: ***. Right: 4 weeks after the beginning of treatment, BLI of two representative mice per group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008536&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/medium/jm-2012-008536_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Left: Ex vivo cecum BLI at the end of the assay (left). The cecum BLI of all mice was quantified. Data are given as cpm mean +/– SD. <i>P</i> < 0.01: **, <i>p</i> < 0.001: ***. Right: At necropsy, the number of mice in each group with mesenteric nodes, liver and lung metastasis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3008536/production/images/large/jm-2012-008536_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3008536&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66041" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66041" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 36 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carnero, A.</span><span> </span><span class="NLM_article-title">Cell Cycle Deregulation: A Common Motif in Cancer</span> <span class="citation_source-journal">Prog. Cell Cycle Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm3008536&amp;key=14593696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm3008536&amp;key=1%3ACAS%3A280%3ADC%252BD3srhs1SqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=5-18&author=M.+Malumbresauthor=A.+Carnero&title=Cell+Cycle+Deregulation%3A+A+Common+Motif+in+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle deregulation: a common motif in cancer</span></div><div class="casAuthors">Malumbres Marcos; Carnero Amancio</div><div class="citationInfo"><span class="NLM_cas:title">Progress in cell cycle research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5-18</span>
        ISSN:<span class="NLM_cas:issn">1087-2957</span>.
    </div><div class="casAbstract">Uncontrolled proliferation is a hallmark of cancer cells.  Molecular analysis of human tumors and animal models have provided a clear basis for the understanding of the cellular processes that govern cell cycle progression in normal and tumor cells.  Many cell cycle regulators controlling the correct entry and progression through the cell cycle are altered in tumors.  In fact, most, if not all, human cancers show a deregulated control of G1 progression, a period when cells decide whether to start proliferation or to stay quiescent.  In addition, tumor cells have impaired cell cycle checkpoints, resulting in the accumulation of genetic aberrations.  Manipulation of these control mechanisms provides new avenues for the design of advanced therapeutic strategies against tumor development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTf8njPNJ4X7sScOqQTSkOffW6udTcc2eaqgnlYEJwalLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srhs1SqsQ%253D%253D&md5=78df5bee1cb7947d6bc24c075d0d56ec</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DCarnero%26aufirst%3DA.%26atitle%3DCell%2520Cycle%2520Deregulation%253A%2520A%2520Common%2520Motif%2520in%2520Cancer%26jtitle%3DProg.%2520Cell%2520Cycle%2520Res.%26date%3D2003%26volume%3D5%26spage%3D5%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Cell Cycle, CDKs and Cancer: A Changing Paradigm</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm3008536&amp;key=10.1038%2Fnrc2602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm3008536&amp;key=19238148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm3008536&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1ans78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=153-166&author=M.+Malumbresauthor=M.+Barbacid&title=Cell+Cycle%2C+CDKs+and+Cancer%3A+A+Changing+Paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle, CDKs and cancer: a changing paradigm</span></div><div class="casAuthors">Malumbres, Marcos; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">153-166</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Tumor-assocd. cell cycle defects are often mediated by alterations in cyclin-dependent kinase (CDK) activity.  Misregulated CDKs induce unscheduled proliferation as well as genomic and chromosomal instability.  According to current models, mammalian CDKs are essential for driving each cell cycle phase, so therapeutic strategies that block CDK activity are unlikely to selectively target tumor cells.  However, recent genetic evidence has revealed that, whereas CDK1 is required for the cell cycle, interphase CDKs are only essential for proliferation of specialized cells.  Emerging evidence suggests that tumor cells may also require specific interphase CDKs for proliferation.  Thus, selective CDK inhibition may provide therapeutic benefit against certain human neoplasias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzlIKlbCPWnLVg90H21EOLACvtfcHk0liIlarNaH3USQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1ans78%253D&md5=2a7eb34b2381e288b3f43ec1bffc0aec</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrc2602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2602%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DCell%2520Cycle%252C%2520CDKs%2520and%2520Cancer%253A%2520A%2520Changing%2520Paradigm%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D153%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. Z.</span><span> </span><span class="NLM_article-title">Activation of Glycogen Synthase Kinase-3 Induces Alzheimer-like Tau Hyperphosphorylation in Rat Hippocampus Slices in Culture</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2006&pages=93-102&author=X.+Liauthor=F.+Luauthor=Q.+Tianauthor=Y.+Yangauthor=Q.+Wangauthor=J.+Z.+Wang&title=Activation+of+Glycogen+Synthase+Kinase-3+Induces+Alzheimer-like+Tau+Hyperphosphorylation+in+Rat+Hippocampus+Slices+in+Culture"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DF.%26aulast%3DTian%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%2BZ.%26atitle%3DActivation%2520of%2520Glycogen%2520Synthase%2520Kinase-3%2520Induces%2520Alzheimer-like%2520Tau%2520Hyperphosphorylation%2520in%2520Rat%2520Hippocampus%2520Slices%2520in%2520Culture%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2006%26volume%3D113%26spage%3D93%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Ougolkov, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billadeau, D. D.</span><span> </span><span class="NLM_article-title">Targeting GSK-3: a Promising Approach for Cancer therapy</span> <span class="citation_source-journal">Future Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm3008536&amp;key=10.2217%2F14796694.2.1.91" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm3008536&amp;key=16556076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm3008536&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhs1Wku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=91-100&author=A.+V.+Ougolkovauthor=D.+D.+Billadeau&title=Targeting+GSK-3%3A+a+Promising+Approach+for+Cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting GSK-3: a promising approach for cancer therapy?</span></div><div class="casAuthors">Ougolkov, Andrei V.; Billadeau, Daniel D.</div><div class="citationInfo"><span class="NLM_cas:title">Future Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-100</span>CODEN:
                <span class="NLM_cas:coden">FOUNBN</span>;
        ISSN:<span class="NLM_cas:issn">1479-6694</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Glycogen synthase kinase (GSK)-3 has emerged as one of the most attractive therapeutic targets for the treatment of multiple neurol. diseases, including Alzheimer's, stroke and bipolar disorders, as well as noninsulin-dependent diabetes mellitus and inflammation.  Although the prominent role of GSK-3 in the adenomatous polyposis coli (APC)-β-catenin destruction complex implies that inhibition of GSK-3 could possibly lead to tumor promotion through the activation of β-catenin, several recent studies have shed new light on the activity of GSK-3 in cancer and provide insight into the mol. mechanisms by which it regulates tumor cell proliferation and survival of multiple human malignancies.  In fact, GSK-3β is a crit. regulator of nuclear factor (NF)κB nuclear activity, suggesting that inhibition of GSK-3β could be effective in the treatment of a wide variety of tumors with constitutively active NFκB.  Herein, the authors will discuss the current understanding of the role of GSK-3 in human cancer and its potential as a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS5GCxxwsF9bVg90H21EOLACvtfcHk0lgfOUGRWsq1qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhs1Wku7s%253D&md5=cd14eef69d01a22dcab963c553f6921b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2217%2F14796694.2.1.91&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252F14796694.2.1.91%26sid%3Dliteratum%253Aachs%26aulast%3DOugolkov%26aufirst%3DA.%2BV.%26aulast%3DBilladeau%26aufirst%3DD.%2BD.%26atitle%3DTargeting%2520GSK-3%253A%2520a%2520Promising%2520Approach%2520for%2520Cancer%2520therapy%26jtitle%3DFuture%2520Oncol.%26date%3D2006%26volume%3D2%26spage%3D91%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wang, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, D. M.</span><span> </span><span class="NLM_article-title">Flavopiridol, the First Cyclin-Dependent Kinase Inhibitor: Recent Advances in Combination Chemotherapy</span> <span class="citation_source-journal">Mini Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1058</span><span class="NLM_x">–</span> <span class="NLM_lpage">1070</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm3008536&amp;key=10.2174%2F1389557511009011058" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=1058-1070&author=L.+M.+Wangauthor=D.+M.+Ren&title=Flavopiridol%2C+the+First+Cyclin-Dependent+Kinase+Inhibitor%3A+Recent+Advances+in+Combination+Chemotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.2174%2F1389557511009011058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557511009011058%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%2BM.%26aulast%3DRen%26aufirst%3DD.%2BM.%26atitle%3DFlavopiridol%252C%2520the%2520First%2520Cyclin-Dependent%2520Kinase%2520Inhibitor%253A%2520Recent%2520Advances%2520in%2520Combination%2520Chemotherapy%26jtitle%3DMini%2520Rev.%2520Med.%2520Chem.%26date%3D2010%26volume%3D11%26spage%3D1058%26epage%3D1070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Raje, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raab, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chhetri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirstea, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsiades, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiziltepe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrasco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauhan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parikh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scadden, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span> </span><span class="NLM_article-title">Preclinical Activity of P276–00, a Novel Small-Molecule Cyclin-Dependent Kinase Inhibitor in the Therapy of Multiple Myeloma</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">961</span><span class="NLM_x">–</span> <span class="NLM_lpage">970</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=961-970&author=N.+Rajeauthor=T.+Hideshimaauthor=S.+Mukherjeeauthor=M.+Raabauthor=S.+Valletauthor=S.+Chhetriauthor=D.+Cirsteaauthor=S.+Pozziauthor=C.+Mitsiadesauthor=M.+Rooneyauthor=T.+Kiziltepeauthor=K.+Podarauthor=Y.+Okawaauthor=H.+Ikedaauthor=R.+Carrascoauthor=P.+G.+Richardsonauthor=D.+Chauhanauthor=N.+C.+Munshiauthor=S.+Sharmaauthor=H.+Parikhauthor=B.+Chabnerauthor=D.+Scaddenauthor=K.+C.+Anderson&title=Preclinical+Activity+of+P276%E2%80%9300%2C+a+Novel+Small-Molecule+Cyclin-Dependent+Kinase+Inhibitor+in+the+Therapy+of+Multiple+Myeloma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaje%26aufirst%3DN.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DMukherjee%26aufirst%3DS.%26aulast%3DRaab%26aufirst%3DM.%26aulast%3DVallet%26aufirst%3DS.%26aulast%3DChhetri%26aufirst%3DS.%26aulast%3DCirstea%26aufirst%3DD.%26aulast%3DPozzi%26aufirst%3DS.%26aulast%3DMitsiades%26aufirst%3DC.%26aulast%3DRooney%26aufirst%3DM.%26aulast%3DKiziltepe%26aufirst%3DT.%26aulast%3DPodar%26aufirst%3DK.%26aulast%3DOkawa%26aufirst%3DY.%26aulast%3DIkeda%26aufirst%3DH.%26aulast%3DCarrasco%26aufirst%3DR.%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DChauhan%26aufirst%3DD.%26aulast%3DMunshi%26aufirst%3DN.%2BC.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DParikh%26aufirst%3DH.%26aulast%3DChabner%26aufirst%3DB.%26aulast%3DScadden%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DPreclinical%2520Activity%2520of%2520P276%25E2%2580%259300%252C%2520a%2520Novel%2520Small-Molecule%2520Cyclin-Dependent%2520Kinase%2520Inhibitor%2520in%2520the%2520Therapy%2520of%2520Multiple%2520Myeloma%26jtitle%3DLeukemia%26date%3D2009%26volume%3D5%26spage%3D961%26epage%3D970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Meijer, L.; Bettayeb, K.; Galons, H.</span><span> </span><span class="NLM_article-title">Roscovitine (CYC202, Seliciclib)</span>. In <span class="NLM_contrib-group">Yue, E.; Smith, P. J.</span>, Eds.  <span class="citation_source-book">Monographs on Enzyme Inhibitors; Vol. 2. CDK Inhibitors and Their Potential as Anti-tumor Agents</span>; <span class="NLM_publisher-name">CRC Press</span>: <span class="NLM_publisher-loc">Boca Raton</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">9</span>, pp  <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=187-226&author=L.+Meijer&author=K.+Bettayeb&author=H.+Galonsauthor=E.+Yue&author=P.+J.+Smith&title=Monographs+on+Enzyme+Inhibitors%3B+Vol.+2.+CDK+Inhibitors+and+Their+Potential+as+Anti-tumor+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DRoscovitine%2520%2528CYC202%252C%2520Seliciclib%2529%26aulast%3DYue%26aufirst%3DE.%26btitle%3DMonographs%2520on%2520Enzyme%2520Inhibitors%253B%2520Vol.%25202.%2520CDK%2520Inhibitors%2520and%2520Their%2520Potential%2520as%2520Anti-tumor%2520Agents%26pub%3DCRC%2520Press%26date%3D2006%26volume%3D9%26spage%3D187%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Chu, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Pinto, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartkovitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">So, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goelzer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moliterni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotouhi, N.</span><span> </span><span class="NLM_article-title">Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6-methoxy phenyl)methanone (R547), a Potent and Selective Cyclin-Dependent Kinase Inhibitor with Significant <i>in Vivo</i> Antitumor Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6549</span><span class="NLM_x">–</span> <span class="NLM_lpage">6560</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0606138" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6549-6560&author=X.+J.+Chuauthor=W.+De+Pintoauthor=D.+Bartkovitzauthor=S.+S.+Soauthor=B.+T.+Vuauthor=K.+Packmanauthor=C.+Lukacsauthor=Q.+Dingauthor=N.+Jiangauthor=K.+Wangauthor=P.+Goelzerauthor=X.+Yinauthor=M.+A.+Smithauthor=B.+X.+Higginsauthor=Y.+Chenauthor=Q.+Xiangauthor=J.+Moliterniauthor=G.+Kaplanauthor=B.+Gravesauthor=A.+Loveyauthor=N.+Fotouhi&title=Discovery+of+%5B4-Amino-2-%281-methanesulfonylpiperidin-4-ylamino%29pyrimidin-5-yl%5D%282%2C3-difluoro-6-methoxy+phenyl%29methanone+%28R547%29%2C+a+Potent+and+Selective+Cyclin-Dependent+Kinase+Inhibitor+with+Significant+in+Vivo+Antitumor+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm0606138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0606138%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DX.%2BJ.%26aulast%3DDe%2BPinto%26aufirst%3DW.%26aulast%3DBartkovitz%26aufirst%3DD.%26aulast%3DSo%26aufirst%3DS.%2BS.%26aulast%3DVu%26aufirst%3DB.%2BT.%26aulast%3DPackman%26aufirst%3DK.%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DGoelzer%26aufirst%3DP.%26aulast%3DYin%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26aulast%3DHiggins%26aufirst%3DB.%2BX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DXiang%26aufirst%3DQ.%26aulast%3DMoliterni%26aufirst%3DJ.%26aulast%3DKaplan%26aufirst%3DG.%26aulast%3DGraves%26aufirst%3DB.%26aulast%3DLovey%26aufirst%3DA.%26aulast%3DFotouhi%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520%255B4-Amino-2-%25281-methanesulfonylpiperidin-4-ylamino%2529pyrimidin-5-yl%255D%25282%252C3-difluoro-6-methoxy%2520phenyl%2529methanone%2520%2528R547%2529%252C%2520a%2520Potent%2520and%2520Selective%2520Cyclin-Dependent%2520Kinase%2520Inhibitor%2520with%2520Significant%2520in%2520Vivo%2520Antitumor%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6549%26epage%3D6560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Tong, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plunkett, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badros, A. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popplewell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coutre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahadocon, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kegley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wierda, W. G.</span><span> </span><span class="NLM_article-title">Phase I and Pharmacologic Study of SNS-032, a Potent and Selective Cdk 2, 7, and 9 Inhibitor, in Patients with Advanced Chronic Lymphocytic Leukemia and Multiple Myeloma</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3015</span><span class="NLM_x">–</span> <span class="NLM_lpage">3022</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm3008536&amp;key=10.1200%2FJCO.2009.26.1347" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=3015-3022&author=W.+G.+Tongauthor=R.+Chenauthor=W.+Plunkettauthor=D.+Siegelauthor=R.+Sinhaauthor=R.+D.+Harveyauthor=A.+Z.+Badrosauthor=L.+Popplewellauthor=S.+Coutreauthor=J.+A.+Foxauthor=K.+Mahadoconauthor=T.+Chenauthor=P.+Kegleyauthor=U.+Hochauthor=W.+G.+Wierda&title=Phase+I+and+Pharmacologic+Study+of+SNS-032%2C+a+Potent+and+Selective+Cdk+2%2C+7%2C+and+9+Inhibitor%2C+in+Patients+with+Advanced+Chronic+Lymphocytic+Leukemia+and+Multiple+Myeloma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1200%2FJCO.2009.26.1347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2009.26.1347%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DW.%2BG.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DPlunkett%26aufirst%3DW.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DSinha%26aufirst%3DR.%26aulast%3DHarvey%26aufirst%3DR.%2BD.%26aulast%3DBadros%26aufirst%3DA.%2BZ.%26aulast%3DPopplewell%26aufirst%3DL.%26aulast%3DCoutre%26aufirst%3DS.%26aulast%3DFox%26aufirst%3DJ.%2BA.%26aulast%3DMahadocon%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DKegley%26aufirst%3DP.%26aulast%3DHoch%26aufirst%3DU.%26aulast%3DWierda%26aufirst%3DW.%2BG.%26atitle%3DPhase%2520I%2520and%2520Pharmacologic%2520Study%2520of%2520SNS-032%252C%2520a%2520Potent%2520and%2520Selective%2520Cdk%25202%252C%25207%252C%2520and%25209%2520Inhibitor%252C%2520in%2520Patients%2520with%2520Advanced%2520Chronic%2520Lymphocytic%2520Leukemia%2520and%2520Multiple%2520Myeloma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2010%26volume%3D18%26spage%3D3015%26epage%3D3022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Baughn, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Liberto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toogood, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottschalk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niesvizky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ely, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen-Kiang, S.</span><span> </span><span class="NLM_article-title">A Novel Orally Active Small Molecule Potently Induces G1 Arrest in Primary Myeloma Cells and Prevents Tumour Growth by Specific Inhibition of Cyclin-Dependent Kinase 4/6</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">7661</span><span class="NLM_x">–</span> <span class="NLM_lpage">7667</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=7661-7667&author=L.+B.+Baughnauthor=M.+Di+Libertoauthor=K.+Wuauthor=P.+L.+Toogoodauthor=T.+Louieauthor=R.+Gottschalkauthor=R.+Niesvizkyauthor=H.+Choauthor=S.+Elyauthor=M.+A.+Mooreauthor=S.+Chen-Kiang&title=A+Novel+Orally+Active+Small+Molecule+Potently+Induces+G1+Arrest+in+Primary+Myeloma+Cells+and+Prevents+Tumour+Growth+by+Specific+Inhibition+of+Cyclin-Dependent+Kinase+4%2F6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaughn%26aufirst%3DL.%2BB.%26aulast%3DDi%2BLiberto%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DK.%26aulast%3DToogood%26aufirst%3DP.%2BL.%26aulast%3DLouie%26aufirst%3DT.%26aulast%3DGottschalk%26aufirst%3DR.%26aulast%3DNiesvizky%26aufirst%3DR.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DEly%26aufirst%3DS.%26aulast%3DMoore%26aufirst%3DM.%2BA.%26aulast%3DChen-Kiang%26aufirst%3DS.%26atitle%3DA%2520Novel%2520Orally%2520Active%2520Small%2520Molecule%2520Potently%2520Induces%2520G1%2520Arrest%2520in%2520Primary%2520Myeloma%2520Cells%2520and%2520Prevents%2520Tumour%2520Growth%2520by%2520Specific%2520Inhibition%2520of%2520Cyclin-Dependent%2520Kinase%25204%252F6%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D7661%26epage%3D7667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Byth, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forder, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mc Gregor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oakes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcombe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Growcott, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, R. W.</span><span> </span><span class="NLM_article-title">AZD5438, a Potent Oral Inhibitor of Cyclin-Dependent Kinases 1, 2, and 9, Leads to Pharmacodynamic Changes and Potent Antitumor Effects in Human Tumor Xenografts</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1856</span><span class="NLM_x">–</span> <span class="NLM_lpage">1866</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm3008536&amp;key=10.1158%2F1535-7163.MCT-08-0836" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=1856-1866&author=K.+F.+Bythauthor=A.+Thomasauthor=G.+Hughesauthor=C.+Forderauthor=A.+Mc+Gregorauthor=C.+Gehauthor=S.+Oakesauthor=C.+Greenauthor=M.+Walkerauthor=N.+Newcombeauthor=S.+Greenauthor=J.+Growcottauthor=A.+Barkerauthor=R.+W.+Wilkinson&title=AZD5438%2C+a+Potent+Oral+Inhibitor+of+Cyclin-Dependent+Kinases+1%2C+2%2C+and+9%2C+Leads+to+Pharmacodynamic+Changes+and+Potent+Antitumor+Effects+in+Human+Tumor+Xenografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0836%26sid%3Dliteratum%253Aachs%26aulast%3DByth%26aufirst%3DK.%2BF.%26aulast%3DThomas%26aufirst%3DA.%26aulast%3DHughes%26aufirst%3DG.%26aulast%3DForder%26aufirst%3DC.%26aulast%3DMc%2BGregor%26aufirst%3DA.%26aulast%3DGeh%26aufirst%3DC.%26aulast%3DOakes%26aufirst%3DS.%26aulast%3DGreen%26aufirst%3DC.%26aulast%3DWalker%26aufirst%3DM.%26aulast%3DNewcombe%26aufirst%3DN.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DGrowcott%26aufirst%3DJ.%26aulast%3DBarker%26aufirst%3DA.%26aulast%3DWilkinson%26aufirst%3DR.%2BW.%26atitle%3DAZD5438%252C%2520a%2520Potent%2520Oral%2520Inhibitor%2520of%2520Cyclin-Dependent%2520Kinases%25201%252C%25202%252C%2520and%25209%252C%2520Leads%2520to%2520Pharmacodynamic%2520Changes%2520and%2520Potent%2520Antitumor%2520Effects%2520in%2520Human%2520Tumor%2520Xenografts%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D7%26spage%3D1856%26epage%3D1866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Brown, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Criswell, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holliman, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evering, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessen, B. A.</span><span> </span><span class="NLM_article-title">Toxicity and Toxicokinetics of the Cyclin-Dependent Kinase inhibitor AG-024322 in Cynomolgus Monkeys Following Intravenous infusion</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1091</span><span class="NLM_x">–</span> <span class="NLM_lpage">1101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm3008536&amp;key=10.1007%2Fs00280-008-0771-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm3008536&amp;key=18509643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm3008536&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFaju77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2008&pages=1091-1101&author=A.+P.+Brownauthor=C.+L.+Courtneyauthor=K.+A.+Criswellauthor=C.+L.+Hollimanauthor=W.+Everingauthor=B.+A.+Jessen&title=Toxicity+and+Toxicokinetics+of+the+Cyclin-Dependent+Kinase+inhibitor+AG-024322+in+Cynomolgus+Monkeys+Following+Intravenous+infusion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicity and toxicokinetics of the cyclin-dependent kinase inhibitor AG-024322 in cynomolgus monkeys following intravenous infusion</span></div><div class="casAuthors">Brown, Alan P.; Courtney, Cynthia L.; Criswell, Kay A.; Holliman, Christopher L.; Evering, Winston; Jessen, Bart A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1091-1101</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Cyclin-dependent kinases (CDKs) play a significant role in the control of cell-cycle progression and exhibit aberrant regulation in various neoplastic diseases.  AG-024322 is a potent inhibitor of CDK1, CDK2, and CDK4 that produces cell-cycle arrest and antitumor activity in preclin. models.  This study evaluated the toxicity of AG-024322 when given by i.v. infusion to cynomolgus monkeys, including reversibility of effects.  Male and female monkeys received AG-024322 by 30-min i.v. infusion once daily for 5 days at doses of 2, 6, and 10 mg/kg (24, 72, and 120 mg/m2, resp.).  Controls received vehicle alone which was aq. 5% dextrose, pH 3.8.  Three animals/sex/group were necropsied on day 6, and two animals/sex/group at 6 and 10 mg/kg were necropsied on day 22 (reversal cohort).  Doses were based upon the results of a dose range-finding study in monkeys; decreased white blood cells occurred at ≥3 mg/kg and 12 mg/kg produced central nervous system effects and was above the max.-tolerated dose.  No deaths occurred and clin. signs of toxicity, including swelling at the i.v. administration site, were seen at ≥6 mg/kg.  AG-024322 at ≥6 mg/kg produced pancytic bone marrow hypocellularity, lymphoid depletion, and vascular injury at the injection site.  Renal tubular degeneration occurred at 10 mg/kg.  These changes were either reversible or in a process of repair following the 17-day recovery period.  Hematol. changes included decreases in reticulocytes and/or granulocytes at ≥6 mg/kg, which were reversible and consistent with changes in the bone marrow.  Lymphoid and bone marrow depletion are consistent with pharmacol. inhibition of CDKs by AG-024322 and were expected findings.  On day 22, vacuolar degeneration of pancreatic acinar cells with increased serum amylase and lipase levels occurred in one female at 10 mg/kg.  Neither sex-related differences in toxicokinetics nor plasma accumulation over 5 days of dosing were seen.  Terminal phase overall mean half-life on day 5 ranged from 6.69 to 8.87 h (across dose levels) and was not dose dependent.  The no-adverse-effect dose of AG-024322 was 2 mg/kg and assocd. with overall mean plasma AUC(0-24.5) of 2.11 μg h/mL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR4ZxVRofSTrVg90H21EOLACvtfcHk0lioytf6Pj0jvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFaju77L&md5=37bbd35e5b7a72dfc728162206facbeb</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs00280-008-0771-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-008-0771-1%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BP.%26aulast%3DCourtney%26aufirst%3DC.%2BL.%26aulast%3DCriswell%26aufirst%3DK.%2BA.%26aulast%3DHolliman%26aufirst%3DC.%2BL.%26aulast%3DEvering%26aufirst%3DW.%26aulast%3DJessen%26aufirst%3DB.%2BA.%26atitle%3DToxicity%2520and%2520Toxicokinetics%2520of%2520the%2520Cyclin-Dependent%2520Kinase%2520inhibitor%2520AG-024322%2520in%2520Cynomolgus%2520Monkeys%2520Following%2520Intravenous%2520infusion%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2008%26volume%3D62%26spage%3D1091%26epage%3D1101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodhead, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulstridge, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devine, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Early, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feltell, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Reilly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seavers, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squires, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trewartha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolford, A. J.</span><span> </span><span class="NLM_article-title">Identification of <i>N</i>-(4-Piperidinyl)-4-(2,6-dichlorobenzoylamino)-1<i>H</i>-pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4986</span><span class="NLM_x">–</span> <span class="NLM_lpage">4999</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800382h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4986-4999&author=P.+G.+Wyattauthor=A.+J.+Woodheadauthor=V.+Berdiniauthor=J.+A.+Boulstridgeauthor=M.+G.+Carrauthor=D.+M.+Crossauthor=D.+J.+Davisauthor=L.+A.+Devineauthor=T.+R.+Earlyauthor=R.+E.+Feltellauthor=E.+J.+Lewisauthor=R.+L.+McMenaminauthor=E.+F.+Navarroauthor=M.+A.+O%E2%80%99Brienauthor=M.+O%E2%80%99Reillyauthor=M.+Reuleauthor=G.+Saxtyauthor=L.+C.+Seaversauthor=D.+M.+Smithauthor=M.+S.+Squiresauthor=G.+Trewarthaauthor=M.+T.+Walkerauthor=A.+J.+Woolford&title=Identification+of+N-%284-Piperidinyl%29-4-%282%2C6-dichlorobenzoylamino%29-1H-pyrazole-3-carboxamide+%28AT7519%29%2C+a+Novel+Cyclin+Dependent+Kinase+Inhibitor+Using+Fragment-Based+X-Ray+Crystallography+and+Structure+Based+Drug+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm800382h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800382h%26sid%3Dliteratum%253Aachs%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26aulast%3DBerdini%26aufirst%3DV.%26aulast%3DBoulstridge%26aufirst%3DJ.%2BA.%26aulast%3DCarr%26aufirst%3DM.%2BG.%26aulast%3DCross%26aufirst%3DD.%2BM.%26aulast%3DDavis%26aufirst%3DD.%2BJ.%26aulast%3DDevine%26aufirst%3DL.%2BA.%26aulast%3DEarly%26aufirst%3DT.%2BR.%26aulast%3DFeltell%26aufirst%3DR.%2BE.%26aulast%3DLewis%26aufirst%3DE.%2BJ.%26aulast%3DMcMenamin%26aufirst%3DR.%2BL.%26aulast%3DNavarro%26aufirst%3DE.%2BF.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%2BA.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DReule%26aufirst%3DM.%26aulast%3DSaxty%26aufirst%3DG.%26aulast%3DSeavers%26aufirst%3DL.%2BC.%26aulast%3DSmith%26aufirst%3DD.%2BM.%26aulast%3DSquires%26aufirst%3DM.%2BS.%26aulast%3DTrewartha%26aufirst%3DG.%26aulast%3DWalker%26aufirst%3DM.%2BT.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.%26atitle%3DIdentification%2520of%2520N-%25284-Piperidinyl%2529-4-%25282%252C6-dichlorobenzoylamino%2529-1H-pyrazole-3-carboxamide%2520%2528AT7519%2529%252C%2520a%2520Novel%2520Cyclin%2520Dependent%2520Kinase%2520Inhibitor%2520Using%2520Fragment-Based%2520X-Ray%2520Crystallography%2520and%2520Structure%2520Based%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4986%26epage%3D4999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Jian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levitt, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonpavde, G.</span><span> </span><span class="NLM_article-title">Enzastaurin Shows Preclinical Antitumor Activity against Human Transitional Cell Carcinoma and Enhances the Activity of Gemcitabine</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1772</span><span class="NLM_x">–</span> <span class="NLM_lpage">1778</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm3008536&amp;key=10.1158%2F1535-7163.MCT-09-0141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm3008536&amp;key=19509273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm3008536&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVynu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1772-1778&author=W.+Jianauthor=H.+Yamashitaauthor=J.+M.+Levittauthor=S.+P.+Lernerauthor=G.+Sonpavde&title=Enzastaurin+Shows+Preclinical+Antitumor+Activity+against+Human+Transitional+Cell+Carcinoma+and+Enhances+the+Activity+of+Gemcitabine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Enzastaurin shows preclinical antitumor activity against human transitional cell carcinoma and enhances the activity of gemcitabine</span></div><div class="casAuthors">Jian, Weiguo; Yamashita, Hideyuki; Levitt, Jonathan M.; Lerner, Seth P.; Sonpavde, Guru</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1772-1778</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Enzastaurin, an oral serine/threonine kinase inhibitor, suppresses signaling through protein kinase C (PKC)-β and the phosphatidylinositol 3-kinase/AKT pathways.  We preclinically evaluated enzastaurin alone and in combination with gemcitabine for transitional cell cancer (TCC).  Immunohistochem. (IHC) was done on 105 human samples from a microarray to show the expression of PKC-β.  The preclin. antitumor activity of enzastaurin and gemcitabine as single agents and in combination against aggressive human -lines (-SUP and 5637) and murine s.c. xenografts bearing 5637 cells was detd.  Western Blot was done on tumor cells in vitro to detect signaling through PKC-β, GSK-3β, and AKT.  The effect on cell migration was detd. in vitro.  Modulation of proliferation (Ki-67), apoptosis (cleaved caspase-3), and angiogenesis (CD31) in vivo was detd. by IHC.  IHC done on human TCC samples from a microarray showed the expression of PKC-β in 33% of tumors.  Enzastaurin induced significant apoptosis and inhibited proliferation in vitro at low micromolar concns.  The in vitro inhibitory activity of combination enzastaurin and gemcitabine by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay seemed synergistic.  Western Blotting revealed down-regulation of Akt, PKC-β, and GSK-3 β phosphorylation.  Enzastaurin inhibited migration at an earlier time point independent of antiproliferative activity.  Combination therapy had significantly superior antitumor activity in murine xenografts compared with untreated controls, whereas single agents did not.  IHC showed reduced Ki-67 and CD31 and increased cleaved caspase-3 with combination therapy compared with controls.  Enzastaurin showed preclin. antitumor activity against human TCC and enhanced the activity of gemcitabine. [Mol Cancer Ther 2009;8(7):1772-8].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSmOhM2_Z9-7Vg90H21EOLACvtfcHk0lioytf6Pj0jvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVynu70%253D&md5=5115f399fb81dcb9515d6d135521ebc0</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0141%26sid%3Dliteratum%253Aachs%26aulast%3DJian%26aufirst%3DW.%26aulast%3DYamashita%26aufirst%3DH.%26aulast%3DLevitt%26aufirst%3DJ.%2BM.%26aulast%3DLerner%26aufirst%3DS.%2BP.%26aulast%3DSonpavde%26aufirst%3DG.%26atitle%3DEnzastaurin%2520Shows%2520Preclinical%2520Antitumor%2520Activity%2520against%2520Human%2520Transitional%2520Cell%2520Carcinoma%2520and%2520Enhances%2520the%2520Activity%2520of%2520Gemcitabine%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D1772%26epage%3D1778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Routier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayerbe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mérour, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coudert, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailly, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierré, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caignard, D.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renard, P.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Activity of 7-Azaindolocarbazoles</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">6621</span><span class="NLM_x">–</span> <span class="NLM_lpage">6630</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=6621-6630&author=S.+Routierauthor=N.+Ayerbeauthor=J.-Y.+M%C3%A9rourauthor=G.+Coudertauthor=C.+Baillyauthor=A.+Pierr%C3%A9author=B.+Pfeifferauthor=D.-H.+Caignardauthor=P.+Renard&title=Synthesis+and+Biological+Activity+of+7-Azaindolocarbazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoutier%26aufirst%3DS.%26aulast%3DAyerbe%26aufirst%3DN.%26aulast%3DM%25C3%25A9rour%26aufirst%3DJ.-Y.%26aulast%3DCoudert%26aufirst%3DG.%26aulast%3DBailly%26aufirst%3DC.%26aulast%3DPierr%25C3%25A9%26aufirst%3DA.%26aulast%3DPfeiffer%26aufirst%3DB.%26aulast%3DCaignard%26aufirst%3DD.-H.%26aulast%3DRenard%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520Biological%2520Activity%2520of%25207-Azaindolocarbazoles%26jtitle%3DTetrahedron%26date%3D2002%26volume%3D58%26spage%3D6621%26epage%3D6630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Routier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peixoto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mérour, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coudert, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailly, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierré, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Léonce, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caignard, D.-H.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of New Naphthocarbazoles As Potential Anticancer Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1401</span><span class="NLM_x">–</span> <span class="NLM_lpage">1413</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049213f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1401-1413&author=S.+Routierauthor=P.+Peixotoauthor=J.-Y.+M%C3%A9rourauthor=G.+Coudertauthor=C.+Baillyauthor=A.+Pierr%C3%A9author=S.+L%C3%A9onceauthor=D.-H.+Caignard&title=Synthesis+and+Biological+Evaluation+of+New+Naphthocarbazoles+As+Potential+Anticancer+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1021%2Fjm049213f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049213f%26sid%3Dliteratum%253Aachs%26aulast%3DRoutier%26aufirst%3DS.%26aulast%3DPeixoto%26aufirst%3DP.%26aulast%3DM%25C3%25A9rour%26aufirst%3DJ.-Y.%26aulast%3DCoudert%26aufirst%3DG.%26aulast%3DBailly%26aufirst%3DC.%26aulast%3DPierr%25C3%25A9%26aufirst%3DA.%26aulast%3DL%25C3%25A9once%26aufirst%3DS.%26aulast%3DCaignard%26aufirst%3DD.-H.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520New%2520Naphthocarbazoles%2520As%2520Potential%2520Anticancer%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1401%26epage%3D1413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Routier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mérour, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dias, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansiaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailly, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Novel Phenylcarbazoles As Potential Anticancer Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">799</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050945x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=789-799&author=S.+Routierauthor=J.-Y.+M%C3%A9rourauthor=N.+Diasauthor=A.+Lansiauxauthor=C.+Baillyauthor=O.+Lozachauthor=L.+Meijer&title=Synthesis+and+Biological+Evaluation+of+Novel+Phenylcarbazoles+As+Potential+Anticancer+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1021%2Fjm050945x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050945x%26sid%3Dliteratum%253Aachs%26aulast%3DRoutier%26aufirst%3DS.%26aulast%3DM%25C3%25A9rour%26aufirst%3DJ.-Y.%26aulast%3DDias%26aufirst%3DN.%26aulast%3DLansiaux%26aufirst%3DA.%26aulast%3DBailly%26aufirst%3DC.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Novel%2520Phenylcarbazoles%2520As%2520Potential%2520Anticancer%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D789%26epage%3D799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ayerbe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillaizeau, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiereanu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caignard, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierré, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Léonce, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coudert, G.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Novel Benzodioxinocarbazoles (BDCZs) as Potential Anticancer Agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4670</span><span class="NLM_x">–</span> <span class="NLM_lpage">4674</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4670-4674&author=N.+Ayerbeauthor=S.+Routierauthor=I.+Gillaizeauauthor=C.+Maiereanuauthor=D.+H.+Caignardauthor=A.+Pierr%C3%A9author=S.+L%C3%A9onceauthor=G.+Coudert&title=Synthesis+and+Biological+Evaluation+of+Novel+Benzodioxinocarbazoles+%28BDCZs%29+as+Potential+Anticancer+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAyerbe%26aufirst%3DN.%26aulast%3DRoutier%26aufirst%3DS.%26aulast%3DGillaizeau%26aufirst%3DI.%26aulast%3DMaiereanu%26aufirst%3DC.%26aulast%3DCaignard%26aufirst%3DD.%2BH.%26aulast%3DPierr%25C3%25A9%26aufirst%3DA.%26aulast%3DL%25C3%25A9once%26aufirst%3DS.%26aulast%3DCoudert%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Novel%2520Benzodioxinocarbazoles%2520%2528BDCZs%2529%2520as%2520Potential%2520Anticancer%2520Agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4670%26epage%3D4674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chiurato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillaumet, G.</span><span> </span><span class="NLM_article-title">New Efficient Access to Fused Aryltetrahydroindolizinones <i>via N</i>-Acyliminium Intermediates</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3011</span><span class="NLM_x">–</span> <span class="NLM_lpage">3021</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=3011-3021&author=M.+Chiuratoauthor=S.+Routierauthor=Y.+Troinauthor=G.+Guillaumet&title=New+Efficient+Access+to+Fused+Aryltetrahydroindolizinones+via+N-Acyliminium+Intermediates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiurato%26aufirst%3DM.%26aulast%3DRoutier%26aufirst%3DS.%26aulast%3DTroin%26aufirst%3DY.%26aulast%3DGuillaumet%26aufirst%3DG.%26atitle%3DNew%2520Efficient%2520Access%2520to%2520Fused%2520Aryltetrahydroindolizinones%2520via%2520N-Acyliminium%2520Intermediates%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2009%26volume%3D18%26spage%3D3011%26epage%3D3021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chiurato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillaumet, G.</span><span> </span><span class="NLM_article-title">New Efficient Access to Fused (Het)aryltetrahydroindolizinones <i>via N</i>-Acyl Iminium Intermediates</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">4647</span><span class="NLM_x">–</span> <span class="NLM_lpage">4653</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=4647-4653&author=M.+Chiuratoauthor=S.+Routierauthor=Y.+Troinauthor=G.+Guillaumet&title=New+Efficient+Access+to+Fused+%28Het%29aryltetrahydroindolizinones+via+N-Acyl+Iminium+Intermediates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiurato%26aufirst%3DM.%26aulast%3DRoutier%26aufirst%3DS.%26aulast%3DTroin%26aufirst%3DY.%26aulast%3DGuillaumet%26aufirst%3DG.%26atitle%3DNew%2520Efficient%2520Access%2520to%2520Fused%2520%2528Het%2529aryltetrahydroindolizinones%2520via%2520N-Acyl%2520Iminium%2520Intermediates%26jtitle%3DTetrahedron%26date%3D2010%26volume%3D66%26spage%3D4647%26epage%3D4653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Honma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukasawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeura, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikuta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki-Takahashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishima, H.</span><span> </span><span class="NLM_article-title">Structure-Based Generation of a New Class of Potent Cdk4 Inhibitors: New de Novo Design Strategy and Library Design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">4615</span><span class="NLM_x">–</span> <span class="NLM_lpage">4627</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0103256" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Fjm3008536&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovFagtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=4615-4627&author=T.+Honmaauthor=Y.+Hayashiauthor=T.+Aoyamaauthor=N.+Hashimotoauthor=T.+Machidaauthor=K.+Fukasawaauthor=T.+Iwamaauthor=C.+Ikeuraauthor=M.+Ikutaauthor=I.+Suzuki-Takahashiauthor=Y.+Iwasawaauthor=T.+Hayamaauthor=S.+Nishimuraauthor=H.+Morishima&title=Structure-Based+Generation+of+a+New+Class+of+Potent+Cdk4+Inhibitors%3A+New+de+Novo+Design+Strategy+and+Library+Design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Generation of a New Class of Potent Cdk4 Inhibitors: New de Novo Design Strategy and Library Design</span></div><div class="casAuthors">Honma, Teruki; Hayashi, Kyoko; Aoyama, Tetsuya; Hashimoto, Noriaki; Machida, Takumitsu; Fukasawa, Kazuhiro; Iwama, Toshiharu; Ikeura, Chinatsu; Ikuta, Mari; Suzuki-Takahashi, Ikuko; Iwasawa, Yoshikazu; Hayama, Takashi; Nishimura, Susumu; Morishima, Hajime</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">4615-4627</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As a first step in structure-based design of highly selective and potent Cdk4 inhibitors, we performed structure-based generation of a novel series of Cdk4 inhibitors.  A Cdk4 homol. model was constructed according to x-ray anal. of an activated form of Cdk2.  Using this model, we applied a new de novo design strategy which combined the de novo design program LEGEND with our inhouse structure selection supporting system SEEDS to generate new scaffold candidates.  In this way, four classes of scaffold candidates including diarylurea were identified.  By constructing diarylurea informer libraries based on the structural requirements of Cdk inhibitors in the ATP binding pocket of the Cdk4 model, we were able to identify a potent Cdk4 inhibitor N-(9-oxo-9H-fluoren-4-yl)-N'-pyridin-2-ylurea (I) with IC50 = 0.10 μM, together with preliminary SAR.  We performed a docking study between I and the Cdk4 model and selected a reasonable binding mode which is consistent with the SAR.  Further modification based on the proposed binding mode provided a more potent compd., N-[(9bR)-5-oxo- 2,3,5,9b-tetrahydro-1H-pyrrolo[2,1-a]isoindol-9-yl]-N'-pyridin-2-ylurea (II) with IC50 = 0.042 μM, x-ray anal. of which was accomplished by the soaking method.  The predicted binding mode of I in Cdk4 was validated by x-ray anal. of the Cdk2-II complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvx3J3Bqyg9LVg90H21EOLACvtfcHk0lj-Qu6tse25yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovFagtrs%253D&md5=0c4458fa88d41c148a672863b3a6daa0</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fjm0103256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0103256%26sid%3Dliteratum%253Aachs%26aulast%3DHonma%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DAoyama%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DN.%26aulast%3DMachida%26aufirst%3DT.%26aulast%3DFukasawa%26aufirst%3DK.%26aulast%3DIwama%26aufirst%3DT.%26aulast%3DIkeura%26aufirst%3DC.%26aulast%3DIkuta%26aufirst%3DM.%26aulast%3DSuzuki-Takahashi%26aufirst%3DI.%26aulast%3DIwasawa%26aufirst%3DY.%26aulast%3DHayama%26aufirst%3DT.%26aulast%3DNishimura%26aufirst%3DS.%26aulast%3DMorishima%26aufirst%3DH.%26atitle%3DStructure-Based%2520Generation%2520of%2520a%2520New%2520Class%2520of%2520Potent%2520Cdk4%2520Inhibitors%253A%2520New%2520de%2520Novo%2520Design%2520Strategy%2520and%2520Library%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D4615%26epage%3D4627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Honma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshizumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawanishi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukasawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeura, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikuta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki-Takahashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishima, H.</span><span> </span><span class="NLM_article-title">A Novel Approach for the Development of Selective Cdk4 Inhibitors: Library Design Based on Locations of Cdk4 Specific Amino Acid Residues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">4628</span><span class="NLM_x">–</span> <span class="NLM_lpage">4640</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010326y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=4628-4640&author=T.+Honmaauthor=T.+Yoshizumiauthor=N.+Hashimotoauthor=K.+Hayashiauthor=K.+Kawanishiauthor=K.+Fukasawaauthor=T.+Takakiauthor=C.+Ikeuraauthor=M.+Ikutaauthor=I.+Suzuki-Takahashiauthor=T.+Hayamaauthor=S.+Nishimuraauthor=H.+Morishima&title=A+Novel+Approach+for+the+Development+of+Selective+Cdk4+Inhibitors%3A+Library+Design+Based+on+Locations+of+Cdk4+Specific+Amino+Acid+Residues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Fjm010326y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010326y%26sid%3Dliteratum%253Aachs%26aulast%3DHonma%26aufirst%3DT.%26aulast%3DYoshizumi%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DN.%26aulast%3DHayashi%26aufirst%3DK.%26aulast%3DKawanishi%26aufirst%3DK.%26aulast%3DFukasawa%26aufirst%3DK.%26aulast%3DTakaki%26aufirst%3DT.%26aulast%3DIkeura%26aufirst%3DC.%26aulast%3DIkuta%26aufirst%3DM.%26aulast%3DSuzuki-Takahashi%26aufirst%3DI.%26aulast%3DHayama%26aufirst%3DT.%26aulast%3DNishimura%26aufirst%3DS.%26aulast%3DMorishima%26aufirst%3DH.%26atitle%3DA%2520Novel%2520Approach%2520for%2520the%2520Development%2520of%2520Selective%2520Cdk4%2520Inhibitors%253A%2520Library%2520Design%2520Based%2520on%2520Locations%2520of%2520Cdk4%2520Specific%2520Amino%2520Acid%2520Residues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D4628%26epage%3D4640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Alsarabi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canet, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troin, Y.</span><span> </span><span class="NLM_article-title">Short Diastereoselective Synthesis of <i>cis</i>- and <i>trans</i>-Hexahydropyrido[2,1-<i>a</i>]isoindole Derivatives</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">9003</span><span class="NLM_x">–</span> <span class="NLM_lpage">9006</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=9003-9006&author=A.+Alsarabiauthor=J.+L.+Canetauthor=Y.+Troin&title=Short+Diastereoselective+Synthesis+of+cis-+and+trans-Hexahydropyrido%5B2%2C1-a%5Disoindole+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlsarabi%26aufirst%3DA.%26aulast%3DCanet%26aufirst%3DJ.%2BL.%26aulast%3DTroin%26aufirst%3DY.%26atitle%3DShort%2520Diastereoselective%2520Synthesis%2520of%2520cis-%2520and%2520trans-Hexahydropyrido%255B2%252C1-a%255Disoindole%2520Derivatives%26jtitle%3DTetrahedron%2520Lett.%26date%3D2004%26volume%3D45%26spage%3D9003%26epage%3D9006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="note"><p class="first last">Valmerin is a nickmane which comes from the sentence “<b>Val</b>orisation des produits de la <b>Mer</b>” (see the <a class="ref internalNav" href="#ack" aria-label="Acknowledgments">Acknowledgments</a>) and from the mane of some CDK inhibitors which use the suffix “In”.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Routier, S.; Guillaumet, G.; Meijer, L.; Chiurato, M.; Boulahjar, R.</span><span> </span><span class="NLM_article-title">10-Amino-1,2,3,4-tetrahydropyrido[2,1-<i>a</i>]isoindol-6(10bH)-ones as CDK1, 5 and GSK-3 inhibitors</span>. Patent WO 201050416;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Routier%2C+S.%3B+Guillaumet%2C+G.%3B+Meijer%2C+L.%3B+Chiurato%2C+M.%3B+Boulahjar%2C+R.+10-Amino-1%2C2%2C3%2C4-tetrahydropyrido%5B2%2C1-a%5Disoindol-6%2810bH%29-ones+as+CDK1%2C+5+and+GSK-3+inhibitors.+Patent+WO+201050416%3B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRoutier%26aufirst%3DS.%26atitle%3D10-Amino-1%252C2%252C3%252C4-tetrahydropyrido%255B2%252C1-a%255Disoindol-6%252810bH%2529-ones%2520as%2520CDK1%252C%25205%2520and%2520GSK-3%2520inhibitors" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19a"><span> <span class="citation_source-journal">Chem. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">431389</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chem.+Abstr.+2009%2C+153%2C+431389."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Abstr.%26date%3D2009%26volume%3D153%26spage%3D431389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Gesson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacquesy, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rambaud, D.</span><span> </span><span class="NLM_article-title">α-<i>N</i>-Acyliminium Ion - 2-Bromoalkene Cyclizations</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2239</span><span class="NLM_x">–</span> <span class="NLM_lpage">2248</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1993&pages=2239-2248&author=J.+P.+Gessonauthor=J.+C.+Jacquesyauthor=D.+Rambaud&title=%CE%B1-N-Acyliminium+Ion+-+2-Bromoalkene+Cyclizations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGesson%26aufirst%3DJ.%2BP.%26aulast%3DJacquesy%26aufirst%3DJ.%2BC.%26aulast%3DRambaud%26aufirst%3DD.%26atitle%3D%25CE%25B1-N-Acyliminium%2520Ion%2520-%25202-Bromoalkene%2520Cyclizations%26jtitle%3DTetrahedron%26date%3D1993%26volume%3D49%26spage%3D2239%26epage%3D2248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Lochead, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proctor, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caton, M. P. L.</span><span> </span><span class="NLM_article-title">Use of Chloroalkenylamines for the Synthesis of 1-Azabicyclo[3.3.0]octane and 1-Azabicyclo[4.3.0]nonane Derivatives</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_fpage">2477</span><span class="NLM_x">–</span> <span class="NLM_lpage">2489</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1984&pages=2477-2489&author=A.+W.+Locheadauthor=G.+R.+Proctorauthor=M.+P.+L.+Caton&title=Use+of+Chloroalkenylamines+for+the+Synthesis+of+1-Azabicyclo%5B3.3.0%5Doctane+and+1-Azabicyclo%5B4.3.0%5Dnonane+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLochead%26aufirst%3DA.%2BW.%26aulast%3DProctor%26aufirst%3DG.%2BR.%26aulast%3DCaton%26aufirst%3DM.%2BP.%2BL.%26atitle%3DUse%2520of%2520Chloroalkenylamines%2520for%2520the%2520Synthesis%2520of%25201-Azabicyclo%255B3.3.0%255Doctane%2520and%25201-Azabicyclo%255B4.3.0%255Dnonane%2520Derivatives%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1984%26spage%3D2477%26epage%3D2489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Huang, M.</span> <span class="citation_source-journal">Contribution from the Chemical Laboratory of Harvard University</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1946</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2487</span><span class="NLM_x">–</span> <span class="NLM_lpage">2488</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Huang%2C+M.Contribution+from+the+Chemical+Laboratory+of+Harvard+University+1946%2C+68%2C+2487%E2%80%932488"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DM.%26jtitle%3DContribution%2520from%2520the%2520Chemical%2520Laboratory%2520of%2520Harvard%2520University%26date%3D1946%26volume%3D68%26spage%3D2487%26epage%3D2488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Löwik, D. W. P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tisi, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, C. R.</span><span> </span><span class="NLM_article-title">Synthesis of 6-Hydroxybenzothiazole-2-carboxylic Acid</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_fpage">1780</span><span class="NLM_x">–</span> <span class="NLM_lpage">1783</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm3008536&amp;key=10.1055%2Fs-2001-17533" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm3008536&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntlGisrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=1780-1783&author=D.+W.+P.+M.+L%C3%B6wikauthor=L.+C.+Tisiauthor=J.+A.+H.+Murrayauthor=C.+R.+Lowe&title=Synthesis+of+6-Hydroxybenzothiazole-2-carboxylic+Acid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 6-hydroxybenzothiazole-2-carboxylic acid</span></div><div class="casAuthors">Lowik, Dennis W. P. M.; Tisi, Lawrence C.; Murray, James A. H.; Lowe, Christopher R.</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1780-1783</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">The synthesis of 6-hydroxybenzothiazole-2-carboxylic acid (I) is presented.  The benzothiazole ring was obtained by ring contraction of a remarkably stable 2-alkoxy-7-hydroxy-2H-benzo[1,4]thiazine intermediate that could be isolated.  I slowly decarboxylated in soln. at ambient temp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiTwJ1ZmPzs7Vg90H21EOLACvtfcHk0ljloOGici35Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntlGisrw%253D&md5=3e7cb79e97dba2444cfcb3c4b0ce3ea4</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1055%2Fs-2001-17533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2001-17533%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6wik%26aufirst%3DD.%2BW.%2BP.%2BM.%26aulast%3DTisi%26aufirst%3DL.%2BC.%26aulast%3DMurray%26aufirst%3DJ.%2BA.%2BH.%26aulast%3DLowe%26aufirst%3DC.%2BR.%26atitle%3DSynthesis%2520of%25206-Hydroxybenzothiazole-2-carboxylic%2520Acid%26jtitle%3DSynthesis%26date%3D2001%26spage%3D1780%26epage%3D1783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Brown, A. D.; Ellis, D.; Smith, C. R.</span>, <span> </span><span class="NLM_article-title">Substituted Triazole Derivatives As Oxytocin Antagonists Their Preparation and Use against Sexual Dysfunction</span>. Patent WO2005028452;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Brown%2C+A.+D.%3B+Ellis%2C+D.%3B+Smith%2C+C.+R.%2C+Substituted+Triazole+Derivatives+As+Oxytocin+Antagonists+Their+Preparation+and+Use+against+Sexual+Dysfunction.+Patent+WO2005028452%3B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BD.%26atitle%3DSubstituted%2520Triazole%2520Derivatives%2520As%2520Oxytocin%2520Antagonists%2520Their%2520Preparation%2520and%2520Use%2520against%2520Sexual%2520Dysfunction" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24a"><span> <span class="citation_source-journal">Chem. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">355271</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chem.+Abstr.+2005%2C+142%2C+355271."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Abstr.%26date%3D2005%26volume%3D142%26spage%3D355271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Aakeröy, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desper, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valdés-Martinez, J.</span><span> </span><span class="NLM_article-title">Robust Building Blocks for Inorganic Crystal Engineering</span> <span class="citation_source-journal">Inorg. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">359</span><span class="NLM_x">, </span> <span class="NLM_fpage">1255</span><span class="NLM_x">–</span> <span class="NLM_lpage">1262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm3008536&amp;key=10.1016%2Fj.ica.2005.09.051" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=2006&pages=1255-1262&author=C.+B.+Aaker%C3%B6yauthor=J.+Desperauthor=B.+Levinauthor=J.+Vald%C3%A9s-Martinez&title=Robust+Building+Blocks+for+Inorganic+Crystal+Engineering"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.ica.2005.09.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ica.2005.09.051%26sid%3Dliteratum%253Aachs%26aulast%3DAaker%25C3%25B6y%26aufirst%3DC.%2BB.%26aulast%3DDesper%26aufirst%3DJ.%26aulast%3DLevin%26aufirst%3DB.%26aulast%3DVald%25C3%25A9s-Martinez%26aufirst%3DJ.%26atitle%3DRobust%2520Building%2520Blocks%2520for%2520Inorganic%2520Crystal%2520Engineering%26jtitle%3DInorg.%2520Chim.%2520Acta%26date%3D2006%26volume%3D359%26spage%3D1255%26epage%3D1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boñaga, L. V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derian, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damiano, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, B. E.</span><span> </span><span class="NLM_article-title">Novel Bis(indolyl)maleimide Pyridinophosphanes That Are Potent, Selective Inhibitors of Glycogen Synthase Kinase-3</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2863</span><span class="NLM_x">–</span> <span class="NLM_lpage">2868</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2863-2868&author=H.+C.+Zhangauthor=L.+V.+R.+Bo%C3%B1agaauthor=H.+Yeauthor=C.+K.+Derianauthor=B.+P.+Damianoauthor=B.+E.+Maryanoff&title=Novel+Bis%28indolyl%29maleimide+Pyridinophosphanes+That+Are+Potent%2C+Selective+Inhibitors+of+Glycogen+Synthase+Kinase-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%2BC.%26aulast%3DBo%25C3%25B1aga%26aufirst%3DL.%2BV.%2BR.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DDerian%26aufirst%3DC.%2BK.%26aulast%3DDamiano%26aufirst%3DB.%2BP.%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26atitle%3DNovel%2520Bis%2528indolyl%2529maleimide%2520Pyridinophosphanes%2520That%2520Are%2520Potent%252C%2520Selective%2520Inhibitors%2520of%2520Glycogen%2520Synthase%2520Kinase-3%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2863%26epage%3D2868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Targeting Cancer with Small Molecule Kinase Inhibitors</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=16&amp;doi=10.1021%2Fjm3008536&amp;key=10.1038%2Fnrc2559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=8&amp;doi=10.1021%2Fjm3008536&amp;key=19104514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Fjm3008536&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1yg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=28-39&author=J.+Zhangauthor=P.+L.+Yangauthor=N.+S.+Gray&title=Targeting+Cancer+with+Small+Molecule+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer with small molecule kinase inhibitors</span></div><div class="casAuthors">Zhang, Jianming; Yang, Priscilla L.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiol. constraints on growth and survival.  To date, 11 kinase inhibitors have received US Food and Drug Administration approval as cancer treatments, and there are considerable efforts to develop selective small mol. inhibitors for a host of other kinases that are implicated in cancer and other diseases.  Herein we discuss the current challenges in the field, such as designing selective inhibitors and developing strategies to overcome resistance mutations.  This Review provides a broad overview of some of the approaches currently used to discover and characterize new kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriSM3BN_uEz7Vg90H21EOLACvtfcHk0ljloOGici35Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1yg&md5=35bc38f414cd21eef5e61ce181b580fb</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1038%2Fnrc2559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2559%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DP.%2BL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520Cancer%2520with%2520Small%2520Molecule%2520Kinase%2520Inhibitors%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D28%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Jacquemard, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dias, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansiaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailly, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logé, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mérour, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routier, S.</span><span> </span><span class="NLM_article-title">Synthesis of 3,5-Bis(2-indolyl)pyridine and 3-[(2-Indolyl)-5-phenyl]pyridine Derivatives as CDK Inhibitors and Cytotoxic Agents</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4932</span><span class="NLM_x">–</span> <span class="NLM_lpage">4953</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=4932-4953&author=U.+Jacquemardauthor=N.+Diasauthor=A.+Lansiauxauthor=C.+Baillyauthor=C.+Log%C3%A9author=J.-M.+Robertauthor=O.+Lozachauthor=L.+Meijerauthor=J.+Y.+M%C3%A9rourauthor=S.+Routier&title=Synthesis+of+3%2C5-Bis%282-indolyl%29pyridine+and+3-%5B%282-Indolyl%29-5-phenyl%5Dpyridine+Derivatives+as+CDK+Inhibitors+and+Cytotoxic+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacquemard%26aufirst%3DU.%26aulast%3DDias%26aufirst%3DN.%26aulast%3DLansiaux%26aufirst%3DA.%26aulast%3DBailly%26aufirst%3DC.%26aulast%3DLog%25C3%25A9%26aufirst%3DC.%26aulast%3DRobert%26aufirst%3DJ.-M.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DM%25C3%25A9rour%26aufirst%3DJ.%2BY.%26aulast%3DRoutier%26aufirst%3DS.%26atitle%3DSynthesis%2520of%25203%252C5-Bis%25282-indolyl%2529pyridine%2520and%25203-%255B%25282-Indolyl%2529-5-phenyl%255Dpyridine%2520Derivatives%2520as%2520CDK%2520Inhibitors%2520and%2520Cytotoxic%2520Agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D4932%26epage%3D4953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Hoffman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Büchler, M. W..</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schemmer, P.</span><span> </span><span class="NLM_article-title">Sorafenib Modulates the Gene Expression of Multi-drug Resistance Mediating ATP-Binding Cassette Proteins in Experimental Hepatocellular Carcinoma</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">4503</span><span class="NLM_x">–</span> <span class="NLM_lpage">4508</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm3008536&amp;key=21115899" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=4503-4508&author=K.+Hoffmanauthor=C.+Franzauthor=Z.+Xiaoauthor=E.+Mohrauthor=S.+Serbaauthor=M.+W..+B%C3%BCchlerauthor=P.+Schemmer&title=Sorafenib+Modulates+the+Gene+Expression+of+Multi-drug+Resistance+Mediating+ATP-Binding+Cassette+Proteins+in+Experimental+Hepatocellular+Carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoffman%26aufirst%3DK.%26aulast%3DFranz%26aufirst%3DC.%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DMohr%26aufirst%3DE.%26aulast%3DSerba%26aufirst%3DS.%26aulast%3DB%25C3%25BCchler%26aufirst%3DM.%2BW..%26aulast%3DSchemmer%26aufirst%3DP.%26atitle%3DSorafenib%2520Modulates%2520the%2520Gene%2520Expression%2520of%2520Multi-drug%2520Resistance%2520Mediating%2520ATP-Binding%2520Cassette%2520Proteins%2520in%2520Experimental%2520Hepatocellular%2520Carcinoma%26jtitle%3DAnticancer%2520Res.%26date%3D2010%26volume%3D30%26spage%3D4503%26epage%3D4508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Fukuyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niculaita, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obusez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalady, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aung, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sizemore, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuyama, R.</span><span> </span><span class="NLM_article-title">Mutated in colorectal Cancer, A Putative Tumor Suppressor for Serrated Colorectal Cancer, Selectively Represses Beta-Catenin-Dependent Transcription</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">6044</span><span class="NLM_x">–</span> <span class="NLM_lpage">6055</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=6044-6055&author=R.+Fukuyamaauthor=R.+Niculaitaauthor=K.+P.+Ngauthor=E.+Obusezauthor=J.+Sanchezauthor=M.+Kaladyauthor=P.+P.+Aungauthor=G.+Caseyauthor=N.+Sizemoreauthor=R.+Fukuyama&title=Mutated+in+colorectal+Cancer%2C+A+Putative+Tumor+Suppressor+for+Serrated+Colorectal+Cancer%2C+Selectively+Represses+Beta-Catenin-Dependent+Transcription"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFukuyama%26aufirst%3DR.%26aulast%3DNiculaita%26aufirst%3DR.%26aulast%3DNg%26aufirst%3DK.%2BP.%26aulast%3DObusez%26aufirst%3DE.%26aulast%3DSanchez%26aufirst%3DJ.%26aulast%3DKalady%26aufirst%3DM.%26aulast%3DAung%26aufirst%3DP.%2BP.%26aulast%3DCasey%26aufirst%3DG.%26aulast%3DSizemore%26aufirst%3DN.%26aulast%3DFukuyama%26aufirst%3DR.%26atitle%3DMutated%2520in%2520colorectal%2520Cancer%252C%2520A%2520Putative%2520Tumor%2520Suppressor%2520for%2520Serrated%2520Colorectal%2520Cancer%252C%2520Selectively%2520Represses%2520Beta-Catenin-Dependent%2520Transcription%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D6044%26epage%3D6055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Debdab, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreaux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renault, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soundararajan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babault, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahtouh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baratte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenreich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazureau, J.-P.</span><span> </span><span class="NLM_article-title">Leucettines, a Class of Potent Inhibitors of cdc2-like Kinases and Dual Specificity, Tyrosine Phosphorylation Regulated Kinases Derived from the Marine Sponge Leucettamine B. Modulation of Alternative Pre-RNA Splicing</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4172</span><span class="NLM_x">–</span> <span class="NLM_lpage">4186</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200274d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4172-4186&author=M.+Debdabauthor=F.+Carreauxauthor=S.+Renaultauthor=M.+Soundararajanauthor=O.+Fedorovauthor=P.+Filippakopoulosauthor=O.+Lozachauthor=L.+Babaultauthor=T.+Tahtouhauthor=B.+Baratteauthor=Y.+Ogawaauthor=M.+Hagiwaraauthor=A.+Eisenreichauthor=U.+Rauchauthor=S.+Knappauthor=L.+Meijerauthor=J.-P.+Bazureau&title=Leucettines%2C+a+Class+of+Potent+Inhibitors+of+cdc2-like+Kinases+and+Dual+Specificity%2C+Tyrosine+Phosphorylation+Regulated+Kinases+Derived+from+the+Marine+Sponge+Leucettamine+B.+Modulation+of+Alternative+Pre-RNA+Splicing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm200274d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200274d%26sid%3Dliteratum%253Aachs%26aulast%3DDebdab%26aufirst%3DM.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DRenault%26aufirst%3DS.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DBabault%26aufirst%3DL.%26aulast%3DTahtouh%26aufirst%3DT.%26aulast%3DBaratte%26aufirst%3DB.%26aulast%3DOgawa%26aufirst%3DY.%26aulast%3DHagiwara%26aufirst%3DM.%26aulast%3DEisenreich%26aufirst%3DA.%26aulast%3DRauch%26aufirst%3DU.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBazureau%26aufirst%3DJ.-P.%26atitle%3DLeucettines%252C%2520a%2520Class%2520of%2520Potent%2520Inhibitors%2520of%2520cdc2-like%2520Kinases%2520and%2520Dual%2520Specificity%252C%2520Tyrosine%2520Phosphorylation%2520Regulated%2520Kinases%2520Derived%2520from%2520the%2520Marine%2520Sponge%2520Leucettamine%2520B.%2520Modulation%2520of%2520Alternative%2520Pre-RNA%2520Splicing%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4172%26epage%3D4186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Leclerc, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoessel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marko, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibb, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greengard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenbrand, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Indirubins Inhibit Glycogen Synthase Kinase - 3<i>β</i> and CDK5/p25, Two Kinases Involved in Abnormal Tau Phosphorylation in Alzheimer’s Disease - A Property Common to Most CDK Inhibitors?</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=251-260&author=S.+Leclercauthor=M.+Garnierauthor=R.+Hoesselauthor=D.+Markoauthor=J.+A.+Bibbauthor=G.+L.+Snyderauthor=P.+Greengardauthor=J.+Biernatauthor=E.-M.+Mandelkowauthor=G.+Eisenbrandauthor=L.+Meijer&title=Indirubins+Inhibit+Glycogen+Synthase+Kinase+-+3%CE%B2+and+CDK5%2Fp25%2C+Two+Kinases+Involved+in+Abnormal+Tau+Phosphorylation+in+Alzheimer%E2%80%99s+Disease+-+A+Property+Common+to+Most+CDK+Inhibitors%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeclerc%26aufirst%3DS.%26aulast%3DGarnier%26aufirst%3DM.%26aulast%3DHoessel%26aufirst%3DR.%26aulast%3DMarko%26aufirst%3DD.%26aulast%3DBibb%26aufirst%3DJ.%2BA.%26aulast%3DSnyder%26aufirst%3DG.%2BL.%26aulast%3DGreengard%26aufirst%3DP.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.-M.%26aulast%3DEisenbrand%26aufirst%3DG.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DIndirubins%2520Inhibit%2520Glycogen%2520Synthase%2520Kinase%2520-%25203%25CE%25B2%2520and%2520CDK5%252Fp25%252C%2520Two%2520Kinases%2520Involved%2520in%2520Abnormal%2520Tau%2520Phosphorylation%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%2520-%2520A%2520Property%2520Common%2520to%2520Most%2520CDK%2520Inhibitors%253F%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D251%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Primot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baratte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gompel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liabeuf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romette, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costantini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Purification of GSK-3 by Affinity Chromatography on Immobilised Axin</span> <span class="citation_source-journal">Protein Expr. Purif.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">394</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm3008536&amp;key=10.1006%2Fprep.2000.1321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm3008536&amp;key=11087679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm3008536&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotFyqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=394-404&author=A.+Primotauthor=B.+Baratteauthor=M.+Gompelauthor=A.+Borgneauthor=S.+Liabeufauthor=J.+L.+Rometteauthor=F.+Costantiniauthor=L.+Meijer&title=Purification+of+GSK-3+by+Affinity+Chromatography+on+Immobilised+Axin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Purification of GSK-3 by Affinity Chromatography on Immobilized Axin</span></div><div class="casAuthors">Primot, Aline; Baratte, Blandine; Gompel, Marie; Borgne, Annie; Liabeuf, Sylvie; Romette, Jean-Louis; Jho, Eek-hoon; Costantini, Frank; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression and Purification</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">394-404</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Glycogen synthase kinase 3 (GSK-3), an element of the Wnt signalling pathway, plays a key role in numerous cellular processes including cell proliferation, embryonic development, and neuronal functions.  It is directly involved in diseases such as cancer (by controlling apoptosis and the levels of β-catenin and cyclin D1), Alzheimer's disease (tau hyperphosphorylation), and diabetes (as a downstream element of insulin action, GSK-3 regulates glycogen and lipid synthesis).  We describe here a rapid and efficient method for the purifn. of GSK-3 by affinity chromatog. on an immobilized fragment of axin.  Axin is a docking protein which interacts with GSK-3β, β-catenin, phosphatase 2A, and APC.  A polyhistidine-tagged axin peptide (residues 419-672) was produced in Escherichia coli and either immobilized on Ni-NTA agarose beads or purified and immobilized on CNBr-activated Sepharose 4B.  These Axin-His6 matrixes were found to selectively bind recombinant rat GSK-3β and native GSK-3 from yeast, sea urchin embryos, and porcine brain.  The affinity-purified enzymes displayed high kinase activity.  This single step purifn. method provides a convenient tool to follow the status of GSK-3 (protein level, phosphorylation state, kinase activity) under various physiol. settings.  It also provides a simple and efficient way to purify large amts. of active recombinant or native GSK-3 for screening purposes.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotZ_PC6B5jmrVg90H21EOLACvtfcHk0ljN6ZUmVb78Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotFyqsbo%253D&md5=e15577cd02c0fcfa388aa64f9ec544f1</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1006%2Fprep.2000.1321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fprep.2000.1321%26sid%3Dliteratum%253Aachs%26aulast%3DPrimot%26aufirst%3DA.%26aulast%3DBaratte%26aufirst%3DB.%26aulast%3DGompel%26aufirst%3DM.%26aulast%3DBorgne%26aufirst%3DA.%26aulast%3DLiabeuf%26aufirst%3DS.%26aulast%3DRomette%26aufirst%3DJ.%2BL.%26aulast%3DCostantini%26aufirst%3DF.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DPurification%2520of%2520GSK-3%2520by%2520Affinity%2520Chromatography%2520on%2520Immobilised%2520Axin%26jtitle%3DProtein%2520Expr.%2520Purif.%26date%3D2000%26volume%3D20%26spage%3D394%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Reinhardt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferandin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Purification CK1 by Affinity Chromatography on Immobilised Axin</span> <span class="citation_source-journal">Protein Expr. Puri.f</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm3008536&amp;key=10.1016%2Fj.pep.2007.02.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm3008536&amp;key=17434749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm3008536&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslCnt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2007&pages=101-109&author=J.+Reinhardtauthor=Y.+Ferandinauthor=L.+Meijer&title=Purification+CK1+by+Affinity+Chromatography+on+Immobilised+Axin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Purification of CK1 by affinity chromatography on immobilised axin</span></div><div class="casAuthors">Reinhardt, Jens; Ferandin, Yoan; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression and Purification</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-109</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Members of the Casein Kinase 1 (CK1) family are implicated in the regulation of a variety of physiol. processes like development and circadian rhythm, as well as in diseases like cancer and Alzheimer's disease.  From that perspective, CK1 family members are interesting targets for potential chemotherapy.  We describe here a rapid and efficient method for the purifn. of CK1 by affinity chromatog. on an immobilized fragment of axin.  Axin is a scaffolding protein that interacts with a multitude of proteins, amongst them APC, GSK-3, β-catenin, CK1α, δ, and ε, and PP2A.  A GST-tagged axin peptide (residues 495-684) was produced in Escherichia coli and either immobilized on glutathione agarose beads or purified and immobilized on CNBr-activated Sepharose 4B.  These "GST-axin" matrixes were found to selectively bind native CK1α and CK1ε from porcine brain.  The affinity-purified enzymes displayed high kinase activity.  This single step purifn. provides a convenient tool to efficiently purify large amts. of active native CK1 for screening purposes.  This single step purifn. also provides a convenient tool to follow the status of the axin-binding CK1 isoforms α, δ, and ε (protein levels, compn. of isoforms, kinase activity) under different physiol. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojnaZtPudqbbVg90H21EOLACvtfcHk0lj7aPCtS_lJDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslCnt7w%253D&md5=8edde52c867ca4879a797e498fea8797</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.pep.2007.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pep.2007.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DReinhardt%26aufirst%3DJ.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DPurification%2520CK1%2520by%2520Affinity%2520Chromatography%2520on%2520Immobilised%2520Axin%26jtitle%3DProtein%2520Expr.%2520Puri.f%26date%3D2007%26volume%3D54%26spage%3D101%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span>Maestro, version 9.3, Glide, version 5.8, <span class="NLM_publisher-name">Schrödinger, LLC</span>, <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro%2C+version+9.3%2C+Glide%2C+version+5.8%2C+Schr%C3%B6dinger%2C+LLC%2C+New+York%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><a href="http://www.rcsb.org/pdb/home/home.do" class="extLink">http://www.rcsb.org/pdb/home/home.do</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.rcsb.org%2Fpdb%2Fhome%2Fhome.do."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36a"><span><span class="NLM_label">(a) </span>Marvin 5.8.0,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">, </span>ChemAxon (<a href="http://www.chemaxon.com" class="extLink">http://www.chemaxon.com</a>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Marvin+5.8.0%2C+2012%2C+ChemAxon+%28http%3A%2F%2Fwww.chemaxon.com%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2012%26jtitle%3DChemAxon" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit36b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sadowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasteiger, J.</span><span> </span><span class="NLM_article-title">From Atoms and Bonds to Three-Dimensional Atomic Coordinates: Automatic Model Builders</span> <span class="citation_source-journal">Chem. Reviews</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">2567</span><span class="NLM_x">–</span> <span class="NLM_lpage">2581</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr00023a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=32&amp;doi=10.1021%2Fjm3008536&amp;key=1%3ACAS%3A528%3ADyaK3sXmt1GgsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1993&pages=2567-2581&author=J.+Sadowskiauthor=J.+Gasteiger&title=From+Atoms+and+Bonds+to+Three-Dimensional+Atomic+Coordinates%3A+Automatic+Model+Builders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36bR"><div class="casContent"><span class="casTitleNuber">36b</span><div class="casTitle"><span class="NLM_cas:atitle">From atoms and bonds to three-dimensional atomic coordinates: automatic model builders</span></div><div class="casAuthors">Sadowski, Jens; Gasteiger, Johann</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2567-81</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    </div><div class="casAbstract">A review with ∼75 refs. in which WIZARD, COBRA, CONCORD, and CORINA are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbdmHfCX7f77Vg90H21EOLACvtfcHk0lj7aPCtS_lJDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmt1GgsLs%253D&md5=fcdb50dfbd981c8f122da06e06e62e27</span></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=10.1021%2Fcr00023a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00023a012%26sid%3Dliteratum%253Aachs%26aulast%3DSadowski%26aufirst%3DJ.%26aulast%3DGasteiger%26aufirst%3DJ.%26atitle%3DFrom%2520Atoms%2520and%2520Bonds%2520to%2520Three-Dimensional%2520Atomic%2520Coordinates%253A%2520Automatic%2520Model%2520Builders%26jtitle%3DChem.%2520Reviews%26date%3D1993%26volume%3D93%26spage%3D2567%26epage%3D2581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit36c"><span><span class="NLM_label">(c) </span><a href="http://www.molecular-networks.com/products/corina" class="extLink">http://www.molecular-networks.com/products/corina</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.molecular-networks.com%2Fproducts%2Fcorina."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OW3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OW3','PDB','2OW3'); return false;">PDB: 2OW3</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i78"><a href="/doi/suppl/10.1021/jm3008536">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_87233"></div></div></div></div></div><hr /></hr><p class="last">Additional characterization for compounds <b>2</b>–<b>45</b>, supplementary Table 1, Discoverx KinomeScan Selectivity Panel, and the <sup>1</sup>H and <sup>13</sup> C NMR spectra for compounds <b>2</b>–<b>45</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3008536/suppl_file/jm3008536_si_001.pdf">jm3008536_si_001.pdf (8.14 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm3008536&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-22%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm3008536" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm3008536" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799ee5a5c503d76","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
